EP-Web Catalog CRS
Uploaded by
ramaiaEP-Web Catalog CRS
Uploaded by
ramaiaList of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0001561 Abacavir sulfate
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
20 mg
1
Information
Monograph Leaflet
2589
Storage
+5C 3C
Extra
Price
charges
79
a
Y0001551 Abacavir for system suitability
10 mg
2589
Yes
+5C 3C
79
Y0001552 Abacavir for peak identification
10 mg
2589
Yes
+5C 3C
79
Y0000055 Acamprosate calcium - reference spectrum
n/a
79
Y0000116 Acamprosate impurity A
50 mg
3-aminopropane-1-sulphonic acid
1585
+5C 3C
79
Y0000500 Acarbose
94.7 mg
94.7 mg CHNO
2089
+5C 3C
79
Y0000354 Acarbose for identification
10 mg
2089
+5C 3C
79
Y0000427 Acarbose for peak identification
20 mg
A0040000 Acebutolol hydrochloride
50 mg
Y0000359 Acebutolol impurity B
10 mg
-[3-acetyl-4-[(2RS)-2-hydroxy-3-[(1-methylethyl)amino]
acetamide (diacetolol)
Y0000127 Acebutolol impurity C
20 mg
N-(3-acetyl-4-hydroxyphenyl)butanamide
Y0000128 Acebutolol impurity I
0.004 mg
N-[3-acetyl-4-[(2RS)-3-(ethylamino)-2-hydroxypropoxy]phenyl]
butanamide
Y0000056 Aceclofenac - reference spectrum
n/a
Y0001094 Aceclofenac for peak identification
10 mg
Y0000085 Aceclofenac impurity F
20 mg
benzyl[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetate ; Batch 1 is
valid until 31 March 2014
1281
Y0000086 Aceclofenac impurity H
10 mg
[[[[[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetyl] oxy]acetyl]oxy]
acetic acid
1281
Y0000810 Acemetacin
100 mg
1686
Y0000811 Acemetacin impurity A
10 mg
Y0000842 Acemetacine impurity mixture
0.06 mg
A0070000 Acesulfame potassium
50 mg
A0070020 Acesulfame potassium impurity B
15 mg
A0100000 Acetazolamide
100 mg
Y0001084 Acetazolamide for system suitability
0.0068 mg
0454
Y0000002 Acetylcholine chloride
50 mg
1485,1971
A0150000 Acetylcysteine
50 mg
A0152000 Acetylcysteine impurity C
10 mg
88.5% CHNOS; N,N'-diacetyl-L-cystine
0967
A0153000 Acetylcysteine impurity D
10 mg
N,-diacetyl-L-cysteine
Y0000565 -Acetyldigoxin
50 mg
98.6% CHO
Y0000642 -Acetyldigoxin for peak identification
10 mg
2168
A0200000 Acetylsalicylic acid
15 mg
0309, 2812
Y0001460 Acetylsalicylic acid for peak identification
10.26 mg
0309
A0208000 N-Acetyltryptophan
125 mg
1383
200 mg
A0202000 N-Acetyltyrosine
Council of Europe, all rights reserved 2014
1585
2089
Batch 1 is valid until 1 May 2013
propoxy]phenyl]
+5C 3C
79
0871
Yes
+5C 3C
79
0871
+5C 3C
79
0871
+5C 3C
79
0871
+5C 3C
79
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
1281
1281
Yes
1686
4-chlorobenzoic acid
1686
+5C 3C
79
Yes
+5C 3C
79
+5C 3C
79
Yes
+5C 3C
79
+5C 3C
79
1282
5-chloro-6-methyl-1,2,3-oxathiazin-4(3)-one 2,2-dioxide ; Batch 3 is valid
until 31 August 2013
1282
0454
Yes
+5C 3C
79
-20C 5C
79
+5C 3C
79
+5C 3C
79
0967
+5C 3C
79
2168
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
0967
Yes
Yes
Yes
79
1384
+5C 3C
a
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0001462 Acetylsulfadiazine
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
0.002 mg 1
Information
Monograph Leaflet
0294
Y0000693 Acholeplasma laidlawii BRP
1 ml
20607
A0220000 Aciclovir
75 mg
0968
Y0001271 Aciclovir for peak identification 1
0.303 mg
0968
Y0001269 Aciclovir for peak identification 2
0.004 mg
0968
Y0001264 Aciclovir for system suitability
10 mg
A0225000 Acitretin
100 mg
Y0001464 Actaea racemosa dry extract for system suitability HRS
1200 mg
Y0001543 Actaea racemosa for assay CRS
300 mg
Y0001463 Actaea racemosa HRS
1200 mg
Y0001121 Adapalene
100 mg
99.9% CHO
2445
Y0001120 Adapalene impurity C
6 mg
1-[2-(methyloxy)phenyl]tricyclo[3.3.1.1]decane
2445
Y0001119 Adapalene for peak identification
2.022 mg
2445
A0230000 Adenine
50 mg
A0230200 Adenosine
50 mg
Y0000110 Adipic acid
50 mg
Y0000882 Adrenaline
5 mg
A0300000 Adrenaline tartrate
Y0000740 Adrenaline impurity mixture
Y0000707 Adrenaline tartrate with impurity A
Y0000883 Adrenaline with impurity F
Y0000728 Agnus castus fruit standardised dry extract
Storage
+5C 3C
Yes
Extra
Price
charges
79
a
-80C 10C
120
+5C 3C
79
Yes
+5C 3C
79
Yes
+5C 3C
79
+5C 3C
79
1385
Yes
+5C 3C
g(b)
79
2069
Yes
-20C 5C
79
2069
Yes
+5C 3C
79
2069
Yes
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
0800,1486
+5C 3C
79
1486
+5C 3C
79
1586
+5C 3C
79
2303
+5C 3C
79
100 mg
0254, 0285,
0732
+5C 3C
79
0.005 mg
0254,2303
Yes
+5C 3C
79
15 mg
0254
Yes
+5C 3C
79
10 mg
2303
Yes
+5C 3C
79
200 mg
2147
Yes
-20C 5C
79
A0325000 Alanine
60 mg
0614,0752
+5C 3C
79
A0325100 Albendazole
50 mg
1386
+5C 3C
79
A0325200 Alcuronium chloride
50 mg
A0325450 Alfacalcidol
5 mg
Y0001601 Alfacalcidol for system suitability
2.5 mg
A0325451 Alfacalcidol - reference spectrum
n/a
A1225000 Alfadex
150 mg
A0325500 Alfentanil hydrochloride - reference spectrum
n/a
1062
A0325800 Alfuzosin hydrochloride
10 mg
1287
Y0001581 Alimemazine for system suitability
5 mg
Y0000832 Alfuzosin for system suitability
10 mg
1287
Y0001583 Alimemazine hemitartrate
15 mg
2650
A0349000 Allantoin
60 mg
1288
Council of Europe, all rights reserved 2014
0968
99.7% CHO
74.7% CHNO; Monoammonium glycyrrhizate
0.13% CHO
Yes
1285
-20C 5C
g(c)
79
1286
Yes
-20C 5C
e(d)
300
1286
Yes
-20C 5C
e(d)
79
1286
79
79
79
99.8% CHO
89.7% [CH0]
1070,1487
+5C 3C
+5C 3C
79
Yes
+5C 3C
79
Yes
+5C 3C
79
+5C 3C
79
+5C 3C
79
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Code
A0350000 Allopurinol
Reference Standard
A0350010 Allopurinol impurity A
Effective from 2014/1/2
Batch n Quantity Sale
Information
per vial Unit
2
100 mg
1 99.9% CHNO
2
10 mg
1 5-amino-1H-pyrazole-4-carboxamide
Monograph Leaflet
0576
Storage
Yes
+5C 3C
+5C 3C
79
C2250000 Clindamycin hydrochloride
200 mg
94.4% CHClNOS
0582,0583,0
996
Yes
+5C 3C
79
C2269000 Clindamycin phosphate
250 mg
95.7% CHClNOPS
0996
Yes
+5C 3C
79
A0350020 Allopurinol impurity B
10 mg
5-formylamino-1H-pyrazole-4-carboxamide
0576
+5C 3C
79
A0350030 Allopurinol impurity C
10 mg
5-(4H-1,2,4-triazol-4-yl)-1H-pyrazole-4-carboxamide ; Batch 2 is valid until 1
May 2013
0576
+5C 3C
79
A0350040 Allopurinol impurity D
15 mg
ethyl 5-amino-1H-pyrazole-4-carboxylate
0576
+5C 3C
79
G0400000 Glycerol (85 per cent) - reference spectrum
n/a
79
A0350050 Allopurinol impurity E
20 mg
+5C 3C
79
A0351000 Allylstrychnine bromide
10 mg
H0215000 Hepatitis C Virus RNA for NAT testing BRP
40 mg
HCV-RNA content 500 IU per vial; For plasma pool testing by NAT
Y0000235 Almagate
25 mg
13.4% carbonic acid
Y0000255 Almagate - reference spectrum
n/a
2010
A0357000 Alprazolam - * psy
100 mg
1065
A0360000 Alprenolol hydrochloride
100 mg
Y0000054 Alprostadil
50 mg
99.4% CHO ; Batch 1 is valid until 31 January 2013
Y0000606 Altizide
150 mg
99.9% CHClNOS
Y0000843 Altizide impurity B
15 mg
3-[(2,2-dimethoxyethyl)sulphanyl]prop-1-ene
Y0000687 Alverine citrate
5 mg
Y0000595 Alverine for peak identification
0.125 mg
Batch 1 is valid until 31 December 2013
2156
Y0000607 Alverine impurity D
10 mg
N-(3-cyclohexylpropyl)-N-ethyl-3-phenylpropan-1-amine
A0363000 Amantadine hydrochloride
100 mg
A0363700 Ambroxol hydrochloride
125 mg
A0900000 Amfetamine sulfate - reference spectrum
n/a
A0365000 Amidotrizoic acid dihydrate
Y0001461 Amidotrizoic acid for system suitability
A0368000 Amikacin
200 mg
See leaflet ; Batch 2 is valid until 28 February 2013
Y0001467 Amikacin impurity I
20 mg
(2S)-4-amino-2-hydroxybutanoic acid
1290
A0365900 Amikacin sulfate
200 mg
The batch 3 is not suitable for use in the assay in monograph 1290:07/2012.
Amikacin CRS A0368000 is also needed. See leaflet.
1290
Y0001117 Amikacin for system suitability
10 mg
amikacin for system suitability CRS 1 is suitable for 01/2010:1289 and
01/2010:1290 only. Batch 2 is suitable for 07/2012:1289 and 07/2012:1290.
1289,1290
100 mg
Batch 1 is valid until 31 May 2014
20 mg
methyl-3,5-diamino-6-chloropyrazine-2-carboxylate ; Batch 2 is valid until 31
August 2013
New A0370000 Amiloride hydrochloride
Y0000020 Amiloride impurity A
Council of Europe, all rights reserved 2014
0576
Extra
Price
charges
79
g
0496,0497
0576
ethyl 5-(formylamino)-1H-pyrazole-4-carboxylate
1285
See leaflet,
20621
Yes
2010
-20C 5C
g(c)
79
-20C 5C
e(d)
242
+5C 3C
79
79
79
+5C 3C
0628,0876
+5C 3C
79
1488
Yes
-20C 5C
g(c)
79
0370,2185
Yes
+5C 3C
79
+5C 3C
79
2185
2156
+5C 3C
79
-20C 5C
79
2156
+5C 3C
79
0463
+5C 3C
79
1489
+5C 3C
79
0368
79
100 mg
0873
+5C 3C
79
0.08 mg
0873
Yes
+5C 3C
79
1289,1290
Yes
+5C 3C
79
+5C 3C
79
Yes
+5C 3C
79
Yes
+5C 3C
79
0651
+5C 3C
79
0651
+5C 3C
79
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0000173 4-Aminobenzoic acid
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
2
60 mg
1
Information
Monograph Leaflet
Storage
1687
+5C 3C
A0420000 Aminocaproic acid
50 mg
A0460000 7-Aminodesacetoxycephalosporanic acid
20 mg
A0496000 Aminoglutethimide
125 mg
A0496005 Aminoglutethimide impurity A
20 mg
(3)-3-(3-aminophenyl)-3-ethylpiperidine-2,6-dione; (3-aminoglutethimide)
A0496020 Aminoglutethimide impurity D
10 mg
3,3'-[diazenediyldi(4,1-phenylene)]bis(3-ethylpiperidine-2,6-dione);
(azoglutethimide)
A0575000 Amiodarone hydrochloride
100 mg
Y0000129 Amiodarone impurity D
20 mg
(2-butyl-benzofuran-3-yl)-(4-hydroxy-3,5-diiodophenyl)methanone
Y0000130 Amiodarone impurity E
20 mg
(2-butylbenzofuran-3-yl)(4-hydroxyphenyl)methanone
A0590000 Amisulpride
10 mg
Y0001534 Amisulpride for system suitability
1.0015 mg
1490
Y0000563 Amitriptyline hydrochloride
10 mg
0464
Y0000049 Amlodipine besilate
150 mg
99.7% CHClNOS
1491
Y0001067 Amlodipine for peak identification
15 mg
Batch 1 is valid until 31 August 2013
1491
Y0001068 Amlodipine impurity A
15 mg
3-ethyl 5-methyl (4RS)-4-(2-chlorophenyl)-2-[[2-(1,3-dioxo-1,3-dihydro-2Hisoindol-2-yl)ethoxy]methyl]-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate ;
Batch 1 is valid until 1 June 2013
1491
Y0001069 Amlodipine impurity B
15 mg
3-ethyl 5-methyl (4RS)-4-(2-chlorophenyl)-6-methyl-2-[[2-[[2(methylcarbamoyl)benzoyl]amino]ethoxy]methyl]-1,4-dihydropyridine-3,5dicarboxylate ; Batch 1 is valid until 30 November 2013
Y0001070 Amlodipine impurity G
15 mg
dimethyl 4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5dicarboxylate ; Batch 1 is valid until 1 June 2013
Y0000302 Ammonio methacrylate copolymer(type A) - reference
spectrum
n/a
Y0000303 Ammonio methacrylate copolymer(type B) - reference
spectrum
n/a
A0650000 Amobarbital - * psy
A0700000 Amobarbital sodium - * psy
A0800000 Amoxicillin trihydrate
Extra
Price
charges
79
a
0874
+5C 3C
79
0708,0813
+5C 3C
79
1291
+5C 3C
79
1291
+5C 3C
79
1291
+5C 3C
79
0803
+5C 3C
g(b)
79
0803
+5C 3C
79
0803
+5C 3C
79
1490
+5C 3C
79
+5C 3C
79
+5C 3C
79
Yes
+5C 3C
79
Yes
+5C 3C
79
Yes
+5C 3C
79
1491
+5C 3C
79
1491
+5C 3C
79
2081
79
2082
79
500 mg
0594
+5C 3C
79
500 mg
0166
+5C 3C
79
200 mg
86.2% CHNOS
0167,0168,0
260,
0577,0578,0
813,
1140,1653
+5C 3C
79
Y0001521 Amoxicillin trihydrate for performance verification
5000 mg
Instructions
Yes
+5C 3C
79
Y0000005 Amphotericin B
100 mg
Batch 4 is not suitable for microbiological assay (see leaflet).
1292
Yes
-20C 5C
79
Y0001014 Amphotericin B for peak identification
10 mg
Batch 1 is valid until 1 June 2013
1292
Yes
-20C 5C
79
Y0001361 Amphotericin B for microbiological assay
100 mg
944 IU per mg
20702
Yes
-20C 5C
79
Council of Europe, all rights reserved 2014
Cefadroxyl impurity B
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
A1000000 Ampicillin (anhydrous)
Effective from 2014/1/2
Batch n Quantity Sale
Information
per vial Unit
5
220 mg
1 97.7% CHNOS ; Batch 4 is valid until 31 December 2013
Monograph Leaflet
0167,0168,0
578,
1168,1169
A1100000 Ampicillin trihydrate
150 mg
Y0001522 Anastrozole
100 mg
100.0% CHN
2406
Y0001531 Anastrozole impurity E
10 mg
2,2'-[5-(hydroxymethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile)
2406
Y0001386 Angelica dahuria root
160 mg
A1200000 Anhydrotetracycline hydrochloride
15 mg
See leaflet
Y0001244 Amylmetacresol
285 mg
99.5% CHO
Y0001245 Amylmetacresol for peak identification
10 mg
Y0001466 Anhydrous Docetaxel
15 mg
A1210000 Antazoline hydrochloride
50 mg
A1220000 Alpha-apo-oxytetracycline
20 mg
Y0001465 Apomorphine hydrochloride hemihydrate
15 mg
Y0001471 Apomorphine impurity B (morphine sulfate) * - narc
40 mg
88.2% CHNOS,5HO; morphine sulfate
A1230000 Beta-apo-oxytetracycline
20 mg
88,0% CHNO
A1250000 Aprotinin solution BRP
0.5 ml
22.3 Ph. Eur. Units per ml
Y0001154 Aprotinin for system suitability
2.7 mg
A1269000 L-Arabinitol
10 mg
Y0000806 Arbutin
100 mg
93.5% CHO
1054
A1270000 Arginine
50 mg
99.8% CHNO
0806,0930,1
654,
2114,2566
Y0000304 Arginine aspartate
0168,0260,0
577,
0578,0808,2
211, 2212
Yes
+5C 3C
Extra
Price
charges
79
a
+5C 3C
79
+5C 3C
79
+5C 3C
79
2556
Yes
+5C 3C
79
0210,0211,1
654
Yes
+5C 3C
79
2405
Yes
+5C 3C
79
2405
Yes
+5C 3C
79
2593
+5C 3C
79
+5C 3C
79
+5C 3C
79
0972
0198
Batch 4 is valid until 31 December 2013
Yes
0136
+5C 3C
79
0136
Yes
+5C 3C
90
0198
Yes
+5C 3C
79
0579,0580
Yes
+5C 3C
79
0580
Yes
+5C 3C
79
1381
+5C 3C
79
Yes
+5C 3C
79
Yes
+5C 3C
79
2096
+5C 3C
79
0805,0885,0
998
+5C 3C
79
+5C 3C
79
+5C 3C
79
20 mg
New A1271000 Arginine hydrochloride
60 mg
Batch 2 is valid until 30 April 2014
New Y0001649 Aripiprazole
170 mg
See leaflet
2617
New Y0001650 Aripiprazole impurity F
10 mg
7-[4-[4-(2,3-dichlorophenyl)-1-oxidopiperazin-1-yl]-3,4-dihydroquinolein-2
(1H)-one
2617
Y0001323 Aristolochia
140 mg
Y0001185 Aristolochic acid I
1 mg
Y0001175 Aristolocholic acid for system suitability
1 mg
Y0000079 Articaine hydrochloride
100 mg
Y0000080 Articaine impurity A
15 mg
Council of Europe, all rights reserved 2014
Yes
Storage
Yes
20821
Yes
+5C 3C
79
20821
Yes
+5C 3C
79
20821
Yes
+5C 3C
79
1688
+5C 3C
79
1688
+5C 3C
79
1.00 mg CHNO
methyl3-[[2-(propylamino)acetyl]amino]-4-methylthiophene-2- carboxylate
5
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0000081 Articaine impurity E
Effective from 2014/1/2
Batch n Quantity Sale
Information
per vial Unit
1
10 mg
1 methyl 4-methyl-3-[[(2RS)-2-[(1-methylethyl)amino]propanoyl]amino]
thiophene-2-carboxylate
Monograph Leaflet
Storage
Extra
Price
charges
79
a
1688
+5C 3C
0253,0958,1
791
+5C 3C
79
A1300000 Ascorbic acid
100 mg
Vitamin C
Y0001024 Ascorbic acid impurity C
20 mg
D-xylo-hex-2-ulosonic acid (D-sorbosonic acid)
0253,1791
+5C 3C
79
Y0001170 Ascorbic acid impurity D
10 mg
methyl D-xylo-hex-2-ulosonate (methyl D-sorbosonate)
0253,1791
+5C 3C
79
Y0000800 Ascorbyl palmitate
10 mg
0807
+5C 3C
79
Y0000305 Asparagine monohydrate
60 mg
2086
+5C 3C
79
A1320000 Aspartame
40 mg
0973
+5C 3C
79
A1321000 Aspartame impurity A
10 mg
A1330000 Aspartic acid
50 mg
Y0001171 Astragaloside IV
40 mg
A1340000 Atenolol
100 mg
Y0001089 Atenolol for system suitability
5 mg
0703
Y0001587 Atomoxetine for impurity A identification
10 mg
N-methyl-3-phenoxy-3-phenylpropan-1-amine
2640
Y0001586 Atomoxetine hydrochloride
110 mg
99,9% CHClNO
2640
Yes
Y0001588 Atomoxetine impurity B
10 mg
(3S)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1amine
2640
Y0001589 Atomoxetine impurity D
5 mg
(3R)-N-methyl-3-(3-methylphenoxy)-3-phenylpropan-1amine
2640
Y0001327 Atorvastatin calcium trihydrate
150 mg
95.3% CHCaFNO ; Batch 1 is valid until 30 November 2013
2191
Y0001328 Atorvastatin impurity A
10 mg
desfluoroatorvastatin ; Batch 1 is valid until 31 January 2014
Y0001329 Atorvastatin impurity B
10 mg
3-epi-atorvastatin ; Batch 1 is valid until 30 November 2013
Y0001330 Atorvastatin impurity C
10 mg
fluoroatorvastatin
Y0001331 Atorvastatin impurity D
10 mg
3-[(4-fluorophenyl)carbonyl]-2-(2-methylpropanoyl)-N,3-diphenyloxirane-2carboxamide ; Batch 1 is valid until 31 August 2013
Y0001332 Atorvastatin impurity E
10 mg
Y0001572 Atovaquone
270 mg
Y0001573 Atovaquone for system suitability
10 mg
Y0000424 Atracurium besilate
120 mg
98.5% CHNOS
Y0000105 Rutoside trihydrate
100 mg
87.6% CHO
Y0000503 Atracurium for impurity F identification
5 mg
Y0000504 Atracurium for peak identification
5 mg
Y0000878 Atropine
30 mg
Y0000845 Atropine for peak identification
0.25 mg
Council of Europe, all rights reserved 2014
0973
+5C 3C
79
0750,0797
+5C 3C
79
2435
-20C 5C
79
0703
+5C 3C
79
Yes
+5C 3C
79
Yes
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
2191
+5C 3C
79
2191
+5C 3C
79
2191
+5C 3C
79
2191
+5C 3C
79
ent-atorvastatin ; Batch 1 is valid until 28 February 2013
2191
+5C 3C
79
99.3% CHClO
2192
Yes
+5C 3C
79
2192
Yes
+5C 3C
79
2-(5-benzyl-3,6-dioxopiperazin-2-yl) acetic acid (diketopiperazine)
97.8% CHO
Yes
1970
Yes
+5C 3C
g(b)
79
1795,1874,2
184,
2427,2639
Yes
+5C 3C
79
1970
Yes
+5C 3C
g(b)
79
1970
Yes
+5C 3C
g(b)
79
+5C 3C
79
+5C 3C
79
2056
Batch 1 is valid until 31 January 2013
0068,2056
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0000816 Atropine impurity B
Effective from 2014/1/2
Batch n Quantity Sale
Information
per vial Unit
1
10 mg
1 (1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl (2RS)-3-hydroxy-2-phenylpropanoate
(noratropine)
A1400000 Atropine sulfate
Y0000029 Azaperone
A1500000 Azathioprine
Monograph Leaflet
Storage
Extra
Price
charges
79
g
0068,2056
+5C 3C
0068
+5C 3C
79
20 mg
50 mg
1708
+5C 3C
79
100 mg
0369
+5C 3C
79
Y0001240 Azathioprine impurity A
10 mg
1-methyl-4-nitro-1H-imidazol-5-amine
0369
+5C 3C
79
Y0001246 Azathioprine impurity G
5 mg
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purin-2-amine
(thiamiprine)
0369
+5C 3C
79
Y0000326 Azelastine hydrochloride
25 mg
1633
+5C 3C
79
Y0000327 Azelastine impurity B
5 mg
1-benzoyl-2-[(4RS)-1-methylhexahydro-1H-azepin-4-yl]diazane
1633
+5C 3C
79
Y0000328 Azelastine impurity D
5 mg
4-(4-chlorobenzyl)phthalazin-1(2H)-one
1633
+5C 3C
79
Y0000329 Azelastine impurity E
5 mg
3-(4-chlorobenzilidene)isobenzofuran-1(3H)-one
1633
+5C 3C
79
Y0000306 Azithromycin
200 mg
94.4% CHNO ; Batch 3 is valid until 31 December 2013
1649
Yes
+5C 3C
79
Y0000637 Azithromycin for peak identification
15 mg
1649
Yes
+5C 3C
79
Y0000641 Azithromycin for system suitability
0.05 mg
Batch 5 is valid until 31 October 2013
1649
Yes
+5C 3C
79
Y0000307 Azithromycin impurity A
10 mg
6-demethylazithromycin
+5C 3C
79
Y0000285 B19 virus DNA for NAT testing BRP
150 mg
B19 virus DNA content log 5.8 IU per ml for plasma pool testing by NAT
Yes
-20C 5C
e(d)
242
B0070000 Bacampicillin hydrochloride
120 mg
92.9% CHClNOS
+5C 3C
79
B0100000 Bacitracin zinc
150 mg
62.9 IU per mg
Yes
-20C 5C
79
B0200000 Baclofen
50 mg
+5C 3C
79
B0200050 Baclofen impurity A
50 mg
91.4% CHClNO; (4RS)-4-(4-chlorophenyl)pyrrolidin-2-one ; Batch 2 is
valid until 31 January 2013
0653
Yes
+5C 3C
79
Y0001273 Baicalin
10 mg
88.5% CHO
2438
Yes
+5C 3C
79
B0250000 Bambuterol hydrochloride
100 mg
1293
+5C 3C
79
B0300000 Barbital - * psy
500 mg
0170
+5C 3C
79
Y0001525 Basic butylated methacrylate copolymer
20 mg
1975
+5C 3C
79
Y0000295 Basic butylated methacrylate copolymer -reference
spectrum
n/a
1975
79
B0305000 Beclometasone dipropionate anhydrous
150 mg
+5C 3C
79
Y0000351 Beclometasone dipropionate monohydrate
10 mg
Y0000352 Beclometasone dipropionate for system suitability
15 mg
Y0000469 Beclometasone dipropionate for peak identification
10 mg
0.052 mg
110 mg
New Y0001073 Beclometasone dipropionate impurities F and N
Y0001607 Belamcanda chinensis rhizome HRS
Council of Europe, all rights reserved 2014
Batch 3 is valid until 31 August 2013
1649
See leaflet,
0557,
1527,1646
0808,0852
0465,0466,2
0702
0653
Yes
99.2% CHClO ; Batch 3 is valid until 1 June 2013
0654,1449,
1709
Yes
+5C 3C
79
Batch 2 is valid until 28 February 2013
0654,1709
Yes
+5C 3C
79
0654,1709
Yes
+5C 3C
79
0654,1709
Yes
+5C 3C
79
2561
Yes
+5C 3C
79
1709
Batch 1 is valid until 30 April 2014
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0001025 Benazepril hydrochloride
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
160 mg
1 99.5 % CHClNO
Information
Monograph Leaflet
2388
Y0001038 Benazepril for system suitability
0.016 mg
Y0001026 Benazepril impurity A
10 mg
B0400000 Bendroflumethiazide
100 mg
Y0000564 Bendroflumethiazide impurity A
5 mg
B0470000 Benperidol
100 mg
B0477000 Benserazide hydrochloride
50 mg
1173
B0477010 Benserazide impurity A
20 mg
(2RS)-2-amino-3-hydroxypropanohydrazide
Y0001071 Benserazide impurity C
10 mg
(2RS)-2-amino-3-hydroxy-2'-[(1EZ)-(2,3,4-trihydroxybenzylidene)]
propanohydrazide
Y0001079 Benserazide for peak identification
10 mg
1173
Y0001064 Benzaldehyde
150 mg
Y0001060 Benzalkonium chloride for system suitability
20 mg
B0490000 Benzarone
10 mg
(2-ethylbenzofuran-3-yl)(4-hydroxyphenyl)methanone
1393
B0500000 Benzathine benzylpenicillin
200 mg
90.7% CHNOS
24.1% CHN (N,N'-dibenzylethylenediamine)
0373
Y0000775 Benzbromarone
10 mg
B0550000 Benzethonium chloride
100 mg
B0600000 Benzocaine
50 mg
Y0001470 Benzoic acid
Y0000647 Benzophenone
Y0000167 Benzyl alcohol
B0670000 Benzyl benzoate - reference spectrum
B0680000 S-Benzylmercaptoacetyltriglycin
+5C 3C
+5C 3C
79
+5C 3C
79
0370
+5C 3C
79
0370
+5C 3C
79
1010,1172,1
254, 1708
+5C 3C
79
+5C 3C
79
1173
+5C 3C
79
1173
+5C 3C
79
Yes
+5C 3C
79
0372,0371
Yes
+5C 3C
79
0371,0372
Yes
+5C 3C
79
+5C 3C
79
Yes
+5C 3C
79
1393
+5C 3C
79
0974
+5C 3C
79
0011,1088
+5C 3C
79
30 mg
0934
+5C 3C
79
40 mg
1784
+5C 3C
79
50 mg
+5C 3C
79
n/a
0705
79
10 mg
1372
+5C 3C
79
B0700000 Benzylpenicillin potassium
100 mg
0113,0148,0
149
+5C 3C
79
B0900000 Benzylpenicillin sodium
200 mg
99.4% CHNNaOS; Penicillin G sodium
+5C 3C
79
Y0001149 Berberine chloride
20 mg
84.3% CHClNO
B0950000 Betadex
200 mg
88.4% [CHO]
Y0000391 Betahistine dihydrochloride
50 mg
B0990000 Betahistine mesilate
100 mg
B1000000 Betamethasone
75 mg
[(3R)-3-[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2-oxo-2,3,4,5tetrahydro-1H-1-benzazepin-1-yl]acetic acid
4-amino-6-(trifluoromethyl)benzene-1,3-disulphonamide
0256,0371,0
372,1827
See leaflet
Yes
Extra
Price
charges
79
a
2388
Council of Europe, all rights reserved 2014
2388
Storage
Yes
0113,0114,0
148, 0149
Yes
1831,2500
Yes
+5C 3C
79
1070,1487,1
804
+5C 3C
79
1665
+5C 3C
79
1071
+5C 3C
79
0312,0354,0
388,
0561,0811
+5C 3C
79
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
B1030000 Betamethasone acetate
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
2
100 mg
1
B1040000 Betamethasone dipropionate
150 mg
Y0001416 Betamethasone dipropionate for peak identification
10 mg
Y0001418 Betamethasone dipropionate for system suitability
10 mg
B1045000 Betamethasone sodium phosphate
B1054000 Betamethasone 17-valerate
B1055000 Betamethasone 21-valerate
Y0001027 Betamethasone valerate for system suitability
Information
Monograph Leaflet
0548,0975
Storage
+5C 3C
Extra
Price
charges
79
g
0809
Yes
+5C 3C
79
0809
Yes
+5C 3C
79
0809
Yes
+5C 3C
79
100 mg
0549,0810
+5C 3C
79
100 mg
0322,0811
+5C 3C
79
15 mg
0811
+5C 3C
79
25 mg
0811
+5C 3C
79
Y0001065 Betamethasone valerate impurity mixture
0.018 mg
0811
+5C 3C
79
B1103000 Betaxolol hydrochloride
60 mg
Batch 1 is valid until 1 June 2013
1072
+5C 3C
79
Y0001615 Beta-sitosterol
25 mg
72.5% CHO
2579
-20C 5C
79
B1103100 Betaxolol impurity A
10 mg
(2RS)-1-(4-ethylphenoxy)-3-[(1-methylethyl)amino]propan-2-ol
1072
+5C 3C
79
Y0001354 Betaxolol impurity C
5 mg
2-[[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]methyl]oxirane
1072
-20C 5C
79
Y0001360 Betaxolol for peak identification
15 mg
+5C 3C
79
B1115000 Bezafibrate
100 mg
Y0001444 Bicalutamide
100 mg
Y0001448 Bicalutamide for system suitability
15 mg
Y0001078 Bicisate labelling kit
24 mg
B1110000 Bifonazole
Y0001421 Bifonazole for system suitability
Y0001059 Bilberry dry extract
B1116000 Biotin
99.5% CHFO; Betamethasone dipropionate CRS 2 is suitable for
monograph 01/008:0809 only.
1072
Yes
Yes
Yes
1394
+5C 3C
79
2196
Yes
+5C 3C
79
2196
Yes
+5C 3C
79
2123
+5C 3C
79
100 mg
1395
+5C 3C
79
10 mg
1395
Yes
+5C 3C
79
250 mg
See leaflet
2394
Yes
-20C 5C
79
20 mg
Vitamin H
1073
+5C 3C
79
B1120000 Biperiden hydrochloride
60 mg
1074
+5C 3C
79
B1121000 Biperiden impurity A
20 mg
1074
+5C 3C
79
B1140000 Bisacodyl
50 mg
0595
+5C 3C
79
Y0000608 Bisacodyl for peak identification
10 mg
0595
Y0000694 Bisacodyl for system suitability
5 mg
0595
Y0000812 Bisoprolol fumarate
50 mg
Y0000877 Bisoprolol for peak identification
1.007 mg
Bisoprolol for system suitability method A CRS has been renamed as
Bisoprolol for peak identification CRS.
New Y0000813 Bisoprolol for system suitability
1.003 mg
Bisoprolol for system suitability method B CRS has been renamed as
Bisoprolol for system suitability CRS ; Batch 2 is valid until 30 April 2014
New B1141000 Bleomycin sulfate
7 mg
99.8% CHFNOS
(1RS)-1-[(1SR,2SR,4SR)-bicyclo[2.2.1]hept-5-en-2-yl]-1-phenyl- 3(piperidin-1-yl)propan-1-ol (endo form)
+5C 3C
79
Yes
+5C 3C
79
+5C 3C
79
1710
Yes
+5C 3C
79
1710
Yes
+5C 3C
79
See leaflet ; Batch 1 is valid until 30 April 2014
0976,20702
Yes
-20C 5C
79
1396, 1816
Yes
+5C 3C
79
1710
Y0000434 Boldine
30 mg
98.8% CHNO
B1142000 Bordetella pertussis mouse antiserum BRP
0.5 mg
Anti-PT: 19.5 ELU/vial Anti-FHA: 69 ELU/vial
Anti-69k: 17 ELU/vial Anti-Fim 2/3: 28 ELU/vial
9
Council of Europe, all rights reserved 2014
90
See leaflet,
Yes
-20C 5C
c
20716
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
New Y0001634 Brimonidine for system suitability
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
1.3 mg
1
Information
Monograph Leaflet
2760
Yes
Storage
+5C 3C
Extra
Price
charges
79
g
New Y0001658 Brimonidine tartrate
5 mg
2760
+5C 3C
79
B1143000 Bromazepam - * psy
60 mg
0778,0879
+5C 3C
79
New Y0000645 Bromazepam for system suitability - * psy
10 mg
0879
+5C 3C
79
B1145000 Bromhexine hydrochloride
100 mg
0706
+5C 3C
79
Y0000200 Bromhexine impurity C
15 mg
0706
+5C 3C
79
B1150000 Bromocriptine mesilate
30 mg
0596
-20C 5C
g(c)
79
Y0000677 Bromocriptine mesilate for system suitability
5 mg
0596
-20C 5C
g(c)
79
B1152000 Bromperidol
100 mg
0616,1178
+5C 3C
79
B1152050 Bromperidol decanoate
60 mg
1397,1431
+5C 3C
79
B1153000 Brompheniramine maleate
100 mg
0977,1196
+5C 3C
79
Y0000468 Brotizolam - * psy
10 mg
2197
+5C 3C
79
Y0000470 Brotizolam impurity B
10 mg
2197
+5C 3C
79
B1155000 Brucella melitensis Rev. 1 strain BRP - * MOT (Biotox)
1 mg
B1157300 Budesonide
110 mg
Y0001148 Budesonide for system suitability
10 mg
B1156000 Bufexamac
100 mg
B1157400 Buflomedil hydrochloride
Y0001529 Buflomedil for peak identification
B1157410 Buflomedil impurity B
20 mg
B1158000 Bumetanide
150 mg
Y0000309 Bumetanide impurity A
5 mg
3-nitro-4-phenoxy-5-sulphamoylbenzoic acid
Y0000310 Bumetanide impurity B
5 mg
3-amino-4-phenoxy-5-sulphamoylbenzoic acid
B1160000 Bupivacaine hydrochloride
100 mg
Y0000088 Bupivacaine impurity B
20 mg
Y0000089 Bupivacaine impurity E
20 mg
Y0001575 Bupivacaine impurity F
70 mg
Y0001108 Buprenorphine - * psy
10 mg
Y0001109 Buprenorphine hydrochloride - * psy
10 mg
1181
Y0001122 Buprenorphine for system suitability - * psy
10 mg
1180,1181
B1168000 Buserelin
2 mg
B1168020 D-His-Buserelin
0.5 mg
Y0000131 Buspirone hydrochloride
5 mg
Y0000471 Buspirone for system suitability
2 mg
Council of Europe, all rights reserved 2014
N-(2-aminobenzyl)-N-methylcyclohexanamine ; Batch 2 is valid until 1 June
2013
2-bromo-4-(2-chlorophenyl)-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]
diazepine (demethylbrotizolam)
Yes
Yes
0793
Yes
+5C 3C
e(b)
79
1075
Yes
+5C 3C
79
1075
Yes
+5C 3C
79
1179
+5C 3C
79
100 mg
1398
+5C 3C
79
0.45 mg
1398
+5C 3C
79
1398
+5C 3C
79
1076
+5C 3C
79
1076
+5C 3C
79
1076
+5C 3C
79
0541
+5C 3C
79
(2RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
0541
+5C 3C
79
6-(butylamino)-N-(2,6-dimethylphenyl)hexanamide
0541
+5C 3C
79
2,6-dimethylaniline
0541
+5C 3C
79
1180
+5C 3C
79
+5C 3C
79
+5C 3C
79
1077
-20C 5C
79
1077
-20C 5C
79
+5C 3C
79
+5C 3C
79
99.7% CHO
4-(pyrrolidin-1-yl)-1-(4-hydroxy-2,6-dimethoxyphenyl)butan-1-one ; Batch 2
is valid until 28 February 2014
2.00 mg per vial of CHNO
Yes
Yes
1711
Batch 1 is valid until 30 April 2014
10
1711
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Code
B1170000 Busulfan
Reference Standard
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
50 mg
1
Information
Monograph Leaflet
0542
Storage
+5C 3C
Extra
Price
charges
79
g
Y0001487 Butyl methacrylate
100 mg
1975
+5C 3C
79
Y0001304 Butyl methanesulfonate
30 L
20537,2053
8, 20539
Yes
+5C 3C
79
B1217000 Butyl parahydroxybenzoate
100 mg
See leaflet
0881,1216
Yes
+5C 3C
79
Y0001357 Butyl parahydroxybenzoate impurity E
15 mg
2-methylpropyl 4-hydroxybenzoate (iso-butyl parahydroxybenzoate)
0881
+5C 3C
79
B1212000 Butylhydroxyanisole
60 mg
Batch 3 is valid until 31 August 2013
0880
+5C 3C
79
B1215000 Butylhydroxytoluene
50 mg
Plastic additive 07
0581,30103,
30105,3010
6, 30107
+5C 3C
79
Y0000472 Cabergoline
100 mg
99.8% CHNO
1773
Yes
-20C 5C
79
C0100000 Caffeine
70 mg
See leaflet
0267,0268,1
504,2412
Yes
+5C 3C
79
Y0000787 Caffeine for system suitability
10 mg
Batch 2 is valid until 30 November 2013
0267, 0268
Yes
+5C 3C
79
C0166000 Calcifediol
5 mg
95.3% CHO ; Batch 3 is valid until 28 February 2013
1295
Yes
-20C 5C
e(d)
150
C0166001 Calcifediol - reference spectrum
n/a
1295
79
Y0000499 Calcipotriol (anhydrous) - reference spectrum
n/a
2011
79
Y0000473 Calcipotriol monohydrate
10 mg
79
Y0000474 Calcipotriol monohydrate - reference spectrum
n/a
79
C0200000 Calcitonin (salmon)
1 mg
Batch 8 is valid until 1 June 2013
Batch 9 is valid until 30 May 2013
0471
-20C 5C
79
Y0000632 Calcitonin-Gly
1 ml
About 0.9 mg per ml
0471
-20C 5C
79
C0200010 N-acetyl-cys1-calcitonin
0.1 mg
about 0.1mg N-acetyl-cys-1-calcitonin per vial
0471
-20C 5C
79
C0225000 Calcitriol
10 mg
99.8% CHO
0883
-20C 5C
e(d)
C0226000 Calcitriol - reference spectrum
n/a
C0249000 Calcium ascorbate - reference spectrum
n/a
C0250000 Calcium folinate
130 mg
C0299000 Calcium glucoheptonate
60 mg
C0300000 Calcium gluconate
100 mg
C0340000 Calcium levulinate dihydrate
250 mg
C0350000 Calcium oxalate monohydrate
500 mg
C0400000 Calcium pantothenate
60 mg
0470
C0405000 Camphor (racemic)
50 mg
Y0001388 Candesartan cilexetil
60 mg
Y0001387 Candesartan cilexetil for peak identification
10 mg
2375
Council of Europe, all rights reserved 2014
94.3% CHO ; Batch 1 is valid until 31 August 2013
2011,2284
Yes
+5C 3C
2284
Yes
Yes
0883
1182
See leaflet ; Batch 5 is valid until 31 March 2014
Calcium digluconate ; Batch 1 is valid until 31 March 2014
Loss of 12.1% m/m (U= 0.2%, n=10, k=2.23)
11
0978,1606
Yes
1000
79
79
+5C 3C
79
1399
+5C 3C
79
0172,0658,0
979,1399,21
61,2162,216
4,2364
+5C 3C
79
1296
+5C 3C
79
+5C 3C
79
+5C 3C
79
0655,1600
+5C 3C
79
2375
+5C 3C
79
+5C 3C
79
20234
Yes
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0001389 Candesartan cilexetil for system suitability
C0410000 Canrenone
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
10 mg
1
3
50 mg
New Y0001642 Capecitabine
150 mg
New Y0001643 Capecitabine impurity A
5 mg
New Y0001644 Capecitabine impurity B
5 mg
New Y0001645 Capecitabine impurity D
Information
Monograph Leaflet
2573
Yes
0688
Storage
+5C 3C
Extra
Price
charges
79
a
+5C 3C
79
+5C 3C
79
+5C 3C
79
2762
+5C 3C
79
10 mg
2762
+5C 3C
79
C0426000 Caprylic acid
200 mg
1401,1471
+5C 3C
79
Y0000671 Capsaicin
50 mg
+5C 3C
79
C0430000 Captopril
10 mg
1079
+5C 3C
79
Y0001182 Captopril for system suitability
20 mg
Batch 1 is valid until 31 August 2013
1079
+5C 3C
79
Y0001219 Captopril impurity B
10 mg
87.4% CHBrNO; (2S)1-[(2S)-3-bromo-2-methylpropanoyl]pyrrolidine-2carboxylic acid
1079
+5C 3C
79
Y0001220 Captopril impurity C
10 mg
84.8% CHOS; (2RS)-2-methyl-3-sulphanylpropanoic acid
1079
Yes
+5C 3C
79
Y0001221 Captopril impurity D
10 mg
85.4% CHBrO; (2RS)-3-bromo-2-methylpropanoic acid
1079
Yes
+5C 3C
79
Y0000435 Captopril impurity E
10 mg
(2S)-1-isobutyryl-pyrrolidine-2-carboxylic acid
1079
+5C 3C
79
Y0001450 Captopril impurity J
10 mg
92.5% CHNOS; (2S)-1-[(2S)-3-(acetylsulfanyl)-2-methylpropanoyl]
pyrrolidine-2-carboxylic acid (acetylcaptopril)
1079
Yes
+5C 3C
79
Y0000113 Carbachol
50 mg
+5C 3C
79
C0450000 Carbamazepine
200 mg
99.9% CHNO ; Batch 4 is valid until 31 October 2013
0543
+5C 3C
79
Y0000033 Carbamazepine impurity A
10 mg
10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide (10,11dihydrocarbamazepine)
0543
+5C 3C
79
C0451000 Carbasalate calcium - reference spectrum
n/a
79
Y0001161 Carbasalate impurity B
5 mg
1185
+5C 3C
79
C0455000 Carbenicillin sodium
50 mg
0956
+5C 3C
79
C0460000 Carbidopa
50 mg
+5C 3C
79
C0465000 Carbimazole
120 mg
+5C 3C
79
C0470000 Carbocisteine
60 mg
0885
+5C 3C
79
C0499900 Carbon dioxide - reference spectrum
n/a
0375
79
C0550000 Carboplatin - reference spectrum
n/a
Y0000475 Carboprost trometamol
40 mg
Y0000536 Carboprost trometamol - reference spectrum
n/a
1712
Y0000035 Carisoprodol
50 mg
Y0000036 Carisoprodol impurity A
10 mg
Y0001214 Carmellose
10 mg
C0580004 Carmustine - reference spectrum
n/a
20 mg
C0580010 Carmustine impurity A
Council of Europe, all rights reserved 2014
98,7% CHNO ; (E)-N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8methylnon-6-enamide ; Batch 1 is valid until 1 April 2013
1859,2336,2
337, 2529
Yes
1971
Yes
1185
0755
99.7% CHNOS
0884
Yes
1081
79
-20C 5C
79
79
1689
+5C 3C
79
1689
+5C 3C
79
2360
+5C 3C
79
1187
79
99.1% CHNO
(2RS)-2-(hydroxymethyl)-2-methylpentyl(1-methylethyl)carbamate
1,3-bis(2-chloroethyl)urea
12
1712
79
1187
-20C 5C
g(c)
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Code
Y0000846 Carprofen
Reference Standard
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
30 mg
1
Information
Monograph Leaflet
2201
Y0000884 Carprofen for system suitability
5 mg
2201
Y0000193 Carteolol for system suitability
30 mg
1972
Y0000192 Carteolol hydrochloride - reference spectrum
n/a
1972
Y0001427 Carvedilol
50 mg
1745
Y0000075 Carvedilol - reference spectrum
n/a
Y0000103 Carvedilol impurity C
15 mg
Y0001426 Carvedilol for system suitability
10 mg
C0600000 Casein BRP
100000 mg
C0630000 Cefaclor
450 mg
94.9% CHClNOS ; Batch 2 is valid until 30 November 2013
C0640000 Delta-3-Cefaclor
20 mg
Batch 3 is valid until 31 March 2014
C0650000 Cefadroxil
250 mg
93,8% CHNOS ; Batch 2 is valid until 1 July 2013
C0675000 Cefalexin monohydrate
150 mg
94.2% CHNOS
C0682000 Cefalotin sodium
100 mg
98.8% CHNNaOS
Y0000505 Cefalotin for impurity B identification
10 mg
C0682300 Cefamandole nafate
125 mg
99.0% CHNNaOS
1402
Y0000240 Cefapirin sodium
100 mg
98.5% CHNNaOS
1650
C0682400 Cefatrizine propylene glycol
150 mg
81.8% CHNOS
C0682410 Cefatrizine impurity A
60 mg
7-amino-(6R,7R)-3-[(2H-1,2,3-triazol-4-yl)sulfanyl]-methyl-8- oxo-5-thia-1azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (7-ACA triazole)
C0682800 Cefazolin
150 mg
99.6% CHNOS
0988
Y0000633 Cefepime dihydrochloride monohydrate
150 mg
95.2% CHClNOS
2126
Y0000634 Cefepime dihydrochloride monohydrate for system
suitability
15 mg
Batch 1 is valid until 28 February 2014
2126
Y0001336 Cefepime impurity E
10 mg
(6R,7R)-7-amino-3-[(1-methylpyrrolidinio)methyl]-8-oxo-5thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
2126
C0684000 Cefixime
200 mg
88.8% CHNOS
1188
C0684750 Cefoperazone dihydrate
100 mg
94.2% CHNOS
1404
C0684800 Cefoperazone sodium - reference spectrum
n/a
Y0000420 Cefotaxime acid
80 mg
C0685000 Cefotaxime sodium
30 mg
Y0000506 Cefotaxime for peak identification
10 mg
C0688000 Cefoxitin sodium
100 mg
Y0001496 Cefoxitin sodium for peak identification
15 mg
Y0001305 Cefpodoxime proxetil
70 mg
10 mg
Y0001318 Cefpodoxime proxetil for impurity H identification
Council of Europe, all rights reserved 2014
Storage
+5C 3C
Yes
+5C 3C
79
+5C 3C
79
79
+5C 3C
79
79
+5C 3C
79
+5C 3C
79
+5C 3C
131
+5C 3C
79
1745
(2RS)-1-[benzyl[2-(2-methoxyphenoxy)ethyl]amino]-3-(9H- carbazol-4-yloxy)
propan-2-ol
1745
1745
Yes
0350
0986
Yes
0986
-20C 5C
79
0260,0577,0
813,2342
Yes
+5C 3C
79
0708,0814
Yes
+5C 3C
79
0987
+5C 3C
79
0987
+5C 3C
79
+5C 3C
79
+5C 3C
79
1403
+5C 3C
79
1403
+5C 3C
79
Yes
+5C 3C
79
+5C 3C
79
Yes
+5C 3C
79
-20C 5C
g(c)
79
Yes
-20C 5C
79
Yes
+5C 3C
79
79
+5C 3C
79
+5C 3C
79
Yes
1404
94.3% CHNOS
0989
Yes
0708,0989
97.4% CHNNaOS
97.1% CHNOS
13
Extra
Price
charges
79
g
0989
Yes
+5C 3C
79
0990
Yes
+5C 3C
79
0990
Yes
+5C 3C
79
2341
Yes
-20C 5C
79
79
2341
Yes
-20C 5C
b
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0001306 Cefpodoxime proxetil for peak identification
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
10 mg
1
Information
Monograph Leaflet
Yes
-20C 5C
2342
Yes
+5C 3C
79
2342
Yes
+5C 3C
79
+5C 3C
79
120 mg
Y0001368 Cefprozil impurity mixture
10 mg
Y0001372 Cefprozil impurity A
20 mg
Y0001367 Cefprozil for peak identification
10 mg
C0690000 Cefradine
300 mg
93.9%
Y0000568 Cefradine for peak identification
15 mg
Y0001174 Cefradine impurity mixture
0.04 mg
C0690500 Ceftazidime
200 mg
85.3% CHNOS
Y0001111 Ceftazidime for peak identification
10 mg
C0691000 Ceftriaxone sodium
100 mg
C0692000 Ceftriaxone impurity A
10 mg
C0694990 Cefuroxime axetil
60 mg
97.3% CHNOS ; Batch 3 is valid until 31 December 2013
1300
C0695000 Cefuroxime sodium
150 mg
96.7% CHNNaOS
0988,0992
Y0001445 Celecoxib
200 mg
99.9% CHFNOS
2591
Yes
Y0001446 Celecoxib impurity A
10 mg
4-[5-(3-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]
benzenesulfonamide
2591
Y0001447 Celecoxib impurity B
10 mg
4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]
benzenesulfonamide
2591
Y0000311 Celiprolol hydrochloride
10 mg
1632
Y0000312 Celiprolol impurity I
0.02 mg
Y0000239 Celiprolol for peak identification
20 mg
1632
Y0000784 Cellulose acetate
40 mg
0887
Y0001585 Cellulose acetate butyrate
60 mg
Y0001054 Cellulose acetate phthalate
10 mg
C0700000 Cephaline hydrochloride
15 mg
C0980650 Cetirizine dihydrochloride
100 mg
C0980651 Cetirizine impurity A
10 mg
Y0001197 Cetirizine for peak identification
1.01 mg
C0984100 Cetostearyl isononanoate - reference spectrum
n/a
Council of Europe, all rights reserved 2014
2342
(2R)-2-amino-2-(4-hydroxyphenyl)acetic acid
(p-hydroxyphenylglycine)
Extra
Price
charges
79
b
2341
Y0001371 Cefprozil
See leaflet CHNOS
Storage
2342
Yes
+5C 3C
79
0167,0168,0
578,
0708,0814
Yes
+5C 3C
79
Must be used with Cefradine impurity mixture CRS Y0001174
0814
Yes
+5C 3C
79
Must be used with Cefradine for peak identification Y0000568
0814
Yes
+5C 3C
79
1405
Yes
+5C 3C
79
1405, 2344
Yes
+5C 3C
79
90.4% CHNNaOS
0991
Yes
+5C 3C
79
E-isomer
0991
+5C 3C
79
Yes
+5C 3C
79
Yes
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
0314
+5C 3C
79
0080,0081,0
093,
0094,1530,1
875
+5C 3C
79
1084
+5C 3C
79
(RS)-1-[(4-chlorophenyl)phenylmethyl]piperazine ; Batch 4 is valid until 31
July 2013
1084
+5C 3C
79
Replaces Cetirizine impurity mixture CRS
1084
+5C 3C
79
79
1632
1-acetyl-1-(4-ethoxyphenyl)-3,3-diethylurea
1085
14
Yes
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Code
C0990000 Cetyl alcohol
Reference Standard
Effective from 2014/1/2
Batch n Quantity Sale
Information
per vial Unit
2
300 mg
1 99.7% CHO ; Batch 1 is valid until 30 November 2013
Monograph Leaflet
0540,0702,0
801,
0802,0847,0
969, 1411
Yes
Storage
+5C 3C
Extra
Price
charges
79
a
Y0000073 Cetyl palmitate 15
60 mg
1906
+5C 3C
79
Y0000074 Cetyl palmitate 95
50 mg
1906
+5C 3C
79
C1000000 Cetylpyridinium chloride
20 mg
0379
+5C 3C
79
C1050000 Chenodeoxycholic acid
125 mg
1189,1275
+5C 3C
79
Y0000104 Chitosan hydrochloride
30 mg
1774
+5C 3C
79
C1100000 Chlorambucil
100 mg
0137
+5C 3C
79
Y0001298 Chlorambucil for system suitability
10 mg
0137
+5C 3C
79
Y0001299 Chlorambucil with impurity G
10 mg
0137
+5C 3C
79
C1200000 Chloramphenicol
500 mg
0071,0473,0
709
+5C 3C
79
C1300000 Chloramphenicol dipalmitate
100 mg
0473
+5C 3C
79
C1350000 Chloramphenicol disodium disuccinate
25 mg
0709
+5C 3C
79
C1400000 Chloramphenicol palmitate isomer
100 mg
0473
+5C 3C
79
C1425000 Chloramphenicol sodium succinate
1500 mg
0709
+5C 3C
79
C1435000 Chlorcyclizine hydrochloride
100 mg
1086
+5C 3C
79
C1450000 Chlordiazepoxide - * psy
50 mg
0656,1974
+5C 3C
79
C1500000 Chlordiazepoxide hydrochloride - * psy
100 mg
0474
+5C 3C
79
10 mg
0474,0656
+5C 3C
79
C1510000 Chlorhexidine
50 mg
0658
+5C 3C
79
C1520000 Chlorhexidine diacetate
10 mg
0657
+5C 3C
79
C1540000 Chlorhexidine dihydrochloride
50 mg
0659
+5C 3C
79
Y0001545 Chlorhexidine for system suitability
15 mg
0658
Yes
+5C 3C
79
New Y0001653 Chlormadinone acetate
120 mg
2702
Yes
+5C 3C
79
New Y0001638 Chlormadinone Acetate for system suitability
10 mg
2702
Yes
+5C 3C
79
New Y0001656 Chlormadinone acetate impurity G
20 mg
2702
C1530000 Chlorhexidine for performance test
50 mg
0657,0659
Y0000569 Chlorogenic acid
25 mg
C2223030 1-(4-Chlorophenyl)-1-phenylethanol
15 mg
C1650000 Chloroquine sulfate
200 mg
0544,0545
C1700000 Chlorothiazide
100 mg
0394
New Y0000476 Chlordiazepoxide impurity A
Council of Europe, all rights reserved 2014
Batch 2 is valid until 31 August 2013
91.1% CHClNNaO
Batch 1 is valid until 31 March 2014
7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one 4-oxide ; Batch 1
is valid until 31 May 2014
97% CHO ; (1S,3R,4R,5R)-3-[(3,4-Dihydroxycinnamoyl)oxy]-1,4,51821,1822,1
trihydroxycyclohexanecarboxylic acid ; Batch 1 is valid until 28 February 2014
823,
1824,1866,1
897, 2389
Clemastine fumarate impurity C
1190
15
Yes
+5C 3C
79
Yes
+5C 3C
79
Yes
+5C 3C
79
-20C 5C
g(c)
79
+5C 3C
79
+5C 3C
79
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
C1800000 Chlorphenamine maleate
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
100 mg
1
Information
Monograph Leaflet
Storage
0386,0977,1
084, 1196
+5C 3C
Extra
Price
charges
79
g
Y0000436 Chlorphenamine impurity A
0.01 mg
2-(4-chlorophenyl)-4-(dimethylamino)-2-[2-(dimethylamino)
ethyl]butanenitrile ; Batch 3 is valid until 31 March 2014
0386
+5C 3C
79
Y0000437 Chlorphenamine impurity C
10 mg
(3RS)-3-(4-chlorophenyl)-N-methyl-3-(pyridin-2-yl)propan-1amine
0386
+5C 3C
79
C1900000 Chlorpromazine hydrochloride
200 mg
0475,20303
+5C 3C
79
Y0000507 Chlorpromazine impurity A
15 mg
3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1amine S-oxide (chlorpromazine sulphoxide)
0475
+5C 3C
79
Y0000479 Chlorpromazine impurity D
10 mg
3-(2-chloro-10H-phenothiazin-10-yl)-N-methypropan-1-amine
(demethylchlorpromazine)
0475
+5C 3C
79
Y0000508 Chlorpromazine impurity E
10 mg
2-chloro-10H-phenothiazine
0475
+5C 3C
79
Y0001449 Chlorpromazine impurity F
2 mg
3-(4-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine
0475
+5C 3C
79
C1905000 Chlorpropamide
100 mg
1087
+5C 3C
79
C1905020 Chlorpropamide impurity B
50 mg
1,3-Dipropylurea
1087
+5C 3C
79
C1915000 Chlorprothixene hydrochloride
50 mg
2.0% E-isomer
0815,1365
Yes
+5C 3C
79
C1950000 Chlortalidone
150 mg
99.7% CHClNOS ; Batch 2 is valid until 31 August 2013
0546
Yes
+5C 3C
79
Y0000779 Chlortalidone for peak identification
1.017 mg
Batch 2 is valid until 30 November 2013
0546
Yes
+5C 3C
79
C2000000 Chlortetracycline hydrochloride
100 mg
92.4% of of CHClNO
0173
Yes
+5C 3C
79
Y0001451 Chlortetracycline for system suitability
20 mg
0173
Yes
+5C 3C
79
C2100000 Cholecalciferol
480 mg
100% CHO ; Vitamin D3
0072,0574,0
575,
0598,1192,1
193
Yes
-20C 5C
g(c)
79
C2150000 Cholecalciferol for system suitability
1 mL
-20C 5C
g(c)
79
C2155000 Cholesterol
100 mg
+5C 3C
79
C2158000 Cholic acid
60 mg
+5C 3C
79
Y0000280 Chondroitin sulfate sodium
250 mg
+5C 3C
79
Y0000593 Chondroitin sulfate sodium (marine)
100 mg
+5C 3C
79
C2160000 Chymotrypsin BRP
100 mg
6.01 microkatals per mg
0476,0694
Yes
+5C 3C
79
Y0001553 Ciclesonide
150 mg
99.8 % CHO
2703
Yes
+5C 3C
79
Y0001554 Ciclesonide containing impurity A
15 mg
(2S)-2-cyclohexyl-11b-hydroxy-3,20-dioxo-16bH-[1,3]dioxolo[4,5:16,17]
pregna-1,4-diene-21-yl 2-methylpropanoate (S-epimer of ciclesonide)
2703
+5C 3C
79
Y0001555 Ciclesonide impurity B
10 mg
(2R)-2-cyclohexyl-11b,21-dihydroxy-16bH-[1,3]dioxolo[4,5:16,17]
pregna-1,4-diene-3,20-dione
2703
+5C 3C
79
Y0001556 Ciclesonide impurity C
10 mg
(2R)-2-[(1RS)-cyclohex-3-enyl]-11b-hydroxy-3,20-dioxo-16bH-[1,3]dioxolo
[4,5:16,17]pregna-1,4-diene-21-yl 2-methylpropanoate
2703
+5C 3C
79
Council of Europe, all rights reserved 2014
0072,0082,0
574,
0575,0598
0593,0993
99.5% CHO
Yes
1189
2064,2090
99.6 % HO(CHNNaOS) ; Batch 1 is valid until 1 May 2013
Yes
2064
16
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Code
Y0000040 Ciclopirox
Reference Standard
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
100 mg
1
Information
Monograph Leaflet
1407
Storage
+5C 3C
Extra
Price
charges
79
g
C2162701 Ciclopirox impurity A
40 mg
()-2-(3-cyclohexyl-5-methyl-4,5-dihydroisoxazol-5-yl)acetic acid
1302,1407
+5C 3C
79
C2162702 Ciclopirox impurity B
20 mg
6-cyclohexyl-4-methyl-2H-pyran-2-one
1302,1407
-20C 5C
79
C2162700 Ciclopirox olamine
150 mg
+5C 3C
79
C2163000 Ciclosporin
120 mg
+5C 3C
79
1302
0994
98.5% CHNO
Yes
Y0000361 Ciclosporin for system suitability
5 mg
0994
+5C 3C
79
New Y0001651 Cilastatin for system suitability 1
5 mg
1408
Yes
+5C 3C
79
New Y0001652 Cilastatin for system suitability 2
Yes
+5C 3C
79
+5C 3C
79
5 mg
1408
C2170000 Cilastatin sodium
10 mg
1408
C2174000 Cilazapril
50 mg
1499
+5C 3C
79
C2174002 Cilazapril impurity A
25 mg
1,1-dimethylethyl(1S,9S)-9-[[(S)-1-ethoxycarbonyl-3-phenylpropyl]
amino]-10-oxo-octahydro-6H-pyridazino[1,2a][1,2]diazepine-1-caboxylate
1499
+5C 3C
79
C2174005 Cilazapril impurity D
10 mg
(1S,9S)-9-[[(R)-1-ethoxycarbonyl-3-phenylpropyl]amino]-10- oxooctahydro-6H-pyridazino[1,2a][1,2]diazepine-1-carboxylic acid
1499
+5C 3C
79
C2175000 Cimetidine
50 mg
0756
+5C 3C
79
C2175500 Cimetidine hydrochloride
100 mg
1500
+5C 3C
79
Y0001130 Cimetidine for peak identification
10 mg
0756
Yes
+5C 3C
79
Y0001146 Cimetidine for system suitability
0.5085 mg
756
Yes
60 mg
Y0000176 Cineole
180 mg
C2180000 Cinnarizine
100 mg
Y0000362 Ciprofibrate
Y0000363 Ciprofibrate for system suitability
Y0000198 Ciprofloxacin
C2190000 Ciprofloxacin hydrochloride
+5C 3C
79
1088
+5C 3C
79
1973
+5C 3C
79
0816
+5C 3C
79
5 mg
2013
+5C 3C
79
5 mg
2013
+5C 3C
79
20 mg
+5C 3C
79
100 mg
See leaflet ; Batch 4 is valid until 31 March 2014
+5C 3C
79
Y0000199 Ciprofloxacin hydrochloride for peak identification
15 mg
Batch 1 is valid until 31 August 2013
C2190050 Ciprofloxacin impurity A
25 mg
7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic
acid (fluoroquinolonic acid)
C2210000 Cisplatin
100 mg
99.7% [PtCl(NH)]
0599
Y0001018 Cisplatin impurity A
15 mg
trans-diamminedichloroplatinum (II)
0599
Y0001019 Cisplatin impurity B
15 mg
94.1% [PtCl(NH)]-; amminetrichloroplatinate(-)
0599
Y0001008 Citalopram hydrobromide
5 mg
Y0001007 Citalopram hydrochloride
5 mg
Y0000855 Citalopram for system suitability
0.065 mg
2203,2288
A1202000 Citric acid (anhydrous)
50 mg
0455
C2219000 Citric acid monohydrate
50 mg
Y0000639 Cladribine
50 mg
New C2177000 Cinchocaine hydrochloride
Council of Europe, all rights reserved 2014
Batch 1 is valid until 31 May 2014
Yes
1089
0888,1353
Yes
0888,1089
Yes
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
2288
+5C 3C
79
2203
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
g(b)
79
0888,1089,2
229
Yes
Yes
Yes
0456
99.1% CHClNO
17
2174
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0000609 Cladribine for peak identification
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
10 mg
1
Information
Monograph Leaflet
2174
Yes
Storage
+5C 3C
Extra
Price
charges
79
g(b)
Y0000610 Cladribine impurity C
5 mg
2-chloro-7H-purin-6-amine
2174
+5C 3C
g(b)
79
Y0000320 Clarithromycin
160 mg
97.7% CHNO
1651
Yes
+5C 3C
79
Y0000321 Clarithromycin for peak identification
40 mg
1651
Yes
+5C 3C
79
Y0000269 Clazuril for system suitability
10 mg
1714
Yes
+5C 3C
79
Y0001193 Clazuril
10 mg
1714
+5C 3C
79
C2221000 Clebopride malate
100 mg
1303
+5C 3C
79
C2223000 Clemastine fumarate
100 mg
1190
+5C 3C
79
Y0001613 Clemastine for system suitability
0.165 mg
1190
+5C 3C
79
C2248000 Clenbuterol hydrochloride
30 mg
1409
+5C 3C
79
C2248010 Clenbuterol impurity B
10 mg
1409
+5C 3C
79
Y0000364 Clioquinol
5 mg
2111
+5C 3C
79
Y0000205 Clobazam - reference spectrum
n/a
1974
79
Y0000241 Clobazam impurity A
10 mg
7-chloro-5-phenyl-1,5-dihydro-1,5-dihydro-3H-1,5-benzodiazepine-2,4-dione
1974
+5C 3C
79
Y0000559 Clobetasol propionate
40 mg
99.6% CHClFO
2127
Yes
+5C 3C
79
Yes
New Y0000570 Clobetasol for peak identification
1-(4-amino-3,5-dichlorophenyl)-2-[(1,1-dimethylethyl)amino] ethanone
Yes
2 mg
Batch 1 is valid until 31 May 2014
2127
+5C 3C
79
Y0000571 Clobetasol impurity J
0.4 mg
(17R)-4'-chloro-5'-ethyl-9-fluoro-11-hydroxy-16-methylspiro
[androsta-1,4-diene-17,2'(3'H)-furan]-3,3'-dione (17 alpha-spiro compound)
2127
+5C 3C
79
C2285000 Clobetasone butyrate
50 mg
1090
+5C 3C
79
Y0001137 Clobetasone butyrate for system suitability
30 mg
1090
+5C 3C
79
Y0000888 Clodronate disodium tetrahydrate
5 mg
1777
+5C 3C
79
Y0000885 Clodronate impurity D
5 mg
1777
+5C 3C
79
Y0000313 Clofazimine
150 mg
2054
+5C 3C
79
Y0000358 Clofazimine for system suitability
10 mg
2054
+5C 3C
79
C2300000 Clofibrate
0.5 ml
0318
+5C 3C
79
C2320000 Clomifene citrate
50 mg
C2332000 Clomifene citrate for performance test
50 mg
C2360000 Clomipramine hydrochloride
100 mg
Y0000132 Clomipramine impurity C
10 mg
94.5% CHClN; 3-(3-chloro-5H-dibenzo[b,f]azepin-5-yl)-N,Ndimethylpropan-1-amine
Y0000133 Clomipramine impurity D
10 mg
Y0000134 Clomipramine impurity F
5 mg
C2385000 Clonazepam - * psy
50 mg
Y0000286 Clonazepam - reference spectrum
n/a
C2385015 Clonazepam impurity B
5 mg
C2400000 Clonidine hydrochloride
100 mg
Council of Europe, all rights reserved 2014
(chloromethylene)bis(phosphonic acid)
Yes
Yes
+5C 3C
79
Yes
+5C 3C
79
+5C 3C
79
0889
Yes
+5C 3C
79
3-(3,7-dichloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,Ndimethylpropan-1-amine
0889
Yes
+5C 3C
79
3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
0889
+5C 3C
79
1974,0415
+5C 3C
79
0890
79
44% of Z-isomer CHClNO
0997,1046
0997
0889
3-Amino-4-(2-chlorophenyl)-6-nitro-1-quinolin-2-one
18
0890
+5C 3C
79
0477
+5C 3C
79
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0000801 Clonidine impurity B
Effective from 2014/1/2
Batch n Quantity Sale
Information
per vial Unit
1
20 mg
1 1-acetyl-2-[(2,6-dichlorophenyl)amino]-4,5-dihydro-1H-imidazole
Monograph Leaflet
0477
+5C 3C
Y0000833 Clopamide
40 mg
1747
Y0000848 Clopamide for system suitability
10 mg
1747
Y0001333 Clopidogrel hydrogen sulfate
60 mg
Y0001335 Clopidogrel impurity A
10 mg
Y0001334 Clopidogrel for system suitability
100 mg
2531
Y0000392 Closantel sodium dihydrate
20 mg
1716
Y0000393 Closantel for system suitability
20 mg
C2424400 Clostridia (multi-component) rabbit antiserum(for
vaccines-vet.use)BRP
1 mg
see information on the accompanying leaflet
C2424550 Clostridium tetani guinea pig antiserum (for vaccines human use) BRP
1 mg
0.20 IU per vial (determined using toxin neutralisation test)
C2424500 Clostridium tetani guinea pig antiserum (for vaccines vet. use) BRP
1 mg
C2425600 Clostridium tetani rabbit antiserum (for vaccines - vet.
use) BRP
1 mg
C2430000 Clotrimazole
100 mg
0757
Y0000818 Clotrimazole impurity E
15 mg
0757
Y0000849 Clotrimazole for peak identification
1.005 mg
0757
Yes
C2450000 Cloxacillin sodium
200 mg
0661,0663,0
668, 2260
Yes
C2460000 Clozapine
60 mg
1191
Y0000758 Clozapine for peak identification
0.41 mg
1191
Y0001472 Coagulation Factors V, VIII, XI and XIII plasma
1 mg
Y0000162 Cocaine hydrochloride - reference spectrum
n/a
0073
C2480000 Cocoyl caprylocaprate
40 mg
1411
Y0000722 Codeine - * narc
20 mg
C2500000 Codeine - reference spectrum
n/a
Y0000334 Codeine impurity A
15 mg
C2500100 Codeine hydrochloride dihydrate - reference spectrum
n/a
C2510000 Codergocrine mesilate
60 mg
Y0001500 Coix seed HRS
1300 mg
C2580000 Colchicine
15 mg
Y0000209 Colchicine for system suitability
Y0000374 Colestyramine
Council of Europe, all rights reserved 2014
(2S)-(2-chlorophenyl)[6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]acetic acid
Storage
Extra
Price
charges
79
a
+5C 3C
79
+5C 3C
79
2531
+5C 3C
79
2531
+5C 3C
79
+5C 3C
79
+5C 3C
79
Yes
Yes
1716
Yes
+5C 3C
79
0362,0363,0
364, 0697
Yes
-20C 5C
90
20708
Yes
-20C 5C
90
34 IU per vial
See leaflet,
0697
Yes
-20C 5C
90
15 IU per vial
See leaflet,
0697
Yes
-20C 5C
90
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
93.9% CHClNNaOS
+5C 3C
79
Yes
+5C 3C
79
Yes
-20C 5C
90
79
+5C 3C
79
+5C 3C
79
79
+5C 3C
79
79
1416,2060
+5C 3C
79
2454
+5C 3C
79
0758
+5C 3C
79
10 mg
0758
+5C 3C
79
10 mg
1775
+5C 3C
79
Factor V : 0.73 IU per vial, Factor VIII : 0.74 IU per vial, Factor XI : 0.59 IU per 0903,1646,2
vial, Factor XIII : 0.79 IU per vial
0740,20722
0076,1839,1
841
See leaflet
Yes
0074,0075,0
076
7,8-didehydro-4,5 alpha-epoxy-3,6 alpha-dimethoxy-17-methylmorphinan
0074,0075,0
076, 1412
1412
Batch 1 is valid until 30 November 2013
19
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
C2600000 Colistimethate sodium
Y0000277 Colistin sulfate
Effective from 2014/1/2
Batch n Quantity Sale
Information
per vial Unit
2
20 mg
1 285000 IU per vial CHNNaOS
4
25 mg
1 See leaflet ; Batch 3 is valid until 28 February 2014
C2700000 Colistin sulfate for microbiological assay
C2725000 Copovidone - reference spectrum
C2800000 Cortisone acetate
Monograph Leaflet
Storage
Extra
Price
charges
79
a
0319,20702
Yes
+5C 3C
0320
Yes
-20C 5C
79
0320
Yes
-20C 5C
79
79
+5C 3C
79
+5C 3C
79
25 mg
n/a
0891
250 mg
0321,0736,0
767
Y0000438 Coumarin
110 mg
C2900000 Cotton wool standard for neps
1000 mg
0036
+5C 3C
79
Y0001053 Crospovidone
5 mg
0892
+5C 3C
79
C2970000 Crotamiton
100 mg
99.2% CHNO (sum of E and Z-isomers); 3.5% Z-isomers CHNO
1194
-20C 5C
79
C2970005 Crotamiton impurity A
70 mg
N-ethyl-N-(2-methylphenyl)but-3-enamide
1194
-20C 5C
79
Y0001061 Cyanidin chloride
25 mg
93.3% CHClO ; Batch 1 is valid until 31 August 2013
C3000000 Cyanocobalamin
20 mg
Vitamin B12
C3090000 Cyclizine hydrochloride
50 mg
Y0000886 Cyclizine impurity A
15 mg
1-methylpiperazine
Y0000887 Cyclizine impurity B
15 mg
diphenylmethanol (benzhydrol)
C3200000 Cyclobenzaprine hydrochloride
100 mg
C3230000 Cyclohexa-1,4-dienylglycine
15 mg
C3245000 Cyclopentolate hydrochloride
50 mg
1093
Y0001088 Cyclopentolate for system suitability
60 mg
1093
C3250000 Cyclophosphamide
50 mg
C3280000 Cyproheptadine hydrochloride
30 mg
Y0001095 Cyproheptadine impurity C
5 mg
C3283000 Cyproterone acetate
30 mg
Y0001390 Cyproterone acetate for peak identification
5 mg
1094
Y0001223 Cyproterone impurity mixture
0.01 mg
1094
C3290000 Cysteine hydrochloride monohydrate
100 mg
C3300000 Cystine
100 mg
C3350000 Cytarabine
150 mg
Y0000733 Dacarbazine
20 mg
Y0000734 Dacarbazine impurity A
20 mg
89.4% CHNO; 3,7-dihydro-4H-imidazo[4,5-d]-1,2,3-triazin-4-one (2azahypoxanthine)
1691
Y0000735 Dacarbazine impurity B
10 mg
87.9% CHO; 5-amino-1H-imidazole-carboxamide
1691
D0070000 Dalteparin sodium
250 mg
10 mg
Y0000600 Danaparoid sodium
Council of Europe, all rights reserved 2014
576 000 IU per vial; For microbiological assay only
99.9% CHO
2120
Yes
+5C 3C
79
0269,0270,0
547,
0710,1505
+5C 3C
79
1092
+5C 3C
79
1092
+5C 3C
g(b)
79
1092
+5C 3C
79
0408,0464
+5C 3C
79
-20C 5C
79
+5C 3C
79
+5C 3C
79
0711
+5C 3C
79
0817,0846
+5C 3C
79
0817
+5C 3C
79
1094
+5C 3C
79
Yes
+5C 3C
79
Yes
+5C 3C
79
0895
+5C 3C
79
0998
+5C 3C
79
0760
+5C 3C
79
1691
+5C 3C
79
Yes
+5C 3C
79
Yes
+5C 3C
79
+5C 3C
79
86.7% CHNO; (2R)-amino(cyclohexa-1,4-dienyl)acetic acid (ddihydrophenylglycine)
Batch 1 is valid until 31 December 2013
2394
Yes
0814
0828
Yes
Yes
Yes
147 anti-factor Xa units per ampoule, 4.3 anti-factor IIa units per ampoule
79
2090
Yes
+5C 3C
b
20
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Code
D0100000 Dapsone
Reference Standard
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
2
100 mg
1
Information
Monograph Leaflet
0077
Storage
+5C 3C
D0125000 Daunorubicin hydrochloride
120 mg
98.5% CHClNO
0662
+5C 3C
79
D0120000 Daunorubicinone
10 mg
Daunorubicin aglycone
0662
+5C 3C
79
D0160000 Deferoxamine mesilate
30 mg
0896
-20C 5C
79
D0201000 Dehydrohexetidine
50 mg
1221
+5C 3C
79
Y0000611 Dembrexine hydrochloride monohydrate
10 mg
2169
+5C 3C
79
D0300000 Demeclocycline hydrochloride
100 mg
D0350000 N-Demethylerythromycin A
10 mg
0179,0274,0
490,
0552,1098
Y0000228 Demethylflumazenil - reference spectrum
n/a
1917
D0406200 Deptropine citrate
60 mg
D0430000 Dequalinium chloride
50 mg
D0431000 Dequalinium chloride for performance test
50 mg
Y0001321 Dermatan sulfate and oversulfated chondroitin sulfate
1 mL
2-ethyl-N-[[1-(2-ethylhexyl)-4-methyl-4,5-dihydro-1H-imidazol-4-yl]methyl]
hexan-1-amine
0176
Yes
Extra
Price
charges
79
a
+5C 3C
79
+5C 3C
79
79
1308
+5C 3C
79
1413
+5C 3C
79
1413
+5C 3C
79
-20C 5C
79
-80C 10C
g(d)
79
+5C 3C
79
92.4% CHClNO
0332,0333
Dermatan sulfate 10 mg/mL
Oversulfated chondroitin sulfate 2.5 mg/mL
Yes
Yes
D0480000 Desacetylvinblastine
1 mg
New Y0001620 2,4-dichlorobenzyl alcohol
250 mg
New Y0001621 2,4-Dichlorobenzyl alcohol impurity A
25 mg
2410
+5C 3C
79
New Y0001622 2,4-Dichlorobenzyl alcohol impurity C
25 mg
2410
+5C 3C
79
Y0000879 Desflurane - reference spectrum
n/a
79
Y0000807 Desflurane impurity A
1 ml
1666
+5C 3C
79
D0500000 Desipramine hydrochloride
100 mg
0481
+5C 3C
79
D0600000 Deslanoside
150 mg
0482
+5C 3C
79
Y0001584 Desloratadine
100 mg
2570
+5C 3C
79
D0630000 Desmethylmetrifonate
30 mg
1133
+5C 3C
79
Y0001582 Desloratadine for system suitability
5 mg
2570
Yes
+5C 3C
79
D0650000 Desmopressin
0.94 mg
0.94 mg per vial of CHNOS ; Batch 7 is valid until 1 March 2013
0712
Yes
-20C 5C
79
Y0000509 Desogestrel
50 mg
99.9% CHO
1717
Yes
+5C 3C
79
10 mg
Batch 1 is valid until 30 April 2014
1717
Yes
+5C 3C
79
D0400000 Desoxycortone acetate
100 mg
0322,0809,0
850, 1327
+5C 3C
79
Y0000001 Detomidine hydrochloride
100 mg
1414
+5C 3C
79
D0660020 Detomidine impurity B
20 mg
1414
+5C 3C
79
New Y0000510 Desogestrel for system suitability
Council of Europe, all rights reserved 2014
1276
2410
99,9% CHClO
Yes
1666
1,1'-oxybis(1,2,2,2-tetrafluoroethane)
98.8% CHO
(RS)-(1-benzyl-1H-imidazol-5-yl)(2,3-dimethylphenyl)methanol
21
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
D0700000 Dexamethasone
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
5
50 mg
1
Information
Monograph Leaflet
0312,0388,0
548,
0768,1376,2
237,0549
+5C 3C
Y0001593 Dexamethasone for peak identification
10 mg
0388
D0710000 Dexamethasone acetate
100 mg
Y0001169 Dexamethasone acetate impurity E
0.013 mg
Y0001177 Dexamethasone for system suitability
10 mg
0388
Y0000538 Dexamethasone isonicotinate
10 mg
2237
Y0000511 Dexamethasone isonicotinate for impurity C identification
10 mg
2237
D0718000 Dexamethasone pivalate
50 mg
1327
D0720000 Dexamethasone sodium phosphate
100 mg
Y0001477 Dexamethasone sodium phosphate for peak
identification
10 mg
D0720800 Dexchlorpheniramine maleate
60 mg
D0730000 Dexpanthenol
5 mg
D0731000 Dextran
25 mg
0999,1000,1
001
D0731005 Dextran 1
50 mg
D0732000 Dextran Vo
10 mg
D0733000 Dextran 4 for calibration
50 mg
M 3050-M 3850
20239
D0734000 Dextran 10 for calibration
50 mg
M 8800 - M 10450
20239
D0735000 Dextran 40 for calibration
50 mg
M 30500- M 40900
D0736000 Dextran 70 for calibration
50 mg
M 58900- M 70300
D0737000 Dextran 250 for calibration
50 mg
M 121800- M 238200
D0738000 Dextran 40 for performance test
50 mg
20239
D0739000 Dextran 60/70 for performance test
50 mg
Y0000744 Dextranomer
50 mg
D0740000 Dextromethorphan hydrobromide
100 mg
5 mg
Y0001058 Dextropropoxyphene hydrochloride - * narc
10 mg
0713
Y0001150 Dextropropoxyphene for system suitability - * narc
5 mg
0713
Yes
Y0001595 Diacerein
150 mg
99.2% CHO
2409
Y0001596 Diacerein impurity B
20 mg
94,4% CHO
2409
New Y0000261 Dextromethorphan impurity A
Council of Europe, all rights reserved 2014
9-fluoro-11beta,17-dihydroxy-16alpha-methyl-3,20-dioxopregn-4-en-21-yl
acetate
Storage
Yes
Extra
Price
charges
79
a
+5C 3C
79
0548,0933,0
975, 2237
+5C 3C
79
0548
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
Yes
Yes
0549,0735,0
810
Yes
+5C 3C
79
0549
Yes
+5C 3C
79
1196
+5C 3C
79
0761
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
Yes
+5C 3C
79
Yes
+5C 3C
79
20239
Yes
+5C 3C
79
20239
Yes
+5C 3C
79
20239
Yes
+5C 3C
79
+5C 3C
79
20239
+5C 3C
79
2338
+5C 3C
79
Batch 3 is valid until 31 January 2013
0020
+5C 3C
79
ent-3-methoxymorphinan ; Batch 1 is valid until 30 April 2014
0020
+5C 3C
79
+5C 3C
79
+5C 3C
79
Yes
+5C 3C
79
Yes
+5C 3C
79
88.3 % CHFNaOP
Average molecule mass : 930-1000
Fraction with less than 3 glucose units : 8.0 to 10.5%
Fraction with more than 9 glucose units : 10.0 to 12.5%
1506
Yes
20239
22
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0001597 Diacerein impurity mixture
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
0.014 mg 1
Information
Monograph Leaflet
Yes
+5C 3C
1213
Yes
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
100 mg
D0940000 Diazepam - * psy
30 mg
0022
Y0000596 Diazepam for system suitability - * psy
0.5 mg
0022
D0950000 Diazoxide
50 mg
0550
D0970000 Dibenzocycloheptene
20 mg
30 mg
Y0000480 Dibrompropamidine diisetionate
10 mg
Y0000481 Dibrompropamidine for system suitability
D1010000 Dibutyl phthalate
Y0000275 Dichlorodiaminocyclohexaneplatinum
Y0000264 Diclazuril for veterinary use - reference spectrum
Y0000259 Diclazuril for system suitability
D1039990 Diclofenac potassium
New D1000000 Dibenzosuberone
New Y0001635 Diclofenac for system suitability
Yes
0817
+5C 3C
79
0464,0817,0
941
+5C 3C
79
2300
+5C 3C
79
20 mg
2300
+5C 3C
79
1 ml
0762
+5C 3C
79
15 mg
2017
+5C 3C
79
n/a
1718
79
20 mg
1718
+5C 3C
79
100 mg
1508
+5C 3C
79
Batch 1 is valid until 31 May 2014
Batch 3 is valid until 1 April 2013
1.002 mg
D1040000 Diclofenac impurity A
0.005 mg
1-(2,6-dichlorophenyl)-1,3-dihydro-2H-indol-2-one ; Batch 7 is valid until 31
December 2013
1002,1281,1
508
D1050000 Dicloxacillin sodium
250 mg
94.7% CHClNNaOS
0661,0663,0
668
D1060000 Dicycloverine hydrochloride
100 mg
1197
Y0000439 Didanosine
10 mg
2200
Y0000440 Didanosine for system suitability
10 mg
2200
Y0000441 Didanosine impurity A
10 mg
1,7-dihydro-6H-purin-6-one (hypoxanthine)
Y0000442 Didanosine impurity G
10 mg
9-(2,3-dideoxy--D-glycero-pentofuranosyl)-9H-purin-6-amine (2',3'dideoxyadenosine)
D1200000 Dienestrol
150 mg
D1300000 Diethylcarbamazine citrate
250 mg
Y0000217 Diethylene glycol (monoethyl ether) - reference spectrum
n/a
D1410000 Diethyl phthalate
1 ml
D1500000 Diethylstilbestrol
100 mg
D1600000 Diethylstilbestrol dimethyl ether
10 mg
D1700000 Diethylstilbestrol monomethyl ether
10 mg
Y0001423 Difloxacin hydrochloride
60 mg
Y0001429 Difloxacin impurity G
15 mg
D1750000 Diflunisal
30 mg
200 mg
D1800000 Digitoxin
Council of Europe, all rights reserved 2014
Extra
Price
charges
79
a
2409
Y0000454 Diacetylfluorescein
See leaflet CHO
Storage
1002
Yes
Yes
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
2200
+5C 3C
79
2200
+5C 3C
79
100% CHO
0484
+5C 3C
79
99.9% CHNO
0271
+5C 3C
79
79
Yes
Yes
Yes
1198
0897
+5C 3C
79
0483,0484
+5C 3C
79
0484
+5C 3C
79
0484
+5C 3C
79
2239
+5C 3C
79
2239
+5C 3C
79
0864
+5C 3C
79
Dried at 100-105C for 2 h. 100% CHO
7-chloro-6-fluoro-1-(4-fluorophenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic
acid
99.4% CHO
23
79
0078,0117
Yes
+5C 3C
g
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Code
Y0000640 Digoxigenin
Reference Standard
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
5 mg
1
Information
Monograph Leaflet
0079
D1900000 Digoxin
30 mg
Y0000554 Digoxin for peak identification
10 mg
0079
D1940001 Dihydralazine sulfate (hydrated) - reference spectrum
n/a
1310
Y0000232 Dihydralazine for system suitability
10 mg
1310
Y0000216 Dihydrocodeine hydrogen tartrate - reference spectrum
n/a
Y0000053 17 alpha-dihydroequilin
10 mg
98.2% CHO
New D1945000 Dihydroergocristine mesilate
250 mg
Batch 2 is valid until 31 May 2014
D1950000 Dihydroergotamine mesilate
100 mg
Y0000831 Dihydroergotamine for peak identification
10 mg
0551
D1952000 Dihydroergotamine tartrate
150 mg
100.0% CHNO. Dried at 100-105C at constant weight
0600
D1954000 Dihydrostreptomycin sulfate
25 mg
23.9 mg per vial of CHNOS
Y0000544 Dihydrotachysterol
30 mg
99.6% CHO
Y0000482 Dihydrotachysterol for system suitability
5 mg
D1980000 Diltiazem hydrochloride
300 mg
Y0001141 Diltiazem for system suitability
10 mg
Replaces Diltiazem impurity A CRS ; Batch 1 is valid until 31 August 2013
Y0001439 Diltiazem impurity F
10 mg
(2S,3S)-5-[2-(dimethylamino)ethyl]-3-hydroxy-2-(4-methoxyphenyl)-2,3dihydro-1,5-benzothiazepin-4(5H)-one
D2000000 Dimenhydrinate
100 mg
Y0000234 N,N-Dimethylacetamide - reference spectrum
Y0001103 Dimenhydrinate for peak identification
D2050000 Dimethyl sulfoxide
Y0001489 2-(Dimethylamino)ethyl methacrylate
D2200000 Dimeticone
200 mg
D2205000 Dimetindene maleate
50 mg
D2255000 Dinoprost trometamol
60 mg
98.2% CHNO
1312
D2250000 Dinoprostone
100 mg
99.8% CHO
1311
D2250015 Dinoprostone impurity C
10 mg
(E)-7-[(1S,2R,3R)-3-hydroxy-2-[(E)-(3S)-3-hydroxyoct-1-enyl]- 5oxocyclopentyl]-hept-5-enoic acid (5-trans-PGE2 ; (5E)-PGE2)
Y0000094 Diosmin
70 mg
90.9% CHO
Y0000095 Diosmin for system suitability
5 mg
1611
D2600000 Diphenhydramine hydrochloride
100 mg
Y0000135 Diphenhydramine impurity A
10 mg
D2630000 Diphenoxylate hydrochloride - reference spectrum
n/a
0819
Y0001415 Diphenoxylate hydrochloride - * narc
15 mg
0819
Y0001430 Diphenoxylate for system suitability - * narc
10 mg
0819
Council of Europe, all rights reserved 2014
Storage
+5C 3C
0079
Extra
Price
charges
79
f
+5C 3C
79
Yes
+5C 3C
79
79
Yes
+5C 3C
79
79
1512
-20C 5C
79
1416,2060
+5C 3C
79
0551
+5C 3C
79
Yes
+5C 3C
79
Yes
+5C 3C
79
0485
Yes
-20C 5C
79
2014
Yes
-20C 5C
g(d)
79
2014
Yes
-20C 5C
g(d)
79
1004
+5C 3C
79
1004
+5C 3C
79
1004
+5C 3C
79
0601
+5C 3C
79
n/a
1667
79
1 mg
0601
+5C 3C
79
1 ml
0763
+5C 3C
79
50 mg
1975
+5C 3C
79
+5C 3C
79
+5C 3C
79
Yes
-20C 5C
79
Yes
-20C 5C
79
-20C 5C
240
+5C 3C
79
+5C 3C
79
0023,0601,1
190
+5C 3C
79
0023,0601
+5C 3C
79
79
+5C 3C
79
+5C 3C
79
98.5% CHO
1776
0138,1470
99.9% dimeticone
Yes
Yes
1417
2-(diphenylmethoxy)-N-methylethanamine
24
1311,1488
1611
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0000258 Diphtheria toxin BRP
Effective from 2014/1/2
Batch n Quantity Sale
Information
per vial Unit
1
1 ml
1 Nominal concentration of Diphtheria toxin: 1 Lf/ml (0.4l/ml)
Systemic toxicity: 77.6 LD/ml (determined in the subcutaneous challenge
test in guinea pigs)
Maximum intradermal toxicity: 75,000Lr/Lf (determined in the guinea pig
intradermal skin test)
Toxicity in the Vero cell assay: concentrations of 5x10- Lf/ml and below
cause cytotoxic effects.
Monograph Leaflet
Storage
Extra
Price
charges
90
g(b)
See leaflet,
0443
Yes
+5C 3C
See leaflet,
20706
Yes
-20C 5C
90
D2700000 Diphtheria vaccine (adsorbed) BRP
32 mg
97 IU per vial
Y0000376 Dipivefrine hydrochloride
100 mg
99.3% CHClNO
1719
+5C 3C
79
Y0000394 Dipivefrine for system suitability
10 mg
1719
+5C 3C
79
D2750100 Dipotassium clorazepate - reference spectrum
n/a
0898
79
D2800000 Diprophylline
100 mg
0486
+5C 3C
79
D2850000 Dipyridamole
50 mg
1199
+5C 3C
79
Y0000802 Dipyridamole for peak identification
2.04 mg
1199
+5C 3C
79
D2880000 Dirithromycin
100 mg
1313
+5C 3C
79
D2900000 Disodium edetate
100 mg
0232
+5C 3C
79
D2920000 Disopyramide
100 mg
1006
+5C 3C
79
D2922000 Disopyramide phosphate
100 mg
1005
+5C 3C
79
D2950000 Disulfiram
100 mg
0603
+5C 3C
79
D2953000 Dithranol
55 mg
1007
+5C 3C
79
D2953025 Dithranol impurity C
15 mg
Dithranol-dimer
4,4',5,5'-tetrahydroxy-9,9'-bianthracenyl-10,10'(9H,9'H)-dione ; Batch 2 is
valid until 1 June 2013
1007
+5C 3C
79
D2953050 Dithranol impurity D
20 mg
94.9% CHO; 1-hydroxyanthracen-9(10H)-one ; Batch 3 is valid until 31
December 2013
1007
+5C 3C
79
D2954000 Dobutamine hydrochloride
100 mg
1200
+5C 3C
79
Y0001239 Dobutamine impurity mixture
0.1 mg
1200
Yes
+5C 3C
79
Y0001133 Docetaxel trihydrate
160 mg
93.5% CHNO ; Batch 1 is valid until 30 November 2013
2449,2593
Yes
+5C 3C
79
Y0001155 Docetaxel for system suitability
10 mg
Batch 1 is valid until 1 March 2013
2449,2593
Yes
Y0001452 Docetaxel impurity E
15 mg
5,20-epoxy-4-(acetyloxy)-1,7,10,13-tetrahydroxy-9-oxotax-11-en-2-yl
benzoate (10-desacetyl-baccatin III)
D2954600 Docosahexaenoic acid ethyl ester
150 mg
93.1% DHA ethyl ester
Y0001567 Docusate sodium
10 mg
1418
D2954500 Docusate sodium - reference spectrum
n/a
1418
Y0000365 Dodecyl gallate
30 mg
2078
D2955000 Domperidone
150 mg
1009
D2957000 Domperidone maleate
150 mg
D2960000 Dopamine hydrochloride
50 mg
Council of Europe, all rights reserved 2014
97.4% CHNO
Batch 1 is valid until 31 March 2014
25
Yes
Yes
+5C 3C
79
+5C 3C
79
-20C 5C
79
+5C 3C
79
79
+5C 3C
79
+5C 3C
79
1008
+5C 3C
79
0664,1200
+5C 3C
79
2593
2063,20429
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0000612 Dopexamine dihydrochloride
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
10 mg
1
Information
Monograph Leaflet
Storage
1748
+5C 3C
Extra
Price
charges
79
a
Y0000613 Dopexamine impurity B
10 mg
2-methoxy-4-[2-[[6-[(2-phenylethyl)amino]hexyl]amino]ethyl]phenol
1748
-20C 5C
79
Y0000614 Dopexamine impurity F
10 mg
4-chloro-5-[2-[[6-[(2-phenylethyl)amino]hexyl]amino]ethyl]benz -ene-1,2-diol
1748
-20C 5C
79
Y0000726 Dorzolamide hydrochloride
50 mg
2359
+5C 3C
79
5 mg
2359
+5C 3C
79
Y0000750 Dorzolamide for system suitability
5 mg
Yes
+5C 3C
79
D2962000 Dosulepin hydrochloride
100 mg
+5C 3C
79
30 mg
1314
Yes
+5C 3C
79
Y0001385 Angelica pubescent root
500 mg
2557
Yes
+5C 3C
79
D2963000 Doxapram hydrochloride
50 mg
1201
+5C 3C
79
Y0000208 Doxapram impurity B
10 mg
(4RS)-1-ethyl-4-[2-[(2-hydroxyethyl)amino]ethyl]-3,3-diphenylpyrolidin-2-one
1201
+5C 3C
79
Y0000553 Doxazosin mesilate
60 mg
See leaflet CHNOS
2125
+5C 3C
79
Y0000551 Doxazosin impurity D
10 mg
6,7-dimethoxyquinazoline-2,4(1H,3H)-dione
2125
+5C 3C
79
New Y0000552 Doxazosin impurity F
2-chloro-6,7-dimethoxyquinazolin-4-amine ; Batch 1 is valid until 30 April 2014
2125
+5C 3C
79
+5C 3C
79
New Y0000727 Dorzolamide impurity A
New D2962005 Dosulepin impurity A
(4R,6R)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2sulphonamide 7,7-dioxide ; Batch 1 is valid until 31 May 2014
2359
1314
(E)-3-(6,11-dihydrodibenzo[b,e]thiepin-11-ylidene)-N,N'dimethylpropan-1-amine -oxide ; Batch 1 is valid until 30 April 2014
15 mg
Y0000838 Doxepin hydrochloride
5 mg
Y0000851 Doxepin for system suitability
1 mg
D2975000 Doxorubicin hydrochloride
150 mg
99.4% CHClNO
D3000000 Doxycycline hyclate
50 mg
92.9% CHClNO corresponding to 85.9% CHNO
Y0001492 Doxylamine for system suitability
100 mg
Y0001562 Doxylamine hydrogen succinate
60 mg
Y0000163 Doxylamine hydrogen succinate - reference spectrum
n/a
1589
D3100000 Droperidol
150 mg
Y0001105 Drospirenone
60 mg
Y0001115 Drospirenone impurity E
0.06 mg
Y0001453 Duloxetine hydrochloride
Y0001454 Duloxetine for system suitability
Y0001455 Duloxetine impurity A
Yes
Yes
1096
1096
Yes
+5C 3C
79
0714,0662,1
590
Yes
-20C 5C
g(c)
79
0272,0820
Yes
+5C 3C
79
1589
Yes
+5C 3C
79
1589
+5C 3C
79
79
1008,1009,1
010, 1172
+5C 3C
79
99.9% CHO
2404
+5C 3C
79
3-oxo-6alpha,7alpha,15alpha,16alpha-tetrahydro-3'H,3''H-dicyclopropa
[6,7:15,16]pregn-4-ene-21,17- carbolactone (17-epidrospirenone)
2404
+5C 3C
79
120 mg
99.8 % CHClNOS
2594
Yes
+5C 3C
79
40 mg
2594
Yes
+5C 3C
79
10 mg
+5C 3C
79
Y0001598 Dutasteride
150 mg
2641
Yes
+5C 3C
79
Y0001603 Dutasteride for system suitability
10 mg
2641
Yes
+5C 3C
79
Y0001004 Dydrogesterone
50 mg
99.5% CHO
2357
+5C 3C
79
Y0001005 Dydrogesterone impurity A
6 mg
9,10-pregna-4,6,8(14)-triene-3,20-dione
2357
+5C 3C
79
Y0001006 Dydrogesterone impurity B
5 mg
pregna-4,6-diene-3,20-dione
2357
+5C 3C
79
Council of Europe, all rights reserved 2014
(3R)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine ;
Batch 1 is valid until 31 March 2014
26
2594
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0000249 Ebastine - reference spectrum
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
n/a
1
Information
Monograph Leaflet
Storage
2015
Extra
Price
charges
79
l
Y0000247 Ebastine impurity C
10 mg
4-(diphenylmethoxy)piperidine
2015
+5C 3C
79
Y0000248 Ebastine impurity D
10 mg
1-[4-(1,1-dimethylethyl)phenyl]-4-(4-hydroxypiperidin-1-yl)butan-1-one
2015
+5C 3C
79
Y0001236 Econazole
10 mg
2049
+5C 3C
79
E0050000 Econazole nitrate
100 mg
0513,0665,0
921, 0935,
1017,1018
+5C 3C
79
Y0000254 Econazole for system suitability
20 mg
E0085000 Eicosapentaenoic acid ethyl ester
200 mg
Y0000537 Emedastine difumarate
10 mg
Y0000512 Emedastine impurity E
10 mg
E0100000 Emetine hydrochloride
100 mg
E0110000 Enalapril for system suitability
Y0001211 Enalapril impurity mixture
E0109000 Enalapril maleate
0665,2049
Yes
+5C 3C
79
2063,20429
Yes
-20C 5C
79
2242
+5C 3C
79
2242
+5C 3C
79
0081,0093,
0094,1530,1
875
+5C 3C
79
20 mg
1420
+5C 3C
79
0.06 mg
+5C 3C
79
50 mg
1420
+5C 3C
79
Y0000615 Enalaprilat dihydrate
100 mg
1749
+5C 3C
79
Y0000629 Enalaprilat for system suitability
10 mg
1749
+5C 3C
79
Y0000678 Enalaprilat impurity G
0.005 mg
1749
+5C 3C
79
Y0000136 Enilconazole
60 mg
1720
+5C 3C
79
Y0000137 Enilconazole impurity E
20 mg
(1RS)-1-(2,4-dichlorophenyl)-2-(-1H-imidazol-1-yl)ethanol
1720
+5C 3C
79
E0150000 Endotoxin standard BRP
10 mg
10 000 IU per vial
E0180000 Enoxaparin sodium
200 mg
Batch 4 is valid until 30 November 2013
E0180500 Enoxolone
100 mg
Y0001259 Enrofloxacin
5 mg
Y0001160 Enrofloxacin for system suitability
10 mg
2229
Y0001249 Entacapone
160 mg
99.9% CHNO
2574
Y0001250 Entacapone impurity A
10 mg
Z isomer of entacapone
E0200000 Enterokinase BRP
200 mg
E0305000 Ephedrine hydrochloride (racemic) - * Drug Precursor
50 mg
E0300000 Ephedrine hydrochloride - * Drug Precursor
150 mg
99.8% CHClNO
E0400000 4-Epianhydrotetracycline hydrochloride
20 mg
87.1% CHNO.HCl
E0440000 4-Epidemeclocycline hydrochloride
20 mg
E0500000 6-Epidoxycycline hydrochloride
50 mg
Council of Europe, all rights reserved 2014
97.5% CHO ; Batch 3 is valid until 17 December 2013
1-(2-ethoxyethyl)-2-(hexahydro-1H-1,4-diazepin-1yl)benzimidazole.
1420
Batch 1 is valid until 30 November 2013
(2SR)-2-[(3SR,8aRS)-3-methyl-1,4-dioxohexahydropyrrolo[1,2-a] pyrazin-2
(1H)-yl]-4-phenylbutanoic acid
Yes
Yes
20614
Yes
-20C 5C
79
0828,1097
Yes
+5C 3C
79
1511
+5C 3C
79
2229
+5C 3C
79
Yes
+5C 3C
79
Yes
+5C 3C
79
2574
+5C 3C
79
0350
+5C 3C
79
0715
+5C 3C
79
Yes
+5C 3C
79
Yes
+5C 3C
79
0176
+5C 3C
79
0272,0820
+5C 3C
79
0487,0488,0
489,1367,24
51
0210,0211,1
654
27
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0001139 Epinastine hydrochloride
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
20 mg
1
Information
Monograph Leaflet
2411
Y0001128 Epinastine hydrochloride for system suitability
10 mg
E0530000 4-Epioxytetracycline
40 mg
81.1% CHNO
E0550000 Epirubicin hydrochloride
100 mg
96.4% CHClNO
E0600000 4-Epitetracycline hydrochloride
30 mg
Y0000052 Equilin
15 mg
Y0001325 Equisetum palustre
200 mg
E0850010 Eq Influenza Subtype 1 Strain A/eq/Newmarket/77
Horse Antiserum BRP
1 mg
Assigned SRH antibody titre: 125 mm +/-20%; Common standard OIE
Strain A/eq/Newmarket/77
See leaflet,
0249
E0850021 Eq Influenza Subtype 2 American-like/Newmarket
Horse Antiserum BRP
1 mg
Assigned SRH antibody titre: 180 mm +/- 20%; Common standard OIE
Strain A/eq/Newmarket/1/93
E0850022 Eq Influenza Subtype 2 European-like/Newmarket
Horse Antiserum BRP
1 mg
Assigned SRH antibody titre: 155 mm +/- 20%; Common standard OIE
Strain A/eq/Newmarket/2/93
Y0000712 Eq Influenza Subtype 2 American-like/South Africa
Horse Antiserum BRP
1 mg
E0900000 Ergocalciferol
500 mg
E1000000 Ergometrine maleate - * Drug Precursor
50 mg
0223
E1100000 Ergosterol
20 mg
0082
E1200000 Ergotamine tartrate - * Drug Precursor
100 mg
Y0000051 Erysipelas ELISA coating antigen BRP
0.4 mg
0.5ml Freeze dried (0.367g protein)
Y0000177 Erythritol
1000 mg
99.8% CHO
E1300000 Erythromycin for microbiological assay
250 mg
960 IU per mg
E1305000 Erythromycin A
250 mg
See leaflet CHNO
E1310000 Erythromycin B
50 mg
See leaflet CHNO
New E1320000 Erythromycin C
50 mg
See leaflet CHNO
E1400000 Erythromycin estolate
100 mg
E1500000 Erythromycin ethylsuccinate
10 mg
E1500800 Erythromycin stearate
50 mg
Council of Europe, all rights reserved 2014
+5C 3C
2411
Yes
+5C 3C
79
Yes
+5C 3C
79
0662,0714,1
590
Yes
-20C 5C
79
+5C 3C
79
-20C 5C
79
+5C 3C
79
Yes
-20C 5C
90
See leaflet,
0249
Yes
-20C 5C
90
See leaflet,
0249
Yes
-20C 5C
90
See leaflet,
0249
Yes
-20C 5C
90
0082,0574,0
575,
0598,1192,1
193
Yes
-20C 5C
g(c)
79
+5C 3C
79
-20C 5C
g(c)
79
1512
Yes
1825
See leaflet; Vitamin D2 ; Batch 7 is valid until 31 August 2013
Extra
Price
charges
79
g
0198,0199
0210,0211,1
654
99.7% CHO
Storage
0224, 0551
+5C 3C
79
See leaflet,
0064
Yes
-20C 5C
90
1803
Yes
+5C 3C
79
20702
Yes
-20C 5C
79
0179,0274,0
293,
0490,0552,1
098
Yes
-20C 5C
79
0179,0274,0
490,
0552,1098
Yes
-20C 5C
79
0179,0274,0
490,
0552,1098
Yes
-20C 5C
79
0552
+5C 3C
79
0274
+5C 3C
79
0490
+5C 3C
79
28
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
E1515000 Erythropoietin BRP
Y0001611 Esculetin
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
3
37.5 mg
1 35280 IU per vial
1
25 mg
1 99.9% CHO
Y0001612 Esculin
Y0000324 Esketamine hydrochloride - reference spectrum
Y0000338 Esketamine impurity D
Information
Monograph Leaflet
Storage
Extra
Price
charges
150
a
1316
Yes
-20C 5C
2452
Yes
+5C 3C
79
2452
Yes
+5C 3C
79
79
1742
+5C 3C
79
25 mg
n/a
10 mg
New Y0001660 Esomeprazole magnesium dihydrate
15 mg
2787
+5C 3C
79
Y0001028 Esomeprazole magnesium trihydrate
10 mg
2372
+5C 3C
79
Y0000749 Essential oil
1000 mg
2098
+5C 3C
79
E1600000 Estradiol benzoate
250 mg
0139
+5C 3C
79
Y0000852 Estradiol benzoate for system suitability
10 mg
0139
+5C 3C
79
Y0000045 Estradiol butyrate
10 mg
1614
+5C 3C
79
E1620000 Estradiol hemihydrate
100 mg
0821,1203
+5C 3C
79
Y0000314 Estradiol for peak identification
10 mg
0821
+5C 3C
79
Y0000046 Estradiol valerate
50 mg
1614
+5C 3C
79
E1680000 Estriol
50 mg
1203
+5C 3C
79
E1680005 Estriol impurity A
20 mg
See leaflet; 9,11-didehydroestriol ; Batch 1 is valid until 31 August 2013
E1700000 Estrone
15 mg
100.0% CHO
E1800000 Etacrynic acid
100 mg
0457
Y0001263 Etacrynic acid for system suitability
10 mg
0457
E1830000 Etamsylate
30 mg
E1840000 Ethacridine lactate monohydrate
50 mg
E1850000 Ethambutol hydrochloride
250 mg
Y0000803 Ethambutol for system suitability
10 mg
A1202800 Ethanol (anhydrous) - reference spectrum
E1860100 Ethanol 96% - reference spectrum
E1900000 Ethinylestradiol
92,4% CHO
1742
(2R)-2-(2-chlorophenyl)-2-(methylamino)cyclohexanone ((R)-ketamine)
Yes
Yes
Yes
1203
Yes
+5C 3C
79
1512,0140
Yes
+5C 3C
79
+5C 3C
79
+5C 3C
79
1204
+5C 3C
79
1591
+5C 3C
79
0553
+5C 3C
79
0553
+5C 3C
79
n/a
1318
79
n/a
1317
79
200 mg
99.8% CHO
Y0001124 Ethinylestradiol for system suitability
1.0124 mg
Batch 1 is valid until 1 May 2013
E2000000 Ethionamide
100 mg
E2150000 Ethosuximide
30 mg
E2250000 Ethosuximide impurity A
30 mg
E2195000 Ethyl acetate - reference spectrum
n/a
E2195900 Ethylcellulose - reference spectrum
n/a
E2202000 1-N-Ethylgaramine sulfate
50 mg
77.6% of 1-N-Ethylgaramin sulphate
E2205500 1,1'-Ethylidenebistryptophan
0.002 mg
0.00182 mg per vial of CHNO ; Batch 4 is valid until 1 May 2013
Y0000617 Ethyl indole-3-carboxylate
10 mg
Council of Europe, all rights reserved 2014
(2RS)-2-ethyl-2-methylbutanedioic acid
0140,0821,0
940
Yes
+5C 3C
79
0140
Yes
+5C 3C
79
0141
+5C 3C
79
0764
+5C 3C
79
0764
+5C 3C
79
0899
79
0822
79
1351
Yes
+5C 3C
79
1272,1383
Yes
+5C 3C
79
+5C 3C
79
2102
29
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
E2300000 Ethylmorphine hydrochloride - reference spectrum
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
n/a
1
Information
Monograph Leaflet
0491
E2400000 Ethylnicotinamide
150 mg
E2425000 Ethyl parahydroxybenzoate
150 mg
Y0001633 Ethylcellulose
100 mg
E2450000 Etifenin
25 mg
75 mg
Batch 1 is valid until 30 April 2014
E2451010 Etilefrine impurity A
20 mg
2-ethylamino-1-(3-hydroxyphenyl)ethanone
Y0000572 Etidronate disodium
10 mg
E2470000 Etodolac
60 mg
E2470050 Etodolac impurity H
10 mg
Y0000768 Etodolac for peak identification
10 mg
1422
E2499900 Etofenamate
40 mg
1513
E2499901 Etofenamate for peak identification
20 mg
E2499914 Etofenamate impurity G
25 mg
E2500000 Etofylline
100 mg
E2503000 Etomidate
50 mg
E2503004 Etomidate impurity B
25 mg
methyl 1-[(1RS)-1-phenylethyl]-1H-imidazole-5-carboxylate
See leaflet ; Batch 5 is valid until 31 May 2014
New E2451000 Etilefrine hydrochloride
New E2600000 Etoposide
Storage
0233
+5C 3C
79
+5C 3C
79
0822
+5C 3C
79
0585
+5C 3C
79
1205
+5C 3C
79
1205
+5C 3C
79
1778
+5C 3C
79
1422
+5C 3C
79
1422
+5C 3C
79
+5C 3C
79
+5C 3C
79
0409,0431,0
900,
1262,1263,2
134
100.0% CHO
2-(7-ethylindol-3-yl)ethanol
1513
2-hydroxyethyl 2-[[3-(trifluoromethyl)phenyl]amino]-benzoate ; Batch 1 is
valid until 30 November 2013
Extra
Price
charges
79
l
Yes
Yes
+5C 3C
79
1513
Yes
+5C 3C
79
0486
+5C 3C
79
1514
+5C 3C
79
1514
+5C 3C
79
150 mg
0823
Yes
+5C 3C
79
Y0001365 Etoposide for system suitability
10 mg
0823
Yes
+5C 3C
79
Y0001605 Eucommia bark HRS
2100 mg
2412
Yes
-20C 5C
79
E5000000 Eugenol
500 l
1100
+5C 3C
79
F0005000 Famotidine
100 mg
1012
+5C 3C
79
Y0000382 Famotidine for system suitability
10 mg
1012
+5C 3C
79
Y0000409 Famotidine impurity D
10 mg
3-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]propanamide
1012
+5C 3C
79
Y0000556 Febantel
110 mg
99.9% CHNOS
2176
+5C 3C
79
Y0000660 Febantel for system suitability
10 mg
2176
+5C 3C
79
Y0000731 Felbinac
10 mg
2304
+5C 3C
79
Y0000732 Felbinac impurity A
20 mg
2304
+5C 3C
79
F0030000 Felodipine
120 mg
1013
+5C 3C
79
Y0000415 Felypressin
0.994 mg
F0040000 Fenbendazole
150 mg
F0040010 Fenbendazole impurity A
20 mg
F0040020 Fenbendazole impurity B
25 mg
Council of Europe, all rights reserved 2014
4-acetyl biphenyl
-20C 5C
79
1208,1458
+5C 3C
79
methyl(1-benzimidazol-2-yl)carbamate
1208
+5C 3C
79
methyl[5(6)-chlorobenzimidazol-2-yl]carbamate
1208
+5C 3C
79
0.994 mg CHNOS
30
1634
Yes
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Code
F0041000 Fenbufen
Reference Standard
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
100 mg
1
Information
Monograph Leaflet
1209
+5C 3C
F0048000 Fenofibrate
100 mg
100.0% CHClO
1322
F0048005 Fenofibrate impurity A
20 mg
(4-chlorophenyl)(4-hydroxyphenyl)methanone
1322
F0048010 Fenofibrate impurity B
10 mg
2[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid (fenofibric acid)
F0048035 Fenofibrate impurity G
25 mg
1-methylethyl 2-[[2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoyl]
oxy]-2-methylpropanoate
Y0000756 Fenoterol for peak identification
1.2 mg
F0050000 Fenoterol hydrobromide
100 mg
F0054990 Fentanyl - reference spectrum
n/a
1210
Y0001509 Fentanyl for system suitability - * narc
25 mg
1210,1103
F0055000 Fentanyl citrate - reference spectrum
n/a
1103
F0060000 Fenticonazole nitrate
50 mg
F0060040 Fenticonazole impurity D
0.01 mg
F0100000 Ferrous gluconate
100 mg
Y0001013 Ferulic acid
20 mg
99.8% CHO
1834,2558
Y0000789 Fexofenadine hydrochloride
60 mg
99.8% CHClNO
2280
Y0000751 Fexofenadine impurity A
5 mg
2-[4-[4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butanoyl]phenyl]-2methylpropanoic acid
Y0000752 Fexofenadine impurity B
0.01 mg
Y0000753 Fexofenadine impurity C
5 mg
Y0001173 Filgrastim
Y0000090 Finasteride
Y0001604 Finasteride for peak identification
15 mg
Y0000091 Finasteride for system suitability
120 mg
Y0000736 Flavoxate hydrochloride
10 mg
Y0000737 Flavoxate impurity A
10 mg
3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylic acid
Y0000738 Flavoxate impurity B
10 mg
ethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate
1692
F0120000 Flecainide acetate
10 mg
Batch 1 is valid until 30 November 2013
1324
F0120005 Flecainide impurity A
50 mg
3-[2,5-bis(2,2,2-trifluoroethoxy)phenyl]-1,5,6,7,8,8a-hexahydroimidazo[1,5a]pyridine ; Batch 2 is valid until 1 May 2013
1324
F0120010 Flecainide impurity B
25 mg
(RS)-(piperidin-2-yl)methanamine
1324
Y0001274 Flecainide for system suitability
10 mg
1324
Yes
Y0001606 Fleeceflower root HRS
300 mg
2433
Yes
Y0000138 Flubendazole
25 mg
1721
Y0000139 Flubendazole for system suitability
20 mg
1721
Council of Europe, all rights reserved 2014
Yes
Extra
Price
charges
79
g
+5C 3C
79
+5C 3C
79
1322
+5C 3C
79
1322
+5C 3C
79
0901
+5C 3C
79
+5C 3C
79
79
79
79
0901
contains 1.3% of impurity A
Storage
Yes
Yes
+5C 3C
1211
+5C 3C
79
1211
+5C 3C
79
0493
+5C 3C
79
Yes
+5C 3C
79
Yes
+5C 3C
79
2280
+5C 3C
79
2-[3-[(1RS)-1-hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl]
phenyl]-2-methylpropanoic acid
2280
+5C 3C
79
(1RS)-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]-1-[4-(1-methylethyl)
phenyl]butan-1-ol
2280
+5C 3C
79
0.2 ml
1.95 mg per ml of CHNOS
2206
Yes
-80C 10C
79
60 mg
99.7% CHNO
1615
Yes
+5C 3C
79
1615
Yes
+5C 3C
79
1615
Yes
+5C 3C
79
1692
+5C 3C
79
1692
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
()-1-[2-(2,4-dichlorophenyl)-2-hydroxyethyl]-3-[4-(phenyl suphanyl)
benzyl]imidazolium nitrate ; Batch 1 is valid until 30 November 2013
Contains 0.9% of impurity A ; Batch 2 is valid until 31 August 2013
31
Yes
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0000892 Flucloxacillin magnesium octahydrate
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
5 mg
1
Information
Monograph Leaflet
Storage
2346
+5C 3C
Extra
Price
charges
79
a
Y0000889 Flucloxacillin impurity C
5 mg
6-aminopenicillanic acid
2346
+5C 3C
79
Y0000890 Flucloxacillin impurity D
5 mg
3-(2-chloro-6-fluorophenyl)-5-methylisoxazole-4-carboxylic acid
2346
+5C 3C
79
Y0000891 Flucloxacillin impurity E
5 mg
6-aminopenicillanic acid flucloxacillin amide
F0150000 Flucloxacillin sodium
250 mg
95.1% CHClFNNaOS
Y0000557 Fluconazole
50 mg
Y0000558 Fluconazole for peak identification
10 mg
2287
Y0000573 Fluconazole impurity B
10 mg
See leaflet; 2-[2-fluoro-4-(1H-1,2,4-triazol-1-yl)phenyl]-1,3-bis(1H-1,2,4 triazol-1-yl)propan-2-ol ; Batch 2 is valid until 31 March 2014
2287
Y0000574 Fluconazole impurity C
5 mg
1,1'-(1,3-phenylene)di-1H-1,2,4-triazole
F0175000 Flucytosine
100 mg
Y0001262 Flucytosine for system suitability
0.3 mg
Y0000419 Fludarabine phosphate
120 mg
1781
Y0001536 Fludarabine for system suitability
15 mg
1781
F0180000 Fludrocortisone acetate
100 mg
0767
F0188000 Flumazenil - reference spectrum
n/a
1326
Y0000335 Flumazenil impurity B
5 mg
F0189000 Flumequine
60 mg
F0189020 Flumequine impurity B
0.1 mg
F0188500 Flumetasone pivalate
100 mg
F0189900 Flunarizine dihydrochloride
Y0000265 Flunarizine dihydrochloride - reference spectrum
Y0000266 Flunarizine dihydrochloride for system suitability
F0190000 Flunitrazepam - * psy
Y0000169 Flunitrazepam - reference spectrum
Y0000443 Flunixin meglumine
2346
Yes
+5C 3C
79
0661,0663,0
668,2346
Yes
-20C 5C
79
+5C 3C
79
Yes
+5C 3C
79
Yes
+5C 3C
79
2287
+5C 3C
79
0766
+5C 3C
79
0766
+5C 3C
79
Yes
+5C 3C
79
Yes
+5C 3C
79
+5C 3C
79
79
+5C 3C
79
1517
+5C 3C
79
1517
+5C 3C
79
1327
+5C 3C
79
100 mg
0816
+5C 3C
79
n/a
1722
79
20 mg
1722
+5C 3C
79
100 mg
1280
+5C 3C
79
n/a
0717
79
10 mg
1696
+5C 3C
79
Y0000444 Flunixin impurity B
10 mg
2-methyl-3-(trifluoromethyl)aniline
1696
+5C 3C
79
New Y0000445 Flunixin impurity C
55 mg
ethyl 2-chloropyridine-3-carboxylate ; Batch 1 is valid until 30 April 2014
1696
+5C 3C
79
F0200000 Fluocinolone acetonide
100 mg
0494
+5C 3C
79
F0230000 Fluocortolone pivalate
100 mg
1212
+5C 3C
79
Y0000796 Fluorescein
120 mg
99.2% CHO
2348
+5C 3C
79
Y0000804 Fluorescein impurity C
0.01 mg
2-(2,4-dihydroxybenzoyl)benzoic acid
2348
+5C 3C
79
F0245000 Fluoresceine sodium - reference spectrum
n/a
1213
79
F0250000 Fluorouracil
40 mg
0611,0766
+5C 3C
79
Council of Europe, all rights reserved 2014
2287
98.3% CHFNOP
ethyl 8-hydroxy-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]
benzodiazepine-3-carboxylate
ethyl(RS)-9-fluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-benzo[i,j]
quinolizine-2-carboxylate
32
1326
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0000762 Fluorouracil impurity A
Y0000763 Fluorouracil impurity B
Effective from 2014/1/2
Batch n Quantity Sale
Information
per vial Unit
1
10 mg
1 pyrimidine-2,4,6(1H,3H,5H)-trione (barbituric acid)
1
15 mg
1 dihydropyrimidine-2,4,5(3H)-trione (isobarbituric acid or 5-hydroxyuracil)
Storage
0611
+5C 3C
Extra
Price
charges
79
a
0611
+5C 3C
79
10 mg
pyrimidine-2,4(1H,3H)-dione (uracil)
0611
+5C 3C
79
10 mg
2-ethoxy-5-fluoropyrimidin-4(1H)-one (2-ethoxy-5-fluorouracil)
0611
0.0002 mg
Y0000764 Fluorouracil impurity C
Y0000765 Fluorouracil impurity F
Y0000791 Fluorouracil impurity mixture
New F0253000 Fluoxetine hydrochloride
Monograph Leaflet
+5C 3C
79
0611
Yes
+5C 3C
79
Yes
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
250 mg
See leaflet ; Batch 4 is valid until 31 May 2014
1104
F0253020 Fluoxetine impurity B
10 mg
methyl(3-phenylpropyl)amine
1104
F0253030 Fluoxetine impurity C
5 mg
()-methyl-[3-phenyl-3-(3-trifluoromethylphenoxy)-propyl] amine
1104
Y0000064 Flupentixol dihydrochloride
100 mg
43.6% of Z-isomer CHClFNOS
1693
Y0000067 Flupentixol impurity D
15 mg
2-[2-[4-[3-[(EZ)-2-(trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl]
piperazin-1-yl]ethoxy]ethanol
1693
Y0000078 Flupentixol impurity F
25 mg
80.9% CHFNOS; 2-[4-[(EZ)-3-[(9RS)-2-(trifluoromethyl)-9Hthioxanthen-9-yl] prop-2-enyl]piperazin-1-yl]ethanol
1693
F0260000 Fluphenazine decanoate
60 mg
1014,1015
+5C 3C
g(b)
79
Y0000009 Fluphenazine enantate
100 mg
1014,1015
+5C 3C
79
F0280000 Fluphenazine dihydrochloride
50 mg
+5C 3C
79
Y0000708 Fluphenazine impurity mixture
0.07 mg
+5C 3C
79
Y0000298 Fluphenazine octanoate
20 mg
1014,1015
+5C 3C
79
Y0000299 Fluphenazine sulfoxide
10 mg
0904,1014,1
015
+5C 3C
79
Y0000211 Flurazepam monohydrochloride - reference spectrum
n/a
0905
79
F0285200 Flurbiprofen
50 mg
F0285202 Flurbiprofen impurity A
25 mg
Y0000236 Fluspirilene
20 mg
Y0000375 Fluspirilene impurity C
10 mg
F0285600 Flutamide
100 mg
Y0001591 Flutamide for system suitability
10 mg
F0285603 Flutamide impurity C
20 mg
N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
1423
Y0000284 Fluticasone propionate
100 mg
99.6% CHFOS
1750
Y0000221 Fluticasone impurity D
20 mg
S-methyl 6a,9a-difluoro-11b-hydroxy-16a-methyl-3-oxo-17apropionyloxy-androsta-1,4-diene-17-carbothioate
(S-methyl derivative)
F0290000 Flutrimazole
100 mg
F0290010 Flutrimazole impurity B
60 mg
Y0001090 Fluvastatin sodium
110 mg
Y0001082 Fluvastatin for system suitability
0.5 mg
2333
Council of Europe, all rights reserved 2014
Yes
Yes
0904,1014
Batch 1 is valid until 30 November 2013
0904
Batch 3 is valid until 28 February 2014
Yes
1519
+5C 3C
79
1519
+5C 3C
79
1723
+5C 3C
79
8-[4,4-bis(4-fluorophenyl)butyl]-3-(hydroxymethyl)-1-phenyl-1,3,8triazaspiro[4.5]decan-4-one
1723
+5C 3C
79
See leaflet ; Batch 1 is valid until 31 December 2013
1423
Yes
+5C 3C
79
1423
Yes
+5C 3C
79
+5C 3C
79
+5C 3C
79
1750
+5C 3C
79
1424
+5C 3C
79
1424
+5C 3C
79
2333
+5C 3C
79
+5C 3C
79
(2RS)-2-(biphenyl-4-yl)propanoic acid ; Batch 1 is valid until 30 November
2013
(RS)-(2-fluorophenyl)(4-fluorophenyl)phenylmethanol
33
Yes
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0000854 Fluvoxamine maleate
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
5 mg
1
Information
Monograph Leaflet
1977
Y0000853 Fluvoxamine for system suitability
1.004 mg
Y0000916 Fluvoxamine impurity D
10 mg
5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one
1977
1977
Y0000386 Foeniculin for peak identification
100 mg
Anise oil
0804
F0300000 Folic acid
300 mg
91.3 % CHNO
0067
Y0001242 Folic acid impurity A
15 mg
(2S)-2-[(4-aminobenzoyl)amino]pentanedioic acid (N-(4-aminobenzoyl)-lglutamic acid)
0067
Y0001243 Folic acid impurity D
70 mg
4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino]benzoic acid
(pteroic acid)
0067
F0372000 Formoterol fumarate dihydrate
10 mg
Y0000339 Formoterol for impurity I identification
10 mg
Y0000340 Formoterol fumarate for system suitability
10 mg
F0380000 Formylfolic acid
30 mg
F0389000 Foscarnet sodium hexahydrate
50 mg
F0389004 Foscarnet impurity B
10 mg
Y0001222 Foscarnet impurity D
50 mg
1520
Y0001213 Foscarnet impurity mixture
0.012 mg
1520
Y0000782 Fosfomycin calcium
10 mg
1328
F0399950 Fosfomycin sodium - reference spectrum
n/a
1329
New F0400000 Fosfomycin trometamol
1500 mg
Y0001227 Fosinopril sodium
60 mg
Y0001228 Fosinopril impurity A
5 mg
Y0001229 Fosinopril impurity B
5 mg
Y0001230 Fosinopril impurity C
Y0001231 Fosinopril impurity D
91.4% CHNO; 10-Formylfolic acid
disodium (ethoxyoxydophosphanyl)formate
Storage
+5C 3C
Yes
Extra
Price
charges
79
g
+5C 3C
79
+5C 3C
79
Yes
+5C 3C
79
Yes
+5C 3C
79
+5C 3C
79
+5C 3C
79
1293,1724
+5C 3C
79
1724
+5C 3C
79
Yes
1724
Yes
+5C 3C
79
0978,1606
Yes
-20C 5C
79
1520
+5C 3C
79
1520
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
79
+5C 3C
79
1751
+5C 3C
79
(2S,4S)-4-cyclohexyl-1-[[(R)-hydroxy(4-phenylbutyl)phosphoryl]acetyl]
pyrrolidine-2-carboxylic acid
1751
+5C 3C
79
(2RS,4RS)-4-cyclohexyl-1-[[(RS)-[(1SR)-2-methyl-1-(1-oxopropoxy)
propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid
1751
+5C 3C
79
10 mg
mixture of (2S,4S)-4-cyclohexyl-1-[[(S)-[(1S)-2-methyl-1-(1-oxopropoxy)
propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid and
(2S,4S)-4-cyclohexyl-1-[[(R)-[(1R)-2-methyl-1-(1-oxopropoxy)propoxy](4phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid
1751
+5C 3C
79
10 mg
(2S,4R)-4-cyclohexyl-1-[[(R)-[(1S)-2-methyl-1-(1-oxopropoxy)propoxy](4phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid
1751
+5C 3C
79
Y0001232 Fosinopril impurity I
5 mg
[(RS)-[(1SR)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphoryl]
acetic acid
1751
+5C 3C
79
Y0001233 Fosinopril impurity K
5 mg
(2S,4S)-4-cyclohexyl-1-(2,2-dimethyl-1-oxopropyl)pyrrolidine-2-carboxylic
acid
1751
+5C 3C
79
Y0001212 Fosinopril impurity mixture
0.02 mg
F0450000 Framycetin sulfate
25 mg
Council of Europe, all rights reserved 2014
1425
Yes
See leaflet ; Batch 2 is valid until 30 April 2014
See leaflet ; Batch 5 is valid until 31 March 2014
34
Yes
1751
Yes
+5C 3C
79
0180,0197,2
0702
Yes
-20C 5C
79
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Code
F0550000 Fructose
Reference Standard
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
100 mg
1
Y0001399 Fulvestrant
Y0001413 Fulvestrant for system suitability
F0600000 Fumaric acid
Information
Monograph Leaflet
0177,0178,0
187,
0188,0204,0
209,
0924,1061,1
570
Storage
+5C 3C
120 mg
+5C 3C
79
40 mg
120 mg
+5C 3C
79
+5C 3C
79
F0700000 Furosemide
100 mg
+5C 3C
79
Y0001493 Furosemide for peak identification
10 mg
F0702000 Furosemide impurity A
5 mg
+5C 3C
79
+5C 3C
79
Y0001411 Fusidic acid
10 mg
0798
Y0001394 Fusidic acid for peak identification
5 mg
0798,0848
Yes
-20C 5C
79
-20C 5C
79
Y0001384 Fusidic acid impurity mixture
0.0475 mg
0798,0848
Yes
Y0001280 Gabapentin
300 mg
99.9% CHNO
2173
Yes
-20C 5C
79
+5C 3C
79
Y0001281 Gabapentin impurity A
20 mg
2-azaspiro[4.5]decan-3-one
Y0001348 Gabapentin impurity B
20 mg
(1-cyanocyclohexyl)acetic acid
2173
+5C 3C
79
2173
-20C 5C
79
Y0001349 Gabapentin impurity D
10 mg
[1-[(3-oxo-2-azaspiro[4.5]dec-2-yl)methyl]cyclohexyl]acetic acid
G0049000 Galactitol
50 mg
2173
+5C 3C
79
1381
+5C 3C
79
G0050000 Galactose
60 mg
Y0001279 Galantamine hydrobromide
10 mg
1215
+5C 3C
79
2366
+5C 3C
79
Y0001190 Galantamine natural for system suitability
Y0001201 Galantamine racemic mixture
10 mg
2366
+5C 3C
79
10 mg
2366
+5C 3C
79
Y0001191 Galantamine synthetic for system suitability
G0150000 Gammacyclodextrin
5 mg
60 mg
Y0001129 Ganciclovir
Y0001144 Ganciclovir impurity mixture
220 mg
1752
0.005 mg
1752
Yes
Y0000675 Gemcitabine hydrochloride
50 mg
See leaflet CHClFNO
2306
Yes
Y0000676 Gemcitabine impurity A
20 mg
4-aminopyrimidin-2(1H)-one (cytosine)
2306
Y0000513 Gemfibrozil
5 mg
Y0000514 Gemfibrozil for system suitability
0.196 mg
Batch 1 is valid until 11 December 2013
G0200000 Gentamicin sulfate
25 mg
see leaflet ; Batch 7 is valid until 31 January 2013
Y0001112 Gestodene
100 mg
99.4%
Y0001363 Gentamicin for peak identification
10 mg
Y0001110 Gestodene for system suitability
10 mg
Council of Europe, all rights reserved 2014
2443
Yes
2443
Yes
0365,0902,1
190, 1592
0391,2185
Extra
Price
charges
79
a
98.8% CHFOS
Batch 1 is valid until 31 January 2013
0391
2-chloro-4-(furfurylamino)-5-sulphamoylbenzoic acid
91,2% CHO ; Batch 1 is valid until 1 June 2013
Yes
0391
Yes
2366
Yes
+5C 3C
79
1070,1487
Yes
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
1694
+5C 3C
79
1694
Yes
+5C 3C
79
0331,20702
Yes
-20C 5C
79
1726
Yes
+5C 3C
79
0331
Yes
-20C 5C
79
1726
Yes
+5C 3C
79
35
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0001116 Gestodene impurity I
Effective from 2014/1/2
Batch n Quantity Sale
Information
Monograph Leaflet
per vial Unit
1
0.01 mg
1 13-ethyl-17-hydroxy-5-methoxy-18,19-dinor-5alpha,17alpha-pregn-15-en-201726
yn-3-one
Y0001012 Ginkgo dry extract for peak identification
150 mg
Y0001010 Ginkgolic Acids
Y0001029 Ginseng dry extract HRS
20 mg
500 mg
Y0001347 Ginsenoside Rb1
30 mg
G0300000 Gitoxin
30 mg
0078,0079,2
168
G0325000 Glibenclamide
100 mg
0718
Y0001511 Glibenclamide for peak identification
30 mg
G0325010 Glibenclamide impurity A
10 mg
4-[2-(5-chloro-2-methoxybenzamido)ethyl]benzene- sulphonamide
0718
Y0000242 Glibenclamide impurity B
20 mg
methyl [[4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]phenyl]
sulphonyl]carbamate
0718
G0326000 Gliclazide
20 mg
G0326004 Gliclazide impurity B
25 mg
2-nitroso-octahydrocyclopenta[c]pyrrole
G0326012 Gliclazide impurity F
50 mg
Y0000515 Glimepiride
60 mg
Y0000516 Glimepiride for system suitability
0.012 mg
G0340000 Glipizide
50 mg
G0342000 Glipizide impurity A
10 mg
4-[2-(5-methylpyrazine-2-carboxamido)ethyl]benzene sulphonamide
Y0000523 Glipizide impurity C
10 mg
Y0000643 Glipizide impurity D
10 mg
Y0001140 Glipizide impurity mixture
0.002 mg
0906
Y0001406 Glucosamine hydrochloride
10 mg
2446
Y0000191 Human glucagon
2.94 mg
Y0001381 Glucosamine for system suitability
40 mg
Y0001407 Glucosamine sulfate sodium chloride
15 mg
G0350500 Glucose
100 mg
G0355000 Glutamic acid
50 mg
Y0000517 Glutathione
10 mg
G0360000 Glutethimide - * psy
Y0001391 Glycerol formal
Council of Europe, all rights reserved 2014
Storage
+5C 3C
Extra
Price
charges
79
a
1827
Yes
-20C 5C
79
1827
Yes
-20C 5C
79
2356
Yes
-20C 5C
79
2356
Yes
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
1524
+5C 3C
79
1524
+5C 3C
79
1-(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-[(2-methylphenyl) sulphonyl]
urea
1524
+5C 3C
79
99.4% CHNOS
2223
+5C 3C
79
Batch 2 is valid until 31 January 2013
2223
+5C 3C
79
0906
+5C 3C
79
0906
+5C 3C
79
ethyl [2-[4-[(cyclohexylcarbamoyl)sulphamoyl]phenyl]ethyl] carbamate
0906
+5C 3C
79
6-methyl-N-[2-(4-sulphamoylphenyl)ethyl]pyrazine-2-carboxamide
0906
+5C 3C
79
+5C 3C
79
+5C 3C
79
-20C 5C
79
+5C 3C
79
2447
+5C 3C
79
0177,0178,0
187,
0188,0204,0
209,
1061,1215,1
570
+5C 3C
79
0750,0797,1
445, 2076
+5C 3C
79
1670
+5C 3C
79
50 mg
1291
+5C 3C
79
20 mg
1671
+5C 3C
79
0.37% of ginkgolic acid C17
88.1 % CHO
0718
2.94 mg pure human glucagon per vial CHNOS
1635
2446,2447
36
Yes
Yes
Yes
Yes
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0000794 Glycerol monocaprylate
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
500 mg
1
Information
Monograph Leaflet
Storage
Extra
Price
charges
79
g
2213
Yes
+5C 3C
2392
Yes
+5C 3C
79
1429
+5C 3C
79
1430
+5C 3C
79
+5C 3C
79
79
+5C 3C
79
+5C 3C
79
Y0000795 Glycerol monocaprylocaprate
500 mg
G0400006 Glycerol monolinoleate
2000 mg
G0400007 Glycerol mono-oleate
2500 mg
G0400008 Glycerol monostearate 40-55
2000 mg
0495
G0400101 Glyceryl trinitrate - reference spectrum
n/a
1331
G0400100 Glyceryl trinitrate solution
0.5 ml
G0450000 Glycine
50 mg
0614,0752
Y0001308 Glycopyrronium bromide
10 mg
1783
+5C 3C
79
Y0001309 Glycopyrronium for peak identification
10 mg
1783
Yes
+5C 3C
79
Y0001358 Glycopyrronium impurity N
10 mg
1783
Yes
+5C 3C
79
Y0000433 Ammonium glycyrrhizate
70 mg
+5C 3C
79
G0460000 Glycyrrhizate (monoammonium)
300 mg
78.6% CHNO
0277,1536,
2378
Yes
+5C 3C
79
G0525000 Gonadorelin
5 mg
4.96 mg per vial of CHNO
0827
Yes
-20C 5C
79
Y0000125 Goserelin
1.87 mg
1636
-20C 5C
79
Y0000126 Gosereline - reference spectrum
n/a
1636
79
Y0000019 4-D-Ser-goserelin
0.1 mg
-20C 5C
79
Y0000194 Goserelin validation mixture
1 mg
Supplied with the Ph. Eur. reference chromatogram
-20C 5C
79
Y0001473 Goserelin for NMR identification
14 mg
replace Y0000126
G0550000 Gramicidin
250 mg
1081 IU per mg
Y0000396 Granisetron hydrochloride
120 mg
Y0000477 Granisetron impurity A
1 mg
Y0000478 Granisetron impurity B
Y0000395 Granisetron impurity E
G0600000 Griseofulvin
In the chromatogram supplied within the leaflet (Rev 02) of the current CRS
batch 1, some peaks have been mislabelled, the correct version of the leaflet
(Rev 03) is now available on the website. The quality of the product itself is
not questioned and can still to be used.
Batch 1 is valid until 1 April 2013
1331,1355
1% m/m in ethanol CHNO
94.0% CHNO+; (3RS)-3-[(2RS)-(2-cyclopentyl-2-hydroxy-2-phenylacetyl)
oxy]-1,1-dimethylpyrrolidinium
Yes
1772
1636
1636
Yes
-20C 5C
79
0907,1662,2
0702
Yes
+5C 3C
79
99.8% CHClNO
1695
Yes
+5C 3C
79
2-methyl-N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-2Hindazole-3-carboxamide
1695
+5C 3C
79
1 mg
N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3carboxamide
1695
+5C 3C
79
15 mg
(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine
1695
+5C 3C
79
50 mg
0182
+5C 3C
79
Y0000619 Guaiacol
1500 mg
G0700000 Guaifenesin
100 mg
Y0000117 Halofantrine hydrochloride
125 mg
99.6% CHClFNO
Y0000118 Halofantrine impurity C
10 mg
[1,3-dichloro-6-(trifluoromethyl)phenantren-9-yl]methanol
H0100000 Haloperidol
60 mg
Batch 1 is valid until 1 July 2013
Council of Europe, all rights reserved 2014
99.6% CHO ; Batch 1 is valid until 30 November 2013
37
1636
Yes
1978
Yes
+5C 3C
79
0615
Yes
+5C 3C
79
1979
+5C 3C
79
1979
+5C 3C
79
0616,0995,1
178, 1503
+5C 3C
79
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
H0100100 Haloperidol decanoate
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
60 mg
1
Information
Monograph Leaflet
1397,1431
Storage
+5C 3C
Extra
Price
charges
79
a
Y0001518 Haloperidol for peak identification
25 mg
0616
Yes
+5C 3C
79
Y0001517 Haloperidol for system suitability
25 mg
0616
Yes
+5C 3C
79
H0150000 Halothane - reference spectrum
n/a
79
Y0000673 Harpagoside
1.03 mg
1.01mg per vial CHO
1095, 1871
Yes
+5C 3C
79
H0185000 Heparin Low-Molecular-Mass for assay BRP
1 mg
Anti-IIa activity : 31 IU per vial; Anti-Xa activity : 104 IU per vial ; Batch 7 is
valid until 30 November 2013
0828
Yes
+5C 3C
90
H0190000 Heparin Low-Molecular-Mass for calibration CRS
25 mg
Mna = 3800 ; Batch 2 is valid until 30 November 2013
H0200000 Heparin sodium BRP
2 ml
1010 IU per ml
Y0001287 Heparin calcium for NMR identification
30 mg
Y0001283 Heparin sodium for NMR identification
30 mg
Y0001282 Heparin for physico-chemical analysis
300 mg
Batch 1 is valid until 31 March 2014
H0205010 Hepatitis A vaccine (inactivated, adsorbed) Type B BRP
0.5 ml
262 IU per ml; Please contact us for information on the type needed for your
use
Y0001192 Hepatitis A Vaccine (Inactivated, Non-Adsorbed) BRP
0.8 ml
To be stored below -50C
Y0001624 Hepatitis A virus Coating Reagent for ELISA - BRR
1 mL
Y0001623 Set of Hepatitis A virus Detection Antibodies for ELISA BRR
Y0000389 Hepatitis B vaccine (rDNA) BRP method A (thiomersal
free)
0393
0828
Yes
+5C 3C
90
0569, 20705
Yes
+5C 3C
79
0332
Yes
+5C 3C
79
0333
Yes
+5C 3C
79
+5C 3C
79
See leaflet,
20714
Yes
+5C 3C
90
20714,1526,
1935, 1107
Yes
-80C 10C
90
Yes
-20C 5C
79
420 L
Yes
-20C 5C
79
0.5 ml
16.6 micrograms per ml
See leaflet,
20715
Yes
+5C 3C
90
H0210010 Hepatitis B vaccine (rDNA) BRP method B
1 ml
20 micrograms per ml
See leaflet,
1056
Yes
+5C 3C
90
H0220000 Heptadecanol
600 mg
97.9% CHO
0801,0802,0
847
+5C 3C
79
Y0000063 Heptaminol hydrochloride
150 mg
1980
+5C 3C
79
Y0000057 Heptaminol impurity A
20 mg
93.4% CHN; (2RS)-6-methylhept-5-en-2-amine
1980
+5C 3C
79
Y0001203 Hesperidin
20 mg
89,9% CHO
2430
+5C 3C
79
H0330000 Hexamidine diisetionate
20 mg
Batch 1 is valid until 31 January 2013
1436
+5C 3C
79
H0325000 Hexetidine
100 mg
1221
+5C 3C
79
H0420000 Hexylresorcinol
100 mg
1437
+5C 3C
79
H0500000 Hide powder
500 mg
20814
+5C 3C
79
H0600000 Histamine dihydrochloride
250 mg
0143
+5C 3C
79
H0750000 Histidine
100 mg
H0755000 Histidine hydrochloride monohydrate
100 mg
H0800000 Homatropine hydrobromide
100 mg
H0830000 Homatropine methylbromide
25 mg
Y0001383 Homatropine methylbromide for system suitability
5 mg
Council of Europe, all rights reserved 2014
0333
Yes
0911
+5C 3C
79
0910
+5C 3C
79
0500,0720
+5C 3C
79
0720
+5C 3C
79
0720
+5C 3C
79
Batch 1 is valid until 31 January 2014
38
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Code
Y0001290 Honokiol
Reference Standard
H0900000 Human albumin for electrophoresis BRP
Effective from 2014/1/2
Batch n Quantity Sale
Information
per vial Unit
1
20 mg
1 99.6% CHO
2
1 ml
1 96,7% to 99,2% of the total protein is the main band (albumin), protein
content : 5%
Monograph Leaflet
Storage
Extra
Price
charges
79
g(c)
2567,2568
Yes
-20C 5C
0255
Yes
-20C 5C
79
Y0000219 Human anti-D immunoglobulin BRP
40 mg
285 IU anti-D immunoglobulin per ampoule
1uc=40 mg
See leaflet,
20713
Yes
-20C 5C
90
Y0000667 Human coagulation factor VII concentrate BRP
25 mg
9.9 IU per vial
See leaflet,
20710
Yes
-20C 5C
79
H0920000 Human coagulation factor VIII concentrate BRP
37 mg
10.4 IU per vial
See leaflet,
20704
Yes
-20C 5C
90
H0920500 Human coagulation factor IX concentrate BRP
30 mg
7.9 IU/vial; Common standard with FDA and WHO (4th IS)
See leaflet,
20711, 1223
Yes
-20C 5C
90
H0950000 Human hepatitis A immunoglobulin BRP
10 mg
10.2 IU per vial
See leaflet,
0338, 0769
Yes
-20C 5C
90
Y0001414 Human Hepatitis B immunoglobulin BRP
100 mg
55 IU/vial
0722, 0338
Yes
-20C 5C
90
Y0001504 Human immunoglobulin BRP (ACA and Molecular size)
1 uc
See leaflet,
0338, 0918
Yes
+5C 3C
90
Y0001512 Human Immunoglobulin BRP (Fc Function and
Molecular size)
9000 mg
See leaflet,
0338, 0918
Yes
+5C 3C
90
50 mg
See leaflet ; Batch 2 is valid until 31 May 2014
0338,0918
Yes
+5C 3C
79
Y0000488 Human immunoglobulin (molecular size) BRP
700 mg
Each vial contains 0.7 gram of immunoglobulin G
See leaflet,
0338,
0918,1928
Yes
+5C 3C
90
H1005000 Human Plasma Pools for NAT validation
3502 mg
Set of 103 plasma pool samples
See leaflet,
20621
Yes
-20C 5C
400
H1100000 Human rabies immunoglobulin BRP
170 mg
91 IU per vial
See leaflet,
0723
Yes
-20C 5C
90
H1110000 Human tetanus immunoglobulin BRP
87 mg
120 IU per vial
0398
Yes
-20C 5C
90
Y0000502 Human vaccinia immunoglobulin
1 ml
23 IU per vial
See leaflet
Yes
-20C 5C
270
H1115000 Hyaluronidase BRP
50 mg
See leaflet
0912
Yes
+5C 3C
79
H1120000 Hydralazine hydrochloride
20 mg
+5C 3C
79
Y0001151 Hydrastine hydrochloride
20 mg
91,7% CHClNO
1831,2500
Yes
-20C 5C
79
H1200000 Hydrochlorothiazide
300 mg
99.8% CHClNOS ; Batch 6 is valid until 31 August 2013
0394
Yes
+5C 3C
79
10 mg
Batch 1 is valid until 30 April 2014
0394
Yes
+5C 3C
79
Y0000646 Hydrocodone hydrogen tartrate 2.5-hydrate - * narc
10 mg
1784
+5C 3C
79
Y0000710 Hydrocodone for peak identification - * narc
10 mg
1784
+5C 3C
79
H1300000 Hydrocortisone
100 mg
0335,0353,0
561
+5C 3C
79
Y0001092 Hydrocortisone for peak identification
5 mg
0335
+5C 3C
79
New H1000000 Human immunoglobulin for electrophoresis BRP
New Y0001494 Hydrochlorothiazide for peak identification
Council of Europe, all rights reserved 2014
0829
39
Yes
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
H1400000 Hydrocortisone acetate
Effective from 2014/1/2
Batch n Quantity Sale
Information
Monograph Leaflet
per vial Unit
9
125 mg
1 99% CHO; Hydrocortisone acetate CRS 8 is suitable for monographs
0321,0334,0 Yes
01/2011:0335, 01/2008:334, 01/2008:0321, 01/2008:0767 and 01/2008:0734
335,
only.
0734,0767
+5C 3C
Extra
Price
charges
79
a
Y0001482 Hydrocortisone acetate for peak identification
15 mg
0334
+5C 3C
79
H1425000 Hydrocortisone hydrogen succinate
100 mg
0768,1131
-20C 5C
79
H1426000 Hydrogenated wool fat
250 mg
0969
+5C 3C
79
Y0000446 Hydromorphone hydrochloride - * narc
10 mg
2099
+5C 3C
79
B0650000 Hydrous benzoyl peroxide - reference spectrum
n/a
0704
79
H1428000 Hydroxocobalamin
10 mg
0913,0914,0
915
+5C 3C
79
Y0000119 Hydroxycarbamide
175 mg
1616
+5C 3C
79
H1429400 Hydroxyethyl salicylate
125 mg
H1429700 4-Hydroxyphenoxymethylpenicillin potassium
20 mg
98.4% CHKNOS
H1430000 D-alpha-(4-Hydroxy-phenyl)glycine
50 mg
(2R)-2-amino-2-(4-hydroxyphenyl)acetic acid - Cefadroxyl impurity A
0813
Y0001277 Hydroxyethyl starch (medium MW)
1200 mg
Average Mw 130100 Da
1785
Yes
Y0001322 Hydroxyethyl starch (high Mw)
800 mg
507900 Da
1785
Yes
Y0000186 Hydroxypropylbetadex
200 mg
Batch 1 is valid until 30 June 2013
1804
H1435000 Hydroxyzine hydrochloride
600 mg
Y0000011 Hymecromone
100 mg
Y0000012 Hymecromone impurity A
25 mg
Resorcinol
Y0000013 Hymecromone impurity B
25 mg
7-hydroxy-2-methyl-4H-1-benzopyran-4-one.
Y0000483 Hyoscine
10 mg
Y0000484 Hyoscine impurity A
10 mg
H1450000 Hyoscine butylbromide
20 mg
Y0000447 Hyoscine butylbromide impurity E
10 mg
H1500000 Hyoscine hydrobromide
50 mg
Y0000448 Hyoscine hydrobromide impurity B
10 mg
H1600000 Hyoscyamine sulfate
100 mg
Y0000449 Hyoscyamine impurity E
10 mg
Y0000915 Hypromellose phthalate
10 mg
I0020000 Ibuprofen
250 mg
B1220000 Ibuprofen impurity B
1.1 mL
solution of 0.06% m/V in acetonitrile - to be diluted as appropriate. CHO;
(2RS)-2-(4-Butylphenyl)propanoic acid ; Batch 6 is valid until 31 August 2013
Y0000140 Ibuprofen impurity F
5 mg
3-[4-(2-methylpropyl)phenyl]propanoic acid
Council of Europe, all rights reserved 2014
99.9% CHNO
Yes
Storage
1225
(1R,2R,4S,5S,7s)-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl
(2S)-3-hydroxy-2-phenylpropanoate (norhyoscine)
(1R,2R,4S,5S,7s)-9-butyl -3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl (2S)-3hydroxy-2-phenylpropanoate (N-butylhyoscine)
(1R,2R,4S,5S,7s)-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl
(2S)-3-hydroxy-2-phenylpropanoate
(1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl(2S)-3-hydroxy-2-phenyl
-propanoate
40
+5C 3C
79
-20C 5C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
0916,1086,1
092
+5C 3C
79
1786
+5C 3C
79
1786
+5C 3C
79
1786
+5C 3C
79
2167
+5C 3C
79
2167
+5C 3C
79
0737
+5C 3C
79
0737
+5C 3C
79
0106,0500
+5C 3C
79
0106
+5C 3C
79
0501
+5C 3C
79
0501
+5C 3C
79
347
+5C 3C
79
0721
+5C 3C
79
0721
+5C 3C
79
0721
+5C 3C
79
0148,0149
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
New Y0000881 Ibuprofen for peak identification
Effective from 2014/1/2
Batch n Quantity Sale
Information
per vial Unit
5
0.09 mg
1 Batch 4 is valid until 31 May 2014
I0050000 Idoxuridine
50 mg
I0060000 Ifosfamide
50 mg
I0060100 Ifosfamide - reference spectrum
Monograph Leaflet
0721
100.0% CHClNOP
Yes
Storage
+5C 3C
Extra
Price
charges
79
a
0669
+5C 3C
79
1529
+5C 3C
79
79
-20C 5C
g(c)
79
+5C 3C
79
+5C 3C
79
n/a
New I0060002 Ifosfamide impurity A
100 mg
3-[(2-chloroethyl)amino]propyl dihydrogen phosphate ; Batch 3 is valid until
31 May 2014
1529
1529
I0060004 Ifosfamide impurity B
40 mg
bis[3-[(2-chloroethyl)amino]propyl] dihydrogen diphosphate ; Batch 1 is valid
until 31 January 2014
1529
I0060010 Ifosfamide impurity E
20 mg
3-chloro-N-(2-chloroethyl)propan-1-amine
1529
I0060012 Ifosfamide impurity F
10 mg
(RS)-2-chloro-3-(2-chloroethyl)-1,3,2-oxazaphosphinane 2-oxide
I0086000 Imidazole
100 mg
I0090000 Imipenem
100 mg
I0100000 Imipramine hydrochloride
50 mg
Y0000893 Imipramine for system suitability
Y0001153 Immunoglobulin for anti-A, anti-B antibodies limit test
BRP
Y0001152 Immunoglobulin panel for anti-A, anti-B antibodies test
Y0000540 Immunoglobulin panel for anti-D antibodies test BRP
Yes
1529
+5C 3C
79
0757,1424,
2270
+5C 3C
79
1226
-20C 5C
79
0029,0408,0
817,
0889,1787
+5C 3C
79
10 mg
0029
+5C 3C
79
45 mg
20620
Yes
-20C 5C
79
96 mg
20620
Yes
-20C 5C
120
2000 mg
See leaflet,
20626
Yes
-20C 5C
90
Y0001205 Imperatorin
20 mg
98.8 % CHO
2556
Yes
+5C 3C
79
I0150000 Indapamide
150 mg
97.6% CHClNOS
1108
Yes
+5C 3C
79
I0150020 Indapamide impurity B
5 mg
4-chloro-N-(2-methyl-1H-indol-1-yl]-3-sulphamoylbenzamide
1108
+5C 3C
79
Y0000788 Indinavir
100 mg
97.2% CHNO
2214
+5C 3C
79
Y0000880 Indinavir sulfate - reference spectrum
n/a
79
Y0000746 Indinavir for system suitability
20 mg
2214
I0200000 Indometacin
50 mg
0092,0922,1
686
0.002 mg
0092
New Y0001640 Indometacine impurity mixture
92.9% CHNOS
2214
Yes
+5C 3C
79
+5C 3C
79
Yes
+5C 3C
79
Y0000349 Insulin aspart
8 mg
See leaflet
2084
Yes
-20C 5C
90
I0305000 Insulin (bovine)
7.99 mg
7.99 mg insulin + A21 desamido per vial CHNOS
0854,1637
Yes
-20C 5C
90
I0310000 Insulin (human)
8 mg
6.94 mg insulin + A21 desamido per vial CHNOS
0838,0854,1
637, 1638
Yes
-20C 5C
90
Y0000348 Insulin lispro
5.75 mg
5.75 mg per vial of CHNOS ; Batch 1 is valid until 1 June 2013
2085
Yes
-20C 5C
90
Y0001542 Insulin glargine
15 mg
14,98 mg
1571
Yes
-20C 5C
79
Y0001544 Insulin glargine for peak identification
3.2 mg
-20C 5C
79
Council of Europe, all rights reserved 2014
2571
41
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
I0320000 Insulin (porcine)
Effective from 2014/1/2
Batch n Quantity Sale
Information
per vial Unit
3
8.61 mg
1 8.61 mg insulin + A21-desamido per vial
see recommandations for use on accompagnying leaflet CHNOS
Monograph Leaflet
Storage
0838,0854,1
637, 1638
Yes
-20C 5C
Extra
Price
charges
90
c
I0320301 Interferon alfa-2b
200 L
About 9.74 mg per mL
1110
Yes
-80C 10C
90
Y0001101 Interferon beta-1a
0.5 mL
335 g of interferon beta-1a per mL CHNOS
1639
Yes
-80C 10C
90
I0320330 Interferon gamma 1b
0.5 mL
about 1 mg per ml
1440
Yes
-80C 10C
90
1440
Yes
-20C 5C
79
1440
Yes
-20C 5C
79
1111,1112,11
13,2351
Yes
+5C 3C
79
New Y0001664 Interferon gamma-1b for system suitability
0.6 mg
I0320331 Interferon gamma-1b validation solution
0.6 mg
The CRS is available in the freeze-dried form.
About 1 mg per ml after reconstitution following instructions provided in the
leaflet. ; Batch 2 is valid until 31 December 2013
I0328000 Iobenguane sulfate
25 mg
See leaflet
Y0000839 Iobenguane sulfate - reference spectrum
n/a
2351
79
Y0001294 Iodixanol
60 mg
2215
+5C 3C
79
Y0001292 Iodixanol impurity C
10 mg
5-[acetyl[3-[[3,5-bis[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl]
amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6triiodobenzene-1,3-dicarboxamide
2215
+5C 3C
79
Y0001291 Iodixanol impurity E
10 mg
5-[acetyl[3-[acetyl[3-carbamoyl-5-[(2,3-dihydroxypropyl)carbamoyl]-2,4,6triiodophenyl]amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide
2215
+5C 3C
79
Y0001293 Iodixanol impurity H
10 mg
5-[acetyl[3-[acetyl[3-[[3-[3-[acetyl[3,5-bis[(2,3-dihydroxypropyl)
carbamoyl]-2,4,6-triiodophenyl]amino]-2-hydroxypropoxy]-2-hydroxypropyl]
carbamoyl]-5-[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl]
amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6triiodobenzene-1,3-dicarboxamide
2215
+5C 3C
79
I0320800 Iohexol
150 mg
1114
+5C 3C
79
I0320810 Iohexol impurity A
50 mg
5-acetamido-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-tri-iodo benzene-1,3dicarboxamide
1114
+5C 3C
79
I0320820 Iohexol impurity J
125 mg
5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-tri-iodobenzene-1,3dicarboxamide
1114,2215
+5C 3C
79
Y0000672 Iohexol for peak identification
10 mg
1114
+5C 3C
79
I0329000 Iopamidol
50 mg
1115
+5C 3C
79
I0329010 Iopamidol impurity A
10 mg
N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-amino-2,4,6-triiodoisophthalamide
1115, 1754
+5C 3C
79
Y0000406 Iopamidol impurity H
10 mg
4-chloro-N,N'-bis(2-hydroxy-1-(hydroxymethyl)ethyl)-5-(2hydroxypropanoyl)amino)2,6-diiodobenzenz-1,3-dicarboxamide
1115
+5C 3C
79
I0330000 Iopanoic acid
100 mg
0700
+5C 3C
79
Y0001297 Iopentol
10 mg
2215
+5C 3C
79
Y0001020 Iopromide
100 mg
98.7% CHINO
1753
+5C 3C
79
Y0001077 Iopromide impurity A
0.125 mg
5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methylbenzene-1,3dicarboxamide
1753
+5C 3C
79
Y0001021 Iopromide for system suitability 1
5 mg
1753
+5C 3C
79
Council of Europe, all rights reserved 2014
42
Yes
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0001022 Iopromide for system suitability 2
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
5 mg
1
Information
Monograph Leaflet
1753
Y0000555 Iotrolan
100 mg
Y0000658 Iotrolan for system suitability
5 mg
1754
Y0000141 Ioxaglic acid
125 mg
Y0000142 Ioxaglic acid impurity A
20 mg
I0360000 Ipratropium bromide
120 mg
Y0000276 Ipratropium impurity A
10 mg
(1R,3r,5S,8r)-3-hydroxy-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]
octane
I0361000 Ipratropium bromide impurity B
10 mg
(1R,3r,5S,8s)-3-[[(2RS)-3-hydroxy-2-phenylpropanoyl]oxy]-8-methyl-8-(1methylethyl)-8-azoniabicyclo[3.2.1]octane
Y0001166 Irbesartan
60 mg
Y0001156 Irbesartan impurity A
10 mg
Y0001616 Irisflorentin
15 mg
I0375000 Isoconazole
200 mg
I0380000 Isoconazole nitrate
200 mg
I0400000 Isoemetine hydrobromide
25 mg
Y0000858 Isoflurane
Y0000037 Isoflurane - reference spectrum
I0460000 Isoleucine
I0465000 Isomalt
Y0000070 Isomaltooligosaccharide
I0500000 Isoniazid
Storage
+5C 3C
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
0919
+5C 3C
79
0772
+5C 3C
79
0919
+5C 3C
79
2465
+5C 3C
79
1-(pentylamino)-N-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]
cyclopentanecarboxamide ; Batch 1 is valid until 31 October 2013
2465
+5C 3C
79
99,5% CHO
2561
97.2%
Yes
Extra
Price
charges
79
a
1754
2009
3-amino-5-[(2-hydroxyethyl)carbamoyl]-2,4,6-triiodobenzoic acid
Yes
2009
+5C 3C
79
1018
+5C 3C
79
1017
+5C 3C
79
0080,0081
+5C 3C
79
1.4 ml
1666
+5C 3C
g(b)
79
n/a
1673
79
50 mg
+5C 3C
79
3000 mg
+5C 3C
79
0.9 mg
1506
+5C 3C
79
100 mg
0146
+5C 3C
79
I0599990 Isoprenaline hydrochloride
50 mg
1332
+5C 3C
79
Y0001577 Isoprenaline impurity A
15 mg
1332
+5C 3C
79
I0600000 Isoprenaline sulfate
500 mg
I0725000 Isopropyl hexadecanoate
100 mg
94.3% CHO
I0750000 Isopropyl tetradecanoate
2 ml
Y0001568 Isoquercitroside
15 mg
I0775000 Isosorbide dinitrate
350 mg
I0775010 Isosorbide mononitrate
150 mg
I0775020 Isosorbide-2-nitrate
50 mg
1118
I0800000 Isotretinoin
60 mg
0693,1019
Y0001218 Isotretinoin for peak identification
10 mg
1019
I0900000 Isoxsuprine hydrochloride
50 mg
1119
Y0000366 Isradipine
125 mg
Council of Europe, all rights reserved 2014
Yes
0770
1531
97.0 % CHO ; Batch 4 is valid until 1 May 2013
1-(3,4-dihydroxyphenyl)-2-[(1-methylethyl)amino]ethanone
Yes
0502
+5C 3C
79
0839
Yes
+5C 3C
79
97.9% CHO
0725
Yes
+5C 3C
79
97% CHO
2528,2667
Yes
+5C 3C
79
40,8% CHNO ; Batch 2 is valid until 1 June 2013
1117,1118
Yes
+5C 3C
79
99.9% CHNO; Isosorbide-5-nitrate ; Batch 3 is valid until 31 January 2013
1117,1118
Yes
+5C 3C
79
+5C 3C
79
+5C 3C
g(b)
79
+5C 3C
g(b)
79
+5C 3C
79
+5C 3C
79
99.2% CHNO
43
2110
Yes
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0000367 Isradipine impurity D
Effective from 2014/1/2
Batch n Quantity Sale
Information
per vial Unit
1
5 mg
1 methyl 1-methylethyl 4-(2,1,3-benzoxadiazol-4-yl)
-2,6-dimethylpyridine-3,5-dicarboxylate
I7000000 Itraconazole
Y0001100 Itraconazole for system suitability
I8000010 Ivermectin
Monograph Leaflet
Storage
Extra
Price
charges
79
g
2110
+5C 3C
+5C 3C
79
20 mg
Batch 2 is valid until 28 February 2014
1335
25 mg
Batch 1 is valid until 30 September 2013
1335
Yes
+5C 3C
79
150 mg
90.6% of CHO (component H2B1a)
1336
Yes
+5C 3C
79
Y0001592 Ivy leaf dry extract HRS
70 mg
16% of CHO
2148
Yes
Y0000575 Ivy leaf standardised tincture
2 ml
0.20% (m/m) of hederacoside C; Ivy leaf standardised tincture CRS has been
replaced with Ivy leaf dry extract HRS Y0001592. ; Batch 1 is valid until 31
October 2013
2148
Y0000041 Josamycin
150 mg
1000 Ph. Eur. units per mg
1982,1983,2
0702
Y0000042 Josamycin propionate
150 mg
975 Ph. Eur. units per mg
Y0001315 Josamycin for peak identification
25 mg
K0100000 Kanamycin B sulfate
20 mg
K0200000 Kanamycin monosulfate
150 mg
Y0000450 Ketamine hydrochloride - * narc
10 mg
K0551000 Ketamine impurity A
50 mg
Y0000246 Ketobemidone hydrochloride - reference spectrum
n/a
Y0000244 Ketobemidone impurity B
5 mg
1-[4-(3-hydroxyphenyl)-1-methylpiperidin-4-yl]ethanone
Y0000245 Ketobemidone impurity C
5 mg
1-[4-(3-hydroxyphenyl)piperidin-4-yl]propan-1-one
K0600000 Ketoconazole
150 mg
K2000000 Ketoprofen
50 mg
K2000010 Ketoprofen impurity A
10 mg
K2000015 Ketoprofen impurity C
15 mg
Y0000486 Ketorolac trometamol
10 mg
Y0000626 Ketorolac trometamol for peak identification
5 mg
1755
Y0001617 Ketotifen for peak identification
15 mg
1592
Y0001619 Ketotifen hydrogen fumarate
10 mg
1592
Y0000164 Ketotifen hydrogen fumarate - reference spectrum
n/a
1592
Y0000161 Ketotifen impurity G
0.0225 mg
4-(1-methylpiperidin-4-ylidene)-4H-benzo(4,5)cyclohepta(1,2-b)
thiophen-9,10-dione ; Batch 3 is valid until 31 August 2013
Y0001200 Kudzuvine root dry extract
200 mg
See leaflet
Council of Europe, all rights reserved 2014
-20C 5C
79
-20C 5C
g(c)
79
Yes
-20C 5C
79
1982,1983,2
0702
Yes
+5C 3C
79
1983
Yes
0032,0033,0
645
799 IU per mg of CHNOS,HO
0032,0033,0
053,
0485,0645,1
289,
1290,20702
Yes
+5C 3C
79
+5C 3C
79
+5C 3C
79
1020
+5C 3C
79
1020,1742
+5C 3C
79
79
+5C 3C
79
1746
+5C 3C
79
0921,1067,1
270
+5C 3C
79
0922,1157,1
209
+5C 3C
79
1-(3-benzoylphenyl)ethanone
0922
+5C 3C
79
3-[(1RS)-1-carboxyethyl]benzoic acid
0922
+5C 3C
79
1755
+5C 3C
79
Yes
+5C 3C
79
Yes
+5C 3C
79
+5C 3C
79
79
1-[(2-chlorophenyl)(methylimino)methyl]cyclopentanol
1746
44
1746
1592
Yes
+5C 3C
79
2434,2483
Yes
-20C 5C
79
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
L0050000 Labetalol hydrochloride
Y0001548 Labetalol impurity A
Effective from 2014/1/2
Batch n Quantity Sale
Information
per vial Unit
2
120 mg
1 99.6 % CHClNO ; Batch 1 is valid until 31 March 2013
1
10 mg
1 2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)-amino]ethyl]benzoic
acid
Monograph Leaflet
0923
Yes
0923
1337
+5C 3C
Extra
Price
charges
79
g
+5C 3C
79
+5C 3C
79
+5C 3C
79
L0129000 Lactitol monohydrate
60 mg
Y0000257 Lactobionic acid
100 mg
A1206000 Lactose (anhydrous)
100 mg
1061
+5C 3C
79
L0100000 Lactose
100 mg
0177,0178,0
187,
0188,0204,0
209,
1215,1570
+5C 3C
79
L0130000 Lactulose
3000 mg
Y0001510 Lactulose for peak identification
2600 mg
Y0000188 Lactulose for system suitability
12 mg
Y0000425 Lamivudine
150 mg
Y0000518 Lamivudine for system suitability 1
10 mg
Y0000426 Lamivudine for system suitability 2
10.3 mg
Y0001030 Lamotrigine
Y0001031 Lamotrigine for peak identification
Y0001085 Lamotrigine for system suitability
Y0001032 Lamotrigine impurity E
Y0000773 Lansoprazole
Y0000774 Lansoprazole for peak identification
93.8% CHO
Yes
Storage
1647
99.7% CHO
0924,1230
Yes
+5C 3C
79
0924
Yes
+5C 3C
79
1230
Yes
+5C 3C
79
2217
+5C 3C
79
2217
+5C 3C
79
2217
+5C 3C
79
10 mg
1756
+5C 3C
79
20 mg
1756
Yes
+5C 3C
79
10 mg
1756
Yes
+5C 3C
79
15 mg
+5C 3C
79
60 mg
+5C 3C
79
1.01 mg
Batch 1 is valid until 31 December 2013
2219
Yes
+5C 3C
79
Y0001474 Lauric acid
1500 mg
97.9%
1848
Yes
+5C 3C
79
Y0000654 Leflunomide
100 mg
100,0% CHFNO
2330
+5C 3C
79
Y0000487 Leflunomide impurity A
25 mg
4-(trifluoromethyl)aniline
2330
Y0000674 Leflunomide for peak identification
1 mg
Y0000685 Letrozole
70 mg
L0375000 Leucine
50 mg
L0376000 Leuprorelin
1 mg
L0376001 Leuprorelin - reference spectrum
n/a
Y0000047 Levamisole hydrochloride for system suitability
60 mg
L0380000 Levamisole hydrochloride
50 mg
Y0000048 Levamisole - reference spectrum
n/a
Y0001253 Levetiracetam
110 mg
100.0% CHNO
2535
Y0001254 Levetiracetam impurity A
10 mg
(2RS)-2-(2-oxopyrrolidin-1-yl)butanoic acid ; Batch 1 is valid until 1 March
2013
2535
Council of Europe, all rights reserved 2014
99.7% CHNOS
1756
2,3-dichlorobenzoic acid
2219
99.7% CHN
0.99 mg per vial of pure leuprorelin peptide CHNO
+5C 3C
79
2330
Yes
+5C 3C
79
2334
Yes
+5C 3C
79
0771,0874
+5C 3C
79
1442
-20C 5C
79
79
+5C 3C
79
+5C 3C
79
79
+5C 3C
79
+5C 3C
79
1442
0726,1728
Batch 3 is valid until 31 December 2013
Yes
0726
1728
45
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0001255 Levetiracetam impurity B
Effective from 2014/1/2
Batch n Quantity Sale
Information
per vial Unit
2
15 mg
1 (2Z)-2-(2-oxopyrrolidin-1-yl)but-2-enamide ; Batch 1 is valid until 31 March
2014
Monograph Leaflet
Storage
2535
+5C 3C
Extra
Price
charges
79
a
New Y0001256 Levetiracetam impurity C
15 mg
pyridin-2-ol ; Batch 1 is valid until 30 April 2014
2535
+5C 3C
79
Y0001257 Levetiracetam impurity D
15 mg
(2R)-2-(2-oxopyrrolidin-1-yl)butanamide ((R)-etiracetam) ; Batch 1 is valid
until 1 October 2013
2535
+5C 3C
79
New Y0001637 Levocabastine for system suitability 2
5.005 mg
1484
Yes
+5C 3C
79
New Y0001636 Levocabastine for system suitability 1
5.028 mg
1484
Yes
+5C 3C
79
L0390000 Levocabastine hydrochloride
125 mg
1484
+5C 3C
79
L0390008 Levocabastine impurity D
20 mg
1484
+5C 3C
79
L0399900 Levocarnitine
125 mg
1339
+5C 3C
79
L0399905 Levocarnitine impurity A
50 mg
1339
+5C 3C
79
L0400000 Levodopa
100 mg
0038
+5C 3C
79
L0420000 Levodropropizine
60 mg
1535
+5C 3C
79
L0420002 Levodropropizine impurity A
25 mg
(2R)-3-(4-phenylpiperazin-1-yl)propane-1,2-diol (dextrodropropizine) ; Batch
2 is valid until 30 November 2013
1535
+5C 3C
79
Y0001033 Levodropropizine impurity B
50 mg
1-phenylpiperazine
1535
+5C 3C
79
Y0001048 Levodropropizine impurity C
300 mg
2,3-epoxypropan-1-ol
1535
-20C 5C
g(c)
79
L0500000 Levomepromazine hydrochloride
100 mg
0505
+5C 3C
79
L0505000 Levomepromazine maleate
50 mg
0925
+5C 3C
79
L0551000 Levonorgestrel
30 mg
0926
+5C 3C
79
Y0001379 Levonorgestrel impurity B
10 mg
+5C 3C
79
Y0001431 Levonorgestrel for system suitability 1
10 mg
+5C 3C
79
Y0001618 Levonorgestrel for system suitability 2
10 mg
L0570000 Levothyroxine sodium
100 mg
Y0001382 Levothyroxine for peak identification
10 mg
H0837000 L-Homocysteine thiolactone hydrochloride - reference
spectrum
n/a
L0595000 Lidocaine
L0600000 Lidocaine hydrochloride
1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-4-phenylpiperidine-4-carboxylic
acid
(E)- or (Z)-4-(trimethylammonio)but-2-enoate
13-ethyl-17-hydroxy-18,19-dinor-17-alpha-pregn-5(10)-en-20-yn-3-one
0926
0926
Yes
0926
Yes
+5C 3C
79
0401,0728
Yes
-20C 5C
79
0401
Yes
-20C 5C
79
1617
79
50 mg
0727
+5C 3C
79
100 mg
0227,1242,1
363
+5C 3C
79
L0650000 Lincomycin hydrochloride
250 mg
Y0001393 Lincomycin hydrochloride for system suitability
10 mg
L0700000 Liothyronine sodium
50 mg
Y0000860 Liothyronine for peak identification
0.0046 mg
0728
L0702000 Lisinopril dihydrate
50 mg
1120
Council of Europe, all rights reserved 2014
89.3% CHINNaO
95.4% CHClNOS
0582,0583,0
996
Yes
+5C 3C
79
0583
Yes
-20C 5C
79
96.6 % CHINNaO
0401,0728
Yes
-20C 5C
79
-20C 5C
79
+5C 3C
79
46
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0001235 Lisinopril for system suitability
Effective from 2014/1/2
Batch n Quantity Sale
Information
per vial Unit
2
2 mg
1 Lisinopril for performance test CRS 3 renamed as lisinopril for system
suitability CRS 1 for the implementation of 01/2011:1120 ; Batch 1 is valid
until 30 November 2013
Monograph Leaflet
1120
Y0001234 Lisinopril impurity F
0.01 mg
(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-cyclohexylpropyl]amino]
hexanoyl]pyrrolidine-2-carboxylic acid (cyclohexyl analogue)
L0720000 Lithium clavulanate
125 mg
97.6% CHLiNO; 1 mg of CHLiNO corresponds to 1.157 mg of CHKNO
L0720800 Lithocholic acid
60 mg
1189,1275
Y0000112 Lobeline hydrochloride
50 mg
L0745000 Lomustine
50 mg
Y0001438 Long pepper for system suitability HRS
600 mg
L0750000 Loperamide hydrochloride
50 mg
Y0000322 Loperamide hydrochloride for system suitability
15 mg
0929
Y0000341 Loperamide oxide monohydrate
20 mg
Y0001498 Lopinavir
200 mg
Y0001506 Lopinavir for peak identification
10 mg
Y0001505 Lopinavir for system suitability
10 mg
Y0000688 Loratadine
Y0000603 Loratadine for system suitability
Y0000604 Loratadine impurity F
Y0000605 Loratadine impurity H
L0750500 Lorazepam - * psy
Yes
1120
Storage
+5C 3C
Extra
Price
charges
79
a
+5C 3C
79
+5C 3C
79
+5C 3C
79
1988
+5C 3C
79
0928
+5C 3C
79
2477, 2453
+5C 3C
79
0921,0929,1
729
+5C 3C
79
+5C 3C
79
1140,1653
Yes
Yes
+5C 3C
79
2615
Yes
+5C 3C
79
2615
Yes
+5C 3C
79
2615
Yes
+5C 3C
79
60 mg
2124
+5C 3C
79
20 mg
2124
+5C 3C
79
10 mg
ethyl 4-[(11RS)-8-chloro-11-fluoro-6,11-dihydro-5H-benzo[5,6]cyclohepta
[1,2-b]pyridin-11-yl]piperidine-1-carboxylate
2124
+5C 3C
79
50 mg
ethyl 4-oxopiperidine-1-carboxylate
2124
+5C 3C
79
100 mg
1121
+5C 3C
79
Y0000576 Lorazepam for system suitability - * psy
0.8032 mg
Batch 1 is valid until 31 December 2013
1121
+5C 3C
79
Y0000718 Lorazepam impurity D
10 mg
(5RS)-7-chloro-5-(2-chlorophenyl)-4,5-dihydro-1H-1,4-benzodiazepine-2,3dione
1121
+5C 3C
79
Y0001062 Losartan potassium
50 mg
2232
+5C 3C
79
Y0001072 Losartan impurity D
6 mg
Y0001076 Losartan for system suitability
0.0015 mg
L0790000 Lovastatin
60 mg
Y0001136 Lovastatin for peak identification
20 mg
Y0001284 Lufenuron
140 mg
Y0001261 Lufenuron for peak identification
0.4028 mg
Y0001265 Lufenuron impurity G
15 mg
L0800000 Lynestrenol
50 mg
0558
Y0001034 Lynestrenol for peak identification
20 mg
0558
Y0000397 Lysine acetate
60 mg
2114
Council of Europe, all rights reserved 2014
1729
95.3 % CHNO
2232
2-butyl-4-chloro-1H-imidazole-5-carbaldehyde
99.5% CHO
99.5% CHClFNO
2,5-dichloro-4-[[[(2,6-difluorophenyl)carbonyl]carbamoyl]amino]phenyl
phenyl carbonate
47
Yes
+5C 3C
79
2232
Yes
+5C 3C
79
1538,1563
Yes
-20C 5C
79
1538
Yes
-20C 5C
79
2177
Yes
+5C 3C
79
2177
Yes
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
2177
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
L0900000 Lysine hydrochloride
Effective from 2014/1/2
Batch n Quantity Sale
Information
per vial Unit
3
50 mg
1 Batch 2 is valid until 31 August 2013
Monograph Leaflet
Storage
0805,0806,0
930, 1654
+5C 3C
Extra
Price
charges
79
a
Y0000745 Macrogol 40 sorbitol heptaoleate
20 mg
2396
+5C 3C
79
Y0001157 Macrogol polyvinyl alcohol grafted copolymer
400 mg
2523
+5C 3C
79
Y0001369 Macrogol 30 dipolyhydroxystearate
100 mg
2584
+5C 3C
79
M0088000 Magnesium aspartate dihydrate
60 mg
Y0001289 Magnolol
20 mg
99.5% CHO
M0120000 Malathion
250 mg
M0120005 Malathion impurity A
10 mg
M0120010 Malathion impurity B
10 mg
diethyl (2RS)-2-(dimethoxy-S-phosphinothioyl)-butanedioate
M0100000 Maleic acid
100 mg
Y0000143 Malic acid - reference spectrum
n/a
M0160000 Maltitol
1200 mg
99.7% CHO
M0200000 Mannitol
1200 mg
98.8% CHO
M0206000 Maprotiline hydrochloride
100 mg
M0206040 Maprotiline impurity D
25 mg
Y0000819 Marbofloxacin
10 mg
2233
Y0000820 Marbofloxacin for peak identification
20 mg
2233
Yes
M0210000 Measles vaccine (live) BRP
80 mg
1057,0213,2
442
Yes
M0215000 Mebendazole
20 mg
1208,1254
Y0000144 Mebendazole for system suitability
20 mg
0845
Y0001086 Mebrofenin
120 mg
M0220000 Meclozine dihydrochloride
150 mg
Renamed for 01/2011:0622 ; Batch 1 is valid until 1 May 2013
Y0001310 Meclozine impurity B
15 mg
Y0001311 Meclozine impurity H
15 mg
M0240000 Medronic acid
20 mg
Y0001107 Medronic acid impurity A
60 l
Tris(1-methylethoxy)phosphane
Y0001106 Medronic acid impurity B
40 l
M0250000 Medroxyprogesterone acetate
100 mg
Y0001484 Medroxyprogesterone acetate for peak identification
25 mg
0673
Y0000598 Medroxyprogesterone acetate for system suitability
10 mg
0673
M0252600 Mefenamic acid
50 mg
Y0001081 Mefenamic acid impurity A
100 mg
M0253000 Mefloquine hydrochloride
100 mg
Y0001514 Megestrol acetate
120 mg
Council of Europe, all rights reserved 2014
+5C 3C
79
2567,2568
1445
Yes
-20C 5C
g(c)
79
99.4% CHOPS
1343
Yes
-20C 5C
g(c)
79
diethyl (2RS)-2-[(methoxy)(methylsulfanyl)-S-phosphinothioyl] butane dioate
1343
-20C 5C
g(c)
79
1343
-20C 5C
g(c)
79
0365,0925
+5C 3C
79
79
1235,1236
2080
Yes
+5C 3C
79
0435,0559,1
381, 1531
Yes
+5C 3C
79
1237
+5C 3C
79
1237
+5C 3C
79
+5C 3C
79
+5C 3C
79
-20C 5C
90
+5C 3C
79
+5C 3C
79
2393
+5C 3C
79
0622
+5C 3C
79
4-chlorobenzhydrol
0622
+5C 3C
79
1-(4-chlorobenzhydryl)piperazine
0622
+5C 3C
79
0641, 2350
+5C 3C
79
2350
+5C 3C
79
Tetrakis(1-methylethyl)methhylenediphosphonate
2350
+5C 3C
79
Batch 2 is valid until 30 November 2013
0673
+5C 3C
79
Yes
+5C 3C
79
Yes
-20C 5C
79
1240
+5C 3C
79
1240
+5C 3C
79
+5C 3C
79
+5C 3C
79
3-(9,10-dihydro-9,10-ethanoanthracen-9-yl)-N-methylprop-2- en-1-amine
4.3 log (ie 20000) infective viral units per vial
2,3-dimethylaniline
Yes
1241
1593
99.1 % CHO
48
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0001524 Megestrol acetate for system suitability
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
50 mg
1
Information
Monograph Leaflet
Storage
1593
Yes
+5C 3C
Yes
Extra
Price
charges
79
a
Y0001507 Megestrol acetate for peak identification
25 mg
1593
+5C 3C
79
Y0001594 Megestrol acetate impurity K
0.01 mg
1551
+5C 3C
79
Y0001209 Meglumine
10 mg
2055
+5C 3C
79
Y0001080 Meloxicam
50 mg
2373
+5C 3C
79
Y0001035 Meloxicam impurity A
5 mg
ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
2373
Yes
+5C 3C
79
Y0001036 Meloxicam impurity B
5 mg
5-methylthiazol-2-amine
2373
Yes
+5C 3C
79
Y0001037 Meloxicam impurity C
5 mg
N-[(2Z)-3,5-dimethylthiazol-2(3H)-ylidene]-4-hydroxy-2-methyl-2H-1,2benzothiazine-3-carboxamide 1,1-dioxide
2373
Yes
+5C 3C
79
Y0001039 Meloxicam impurity D
5 mg
N-[(2Z)-3-ethyl-5-methylthiazol-2(3H)-ylidene]-4-hydroxy-2-methyl-2H-1,2benzothiazine-3-carboxamide 1,1-dioxide
2373
Yes
+5C 3C
79
Y0001158 Melphalan hydrochloride
100 mg
99.4% CHClNO
1698
Yes
+5C 3C
79
Y0001513 Melphalan - reference spectrum
1 uc
1698
79
Y0001457 Melphalan for system suitability
10 mg
1698
+5C 3C
79
M0300000 Menadione
100 mg
0507
+5C 3C
79
M0350000 Menthol
150 mg
0619,0623
+5C 3C
79
M0370000 Mepivacaine hydrochloride
100 mg
1242
+5C 3C
79
M0370020 Mepivacaine impurity B
60 mg
M0400000 Meprobamate - * psy
100 mg
M0500000 Mepyramine maleate
1000 mg
Y0000679 Mepyramine impurity A
10 mg
N-(4-methoxybenzyl)pyridin-2-amine
Y0000680 Mepyramine impurity C
10 mg
pyridin-2-amine
0278
Y0001252 Meropenem trihydrate
110 mg
87.0% CHNOS,3HO
2234
Y0000297 Mesalazine
125 mg
10 mg
Y0001563 Mesalazine impurity A
15 mg
Y0001569 Mesalazine impurity C
15 mg
Y0001040 Mesityl oxide
100 mg
Y0000337 Mesna - reference spectrum
n/a
Y0000316 Mesna impurity C
10 mg
2-(acetylsulphanyl)ethanesulphonic acid
1674
Y0000317 Mesna impurity D
10 mg
2,2'-(disulphanediyl)bis(ethanesulphonic acid)
1674
Y0000227 Meso-rich exametazime
0.5 mg
1925
Y0000097 Mesterolone
120 mg
99.8% CHO
1730
Y0000096 Mesterolone impurity A
30 mg
17-hydroxy-1alpha-methylandrost-4-en-3-one
M0600000 Mestranol
100 mg
Y0000301 Metacresol - reference spectrum
n/a
2077
M0600500 Metacycline hydrochloride
50 mg
0272,0820
New Y0001574 Mesalazine for system suitability
Council of Europe, all rights reserved 2014
Yes
1242
+5C 3C
79
0407,1689
+5C 3C
79
0278
+5C 3C
79
0278
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
1699
+5C 3C
79
1699
+5C 3C
79
2358
+5C 3C
g(b)
79
1674
79
+5C 3C
79
+5C 3C
79
Yes
+5C 3C
79
Yes
+5C 3C
79
1730
+5C 3C
79
0509
+5C 3C
79
79
+5C 3C
79
(RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
Yes
1699,1993
Batch 1 is valid until 30 April 2014
49
1699
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
M0600900 Metamizole sodium
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
3
100 mg
1
Information
Monograph Leaflet
1346
M0600905 Metamizole impurity A
15 mg
4-formylamino-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one
1346
Y0001481 Metamizole impurity E
0.01 mg
4-N-demethylanalgin ; Batch 1 is valid until 31 August 2013
1346
M0605000 Metformin hydrochloride
50 mg
Y0001590 Metformin impurity A
25 mg
Cyanoguanidine
Y0001600 Metformin impurity F
72 mg
Dimethylamine hydrochloride
N-methylmethanamine
Y0000770 Methacrylic acid-ethyl acrylate copolymer (1:1) - type A
200 mg
Y0000323 Methacrylic acid-ethyl acrylate copolymer (1:1) - type B
200 mg
M0610000 Methacrylic acid-ethylacrylate copolymer(1:1) reference spectrum
M0610030 Methacrylic acid-ethylacrylate copolymer (1:1),
dispersion 30%-ref.sp
Storage
+5C 3C
Extra
Price
charges
79
a
+5C 3C
79
+5C 3C
79
0931
+5C 3C
79
0931
+5C 3C
79
0931
+5C 3C
79
1128
+5C 3C
79
1128
+5C 3C
79
n/a
1128
79
n/a
1129
79
M0620000 Methacrylic acid-methylmethacrylate copolymer(1:1)reference spectrum
n/a
1127
79
M0630000 Methacrylic acid-methylmethacrylate copolymer(1:2)reference spectrum
n/a
1130
79
M0800000 Methadone hydrochloride - reference spectrum
n/a
0408,1787
79
Y0000428 Methanol - reference spectrum
n/a
1989
79
Y0000754 Methenamine
10 mg
1545
+5C 3C
79
M0950000 DL-Methionine
50 mg
0624
+5C 3C
79
M0960000 Methionine
50 mg
Batch 1 is valid until 28 February 2014
+5C 3C
79
M1000000 Methotrexate
100 mg
88.2 % CHNO ; Batch 5 is valid until 31 January 2013
+5C 3C
79
Y0000602 Methotrexate for peak identification
20 mg
+5C 3C
79
Y0000663 Methotrexate impurity C
10 mg
(2S)-2-[[4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]methylamino]
benzoyl]amino]pentanedioic acid (N-methylfolic acid, methopteridine)
0560
+5C 3C
79
M1000008 Methotrexate impurity D
10 mg
4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]methylamino]benzoic
acid (N10-methylpteroic acid)
0560
+5C 3C
79
Y0000664 Methotrexate impurity E
10 mg
4-[[(2,4-diaminopteridin-6-yl)methyl]methylamino]benzoic acid (4-aminoN10-methylpteroic acid, APA)
0560
+5C 3C
79
M1300000 Methylatropine bromide
100 mg
0919
+5C 3C
79
M1450000 Methylcarbidopa
1 mg
0755
+5C 3C
79
M1470000 Methyl 2-(4-chlorophenoxy)-2-methylpropionate
0.5 ml
0318
+5C 3C
79
Y0001488 Methyl methacrylate
50 mg
1975
+5C 3C
79
M1500000 Methyldopa
50 mg
0045,0755
+5C 3C
79
Y0001374 Racemic methyldopa
5 mg
0045
+5C 3C
79
Y0001083 Methyldopa for system suitability
0.024 mg
0045
+5C 3C
79
M1550000 Methylene chloride
2 ml
0932
+5C 3C
79
Council of Europe, all rights reserved 2014
50
Yes
0788,1027
0560
Yes
0560
Yes
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
M1556000 Methyl 12-hydroxystearate
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
2
100 mg
1
Information
Monograph Leaflet
Storage
1497
+5C 3C
Extra
Price
charges
79
a
Y0000398 Methyl nicotinate
25 mg
2129
+5C 3C
79
Y0000776 Methylergometrine maleate
10 mg
1788
+5C 3C
79
Y0000777 Methylergometrine for system suitability
0.53 mg
1788
+5C 3C
79
M1625000 Methylnitrosoindoline
110 mg
1108
+5C 3C
79
M1650000 Methyl parahydroxybenzoate
150 mg
+5C 3C
79
Y0001017 Methylphenidate hydrochloride - * narc
40 mg
Y0001490 Methylphenidate impurity C
10 mg
Y0000910 Methylphenidate impurity mixture
0.04 mg
2235
M1700000 Methylphenobarbital - * psy
500 mg
0189
M1750000 Methylprednisolone
150 mg
M1755000 Methylprednisolone acetate
100 mg
Y0001602 Methylprednisolone for system suitability
10 mg
0561
M1755200 Methylprednisolone hydrogen succinate
125 mg
0768,1131
M1755220 Methylprednisolone hydrogen succinate for
performance test
50 mg
Y0001376 2-methylpyrazine
100 mg
Y0000190 N-Methylpyrrolidone - reference spectrum
n/a
M1770180 Methyl ricinoleate
Y0000418 Methylrosanilinium chloride
Y0000407 Methylrosanilinium for system suitability
M1770200 Methyl stearate
100.0% CHO; batch 2 valid until 31/12/10 for use with monograph 2134
and 1999.
0409,1262,2
134,1999
Yes
Yes
2235
+5C 3C
79
2235
+5C 3C
79
+5C 3C
79
+5C 3C
79
0312,0561
+5C 3C
79
0933
+5C 3C
79
+5C 3C
79
+5C 3C
79
1131
+5C 3C
79
2446,2447
+5C 3C
79
1675
79
125 mg
0051,2367
+5C 3C
79
40 mg
1990
+5C 3C
79
10 mg
1990
+5C 3C
79
100 mg
0051,1497
+5C 3C
79
M1800000 Methyltestosterone
100 mg
0410
+5C 3C
79
Y0000861 Methyltestosterone for system suitability
10 mg
0410
+5C 3C
79
M1800900 Methylthioninium chloride
50 mg
1132
+5C 3C
79
M1800902 Methylthioninium impurity A
20 mg
1132
+5C 3C
79
M1808000 Metixene hydrochloride
75 mg
1347
+5C 3C
79
M1824990 Metoclopramide
100 mg
1348
+5C 3C
79
M1825000 Metoclopramide hydrochloride
50 mg
0674,0856,1
303
+5C 3C
79
M1824995 Metoclopramide impurity A
25 mg
4-(acetylamino)-5-chloro-N-(2-diethylaminoethyl)-2-methoxy benzamide ;
Batch 1 is valid until 31 August 2013
1348
+5C 3C
79
M1825010 Metoclopramide impurity E
40 mg
N,N-diethylethane-1,2-diamine
1575
+5C 3C
79
Y0000701 Metolazone
80 mg
99.4% CHClNOS
1757
+5C 3C
79
Y0000702 Metolazone for system suitability
10 mg
1757
+5C 3C
79
Y0000171 Metoprolol succinate - reference spectrum
n/a
1448
79
Council of Europe, all rights reserved 2014
(2RS)-2-phenyl-2-[(2R)-piperidin-2-yl]ethanamide
3-(dimethylamino)-7-(methylamino)phenothiazin-5-ylium
51
Yes
Yes
Yes
Yes
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
New M1830000 Metoprolol tartrate
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
2
60 mg
1
Information
Monograph Leaflet
1028
5 mg
M1845000 Metrifonate
100 mg
M1850000 Metronidazole
50 mg
M1851000 Metronidazole benzoate
50 mg
1424
Y0000069 Metronidazole benzoate - reference spectrum
n/a
0934
Y0000087 Metronidazole impurity A
10 mg
M1860000 Mexiletine hydrochloride
100 mg
Y0000202 Mexiletine impurity C
2 mg
Y0000203 Mexiletine impurity D
2 mg
M1875000 Mianserin hydrochloride
100 mg
Y0001041 Mianserin impurity B
10 mg
Y0000862 Mianserin for system suitability
1.01 mg
M1880000 Miconazole
70 mg
M1900000 Miconazole nitrate
100 mg
M2200000 Midazolam - * psy
50 mg
0.08 mg
Y0000599 Midazolam for system suitability - * psy
1 mg
Y0000539 Milk thistle standardised dry extract
120 mg
Content silibinin A and silibinin B: 26.9 % of
M2280000 Minocycline hydrochloride
125 mg
90.9 % CHClNO
M2300000 Minoxidil
50 mg
0937
Y0001432 Minoxidil for system suitability
10 mg
0937
Y0000705 Mirtazapine
10 mg
2338
Y0000721 Mirtazapine for system suitability
10 mg
2338
Yes
Y0000490 Misoprostol
60 mg
1731
Y0001162 Misoprostol for system suitability
5 mg
1731
Y0000378 Mitomycin
120 mg
99.3% CHNO
M2305000 Mitoxantrone hydrochloride
50 mg
97.7% CHClNO
M2305005 Mitoxantrone impurity A
5 mg
1-amino-5,8-dihydroxy-4-[[2-[(2-hydroxyethyl)amino]ethyl] amino]
anthracene-9,10-dione
1243
Y0000635 Modafinil
110 mg
100.0% CHNOS
2307
Y0000636 Modafinil for system suitability
0.1 mg
Y0000251 Molgramostim
0.3 ml
Y0000821 Molsidomine
5 mg
New Y0000562 Midazolam impurity C
Council of Europe, all rights reserved 2014
1028,1448
+5C 3C
Y0000145 Metoprolol impurity A
(2RS)-1-(ethylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol ; Batch 2 is
valid until 31 December 2013
Storage
Yes
Extra
Price
charges
79
a
+5C 3C
79
1133
+5C 3C
79
0675,0934
+5C 3C
79
+5C 3C
79
79
0675, 0934
+5C 3C
79
1029
+5C 3C
79
1,1'-[(3,3',5,5'-tetramethylbiphenyl-4,4'-diyl)bisoxy]dipropan-2-amine
1029
+5C 3C
79
(2RS)-2-(2,6-dimethylphenoxy)propan-1-amine
1029
+5C 3C
79
0846
+5C 3C
79
0846
+5C 3C
79
+5C 3C
79
0935
+5C 3C
79
0513,1148
+5C 3C
79
2-methyl-4-nitroimidazole
(14bRS)-2-methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]
azepine-8-sulfonic acid
0846
Yes
0936,1065
acide 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a]
[1,4]benzodiazepine-3-carboxylique ; Batch 2 is valid until 30 April 2014
98.5% CHO
13.45 mg protein per ml CHNOS
+5C 3C
79
0936
Yes
+5C 3C
79
0936
Yes
+5C 3C
79
2071,1860
Yes
-20C 5C
79
1030
Yes
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
Yes
-20C 5C
g(c)
79
Yes
-20C 5C
g(c)
79
1655
Yes
+5C 3C
79
1243
Yes
+5C 3C
79
+5C 3C
79
+5C 3C
79
2307
Yes
+5C 3C
79
1641
Yes
-80C 10C
79
+5C 3C
79
1701
52
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0000822 Molsidomine impurity B
Y0000823 Molsidomine impurity D
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
10 mg
1 N-nitrosomorpholine
1
10 mg
1 morpholine-4-carbaldehyde
Information
Monograph Leaflet
+5C 3C
1701
+5C 3C
79
1449
+5C 3C
79
+5C 3C
79
+5C 3C
79
100 mg
Y0001436 Montelukast dicyclohexylamine
150 mg
99.4% CHClNOS
2583
Y0001433 Montelukast racemate
10 mg
Batch 1 is valid until 31 August 2013
2583
Y0001434 Montelukast sodium
20 mg
Batch 1 is valid until 31 August 2013
2583
Y0001435 Montelukast for peak identification
20 mg
Batch 1 is valid until 31 August 2013
2583
Y0000028 Morantel hydrogen tartrate
50 mg
Y0000451 Morphine hydrochloride (trihydrate) - * narc
25 mg
Y0000452 Morphine sulfate - * narc
40 mg
Y0000830 Morphine for system suitability - * narc
15 mg
Y0000772 Moxidectin
70 mg
Y0000747 Moxidectin for system suitability
10 mg
Y0000703 Moxifloxacin hydrochloride
110 mg
Y0000717 Moxifloxacin for peak identification
10 mg
Y0000226 Moxonidine
50 mg
99.7% CHClNO
Y0000222 Moxonidine impurity A
10 mg
4,6-dichloro-N-(imidazolidin-2-ylidene)-2-methylpyrimidin-5-amine
M3600000 Mumps vaccine (live) BRP
165 mg
4.6 log (ie40000) infective viral units per vial
M3805000 Mupirocin - reference spectrum
n/a
M3805500 Mupirocin calcium - reference spectrum
n/a
M3806000 Mupirocin lithium
100 mg
Y0000489 Mycophenolate mofetil
30 mg
Y0000519 Mycophenolate mofetil for peak identification
10 mg
1700
Y0000692 Mycoplasma fermentans BRP
1 ml
20607
Y0000690 Mycoplasma hyorhinis BRP
1 ml
Y0000691 Mycoplasma orale BRP
1 ml
Y0000689 Mycoplasma synoviae BRP
1 ml
Y0000485 Myo-inositol
1020 mg
99.8% CHO
1805
N0020000 Nabumetone
60 mg
99.8% CHO
1350
N0020020 Nabumetone impurity D
10 mg
(E)-4-(6-methoxynaphthalen-2-yl)but-3-en-2-one
1350
N0020030 Nabumetone impurity F
10 mg
6,6'-dimethoxy-2,2'-binaphthalenyl ; Batch 3 is valid until 31 May 2013
Y0000146 Nadolol
100 mg
Y0001215 Nadolol impurity mixture
0.01 mg
N0025000 Nadroparin calcium
250 mg
Y0000077 Naftidrofuryl - reference spectrum
n/a
Council of Europe, all rights reserved 2014
Yes
+5C 3C
79
Yes
+5C 3C
79
+5C 3C
79
Yes
+5C 3C
79
+5C 3C
79
1546
0097,1839,1
841
1244,1784
97.4% CHNO
96.1 % CHClFNO
1244, 0097
Yes
+5C 3C
79
1656
Yes
+5C 3C
79
1656
Yes
+5C 3C
79
2254
Yes
+5C 3C
79
2254
Yes
+5C 3C
79
+5C 3C
79
+5C 3C
79
-80C 10C
90
1450
79
1451
79
+5C 3C
79
+5C 3C
79
Yes
+5C 3C
79
Yes
-80C 10C
120
20607
Yes
-80C 10C
120
20607
Yes
-80C 10C
120
20607
Yes
-80C 10C
120
+5C 3C
79
+5C 3C
79
+5C 3C
79
1350
+5C 3C
79
1789
+5C 3C
79
+5C 3C
79
+5C 3C
79
79
1758
1758
0538,1057
1450,1451
93.7% CHOLi
Yes
Yes
1700
1789
Batch 1 is valid until 30 November 2013
0828,1134
1594
53
Extra
Price
charges
79
g(b)
1701
M2900000 Mometasone furoate
See leaflet
Storage
Yes
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0000120 Naftidrofuryl impurity A
Y0000121 Naftidrofuryl impurity B
Effective from 2014/1/2
Batch n Quantity Sale
Information
per vial Unit
1
10 mg
1 2-[(naphtalen-1-yl)methyl]-3-(tetrahydrofuran-2-yl)propanoic acid
2
25 mg
1 ethyl 2-[(naphtalen-1-yl)methyl]- 3-(tetrahydrofuran-2-yl)propanoate
Monograph Leaflet
1594
+5C 3C
+5C 3C
79
1594
+5C 3C
79
0701
+5C 3C
79
10 mg
N0050000 Nalidixic acid
100 mg
N0075000 Naloxone hydrochloride dihydrate
100 mg
5.075 mg
Y0001571 Naloxone impurity D
25 mg
Y0000400 Naltrexone hydrochloride
50 mg
Y0000410 Naltrexone impurity C
15 mg
Y0000542 Nandrolone decanoate
5 mg
Y0000547 Nandrolone decanoate for peak identification
10 mg
1992
Y0000548 Nandrolone decanoate for system suitability
10 mg
1992
N0080000 Naphazoline hydrochloride
50 mg
N0100000 Naphazoline nitrate
10 mg
N0200000 Naphazoline impurity A
15 mg
N0250000 Naproxen
100 mg
Y0000399 Naproxen (racemic)
10 mg
Y0000631 Naproxen impurity L
10 mg
1-(6-methoxynaphthalen-2-yl)ethanone
Y0001378 Naringin
20 mg
88.3% CHO
2563
Yes
Y0001437 Nateglinide
200 mg
99.9% CHNO
2575
Yes
Y0001440 Nateglinide impurity A
10 mg
trans-4-(1-methylethyl)cyclohexanecarboxylic acid
2575
Y0001441 Nateglinide impurity B
15 mg
N-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]-Lphenylalanine (Lphenylalanine isomer)
2575
Y0001442 Nateglinide impurity C
10 mg
N-[[cis-4-(1-methylethyl)cyclohexyl]carbonyl]-D-phenylalanine (cis-isomer)
N0300000 Neamine
0.5 mg
76.3% CHNO
N0399000 Neohesperidin-dihydrochalcone
125 mg
N0399004 Neohesperidin-dihydrochalcone impurity B
10 mg
N0400000 Neomycin sulfate
50 mg
N0401000 Neomycin sulfate for microbiological assay
25 mg
N0500000 Neostigmine bromide
50 mg
0046
N0550000 Neostigmine metilsulfate
50 mg
0626
New Y0000695 Naloxone for peak identification
Council of Europe, all rights reserved 2014
Extra
Price
charges
79
a
1594
Y0000331 Naftidrofuryl impurity F
2-[(diethylamino)ethyl 2-[(naphthalen-2-yl)methyl]-3- (tetrahydrofuran-2-yl)
propanoate
Storage
0729,2099
+5C 3C
79
0729
Yes
+5C 3C
79
0729
Yes
+5C 3C
79
1790
+5C 3C
79
1790
+5C 3C
79
1992
-20C 5C
79
-20C 5C
79
-20C 5C
79
0730,1162
+5C 3C
79
0147
+5C 3C
79
N-(2-aminoethyl)-2-(naphthalen-1-yl)acetamide
(naphthylacetylethylenediamine)
0147,0730
+5C 3C
79
Batch 1 is valid until 1 June 2013
0731,1702
+5C 3C
79
0731,1702
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
Batch 1 is valid until 31 May 2014
N-(3-butenyl)-noroxymorphone
Yes
0731,1702
+5C 3C
79
0180,0197
Yes
+5C 3C
79
89.9% CHO
1547
Yes
-20C 5C
79
86.4% CHO ; 7-[[2-O-(6-deoxy--L-mannopyranosyl) --Dglucopyranosyl]oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1benzopyran-4-one (neodiosmin)
1547
Yes
+5C 3C
79
Not to be used for microbiological assay
0032,0033,0
053,
0180,0197,0
485, 0645
Yes
-20C 5C
79
19850 IU per vial ; Batch 3 is valid until 31 August 2013
0197,20702
Yes
-20C 5C
79
+5C 3C
79
+5C 3C
79
54
2575
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
N0559000 Netilmicin sulfate
Y0000520 Nevirapine (anhydrous)
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
25 mg
2 14656 IU per vial
1
30 mg
1 99.8% CHNO
Information
Monograph Leaflet
1351,20702
2255, 2479
-20C 5C
Extra
Price
charges
79
a
+5C 3C
79
Yes
+5C 3C
79
+5C 3C
79
Yes
-20C 5C
180
1998
+5C 3C
79
1998
+5C 3C
79
+5C 3C
79
+5C 3C
79
0679,0680
+5C 3C
79
0047
+5C 3C
79
79
Yes
+5C 3C
79
+5C 3C
79
Yes
-20C 5C
g(c)
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
0627
+5C 3C
79
0627
+5C 3C
79
2115
+5C 3C
79
2215
+5C 3C
79
2115
+5C 3C
79
2115
+5C 3C
79
1999
+5C 3C
79
0233
+5C 3C
79
100.0% CHFNO
2256
+5C 3C
79
4-nitro-3-(trifluoromethyl)aniline
2256
+5C 3C
79
+5C 3C
79
+5C 3C
79
1548
+5C 3C
79
1245
+5C 3C
79
+5C 3C
79
Y0000521 Nevirapine for peak identification
0.058 mg
Y0001499 Nevirapine hemihydrate
15 mg
Y0000388 Newcastle Disease Vaccine (inactivated) BRP
40 mg
Y0001373 Nicergoline
50 mg
Y0001356 Nicergoline impurity D
20 mg
Y0001362 Nicergoline for peak identification
1 mg
1998
Y0001352 Nicergoline for system suitability
10 mg
1998
N0560000 Niclosamide (anhydrous)
50 mg
N0600000 Nicotinamide
50 mg
N0590000 Nicotine - reference spectrum
n/a
N0590200 Nicotine ditartrate
120 mg
Y0001425 Nicotine ditartrate dihydrate
15 mg
2599
Y0001023 Nicotine for system suitability
1 mg
1452, 1792,
2599
N0700000 Nicotinic acid
100 mg
0459
Y0001268 Nicotinic acid impurity mixture
0.12 mg
0459
N0750000 Nifedipine
50 mg
0627,1013
N0750010 Nifedipine impurity A
25 mg
Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxylate
N0750015 Nifedipine impurity B
25 mg
Dimethyl 2,6-dimethyl-4-(2-nitrosophenyl)pyridine-3,5-dicarboxylate
Y0000824 Niflumic acid
10 mg
Y0000825 Niflumic acid impurity A
10 mg
2-chloropyridine-3-carboxylic acid
Y0000826 Niflumic acid impurity B
10 mg
2-hydroxy-N-(3-(trifluoromethyl)phenyl)pyridine-3-carboxamide
Y0000827 Niflumic acid impurity E
15 mg
6-((3-(trifluoromethyl)phenyl)amino)pyridine-3-carboxylic acid
Y0000836 Nifuroxazide
10 mg
N0800000 Nikethamide
1 ml
Y0000829 Nilutamide
110 mg
Y0000894 Nilutamide impurity B
5 mg
N0845000 Nimesulide
100 mg
1548
Y0001237 Nimesulide for peak identification
10 mg
1548
N0845008 Nimesulide impurity D
0.004 mg
N0850000 Nimodipine
50 mg
N0850010 Nimodipine impurity A
1 mL
Council of Europe, all rights reserved 2014
Yes
Storage
2255, 2479
2479
The kit contains :1 vial BRP1 NDV reference antigen, 1 vial BRP1 NDV control
antigen, 1 vial BRP1 NDV coating antibody, 1 vial BRP1 NDV conjugated,
detection antibody
5-bromopyridine-3-carboxylic acid
0870
Yes
1452,1792
1792
92.8% CHN x 2 CHO ; Batch 3 is valid until 1 May 2013
4-nitro-2-phenoxyaniline
2-methoxyethyl 1-methylethyl 2,6-dimethyl-4-(3-nitrophenyl)
pyridine-3,5-dicarboxylate ; Batch 3 is valid until 1 June 2013
55
1245
Yes
Yes
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
N0900000 Nitrazepam - * psy
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
100 mg
1
Information
Monograph Leaflet
N0905000 Nitrendipine
60 mg
Y0001456 Nitrendipine for peak identification
10 mg
N0905005 Nitrendipine impurity A
30 mg
N0930000 Nitric oxide - reference spectrum
n/a
N0950000 Nitrofural
100 mg
Y0001377 Nitrofural for peak identification
0.11 mg
Y0001570 Nitrofural impurity B
30 mg
N1000000 Nitrosotriaminopyrimidine
50 mg
N1090000 Nizatidine
250 mg
Y0001278 Nizatidine for system suitability
10 mg
N1090060 Nizatidine impurity F
10 mg
(EZ)-N,N'-[thiazole-2,4-diylbis(methylenesulphanediylethylene)]bis(N'methyl-2-nitroethene-1,1-diamine)
N1080000 Nomegestrol acetate
100 mg
N1080005 Nomegestrol acetate impurity A
50 mg
425 mg
Y0000670 Nonivamide
10 mg
Y0000755 Nonoxinol 9
10 mg
N1100000 Noradrenaline tartrate
200 mg
Y0000681 Noradrenaline impurity D
15 mg
Y0000682 Noradrenaline impurity E
10 mg
Y0000686 Noradrenaline impurity F
10 mg
N1130000 Norcyclobenzaprine
25 mg
N1140000 Nordazepam -* psy
50 mg
N1200000 Norethisterone
50 mg
N1225000 Norethisterone acetate
Y0001532 Norethisterone acetate for system suitability
Y0000522 Norethisterone for system suitability
N1230000 Norfloxacin
N1230010 Norfloxacin impurity A
Y0001015 Norfloxacin for system suitability
New Y0001314 1-nonadecanol
Council of Europe, all rights reserved 2014
Extra
Price
charges
79
j
0415,0898,1
121
+5C 3C
1246
+5C 3C
79
+5C 3C
79
+5C 3C
79
79
1246
ethyl methyl-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5- dicarboxylate;
(nitrophenylpyridine analogue)
Storage
Yes
1246
1550
1135
+5C 3C
79
1135
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
1453
+5C 3C
79
Batch 1 is valid until 31 March 2014
1551
+5C 3C
79
6alpha-methyl-3,20-dioxo-19-norpregn-4-en-17-yl acetate
1551
+5C 3C
79
Batch 1 is valid until 31 May 2014
0801,0802,0
847
+5C 3C
79
99.1% CHNO
1859,2336,2
337, 2529
+5C 3C
79
1454
+5C 3C
79
0254,0285,0
732, 2303
+5C 3C
79
+5C 3C
79
4[(1R)-2-amino-1-methoxyethyl]benzene-1,2-diol (noradrenaline methyl ether) 0285,0732
2-chloro-1-(3,4-dihydroxyphenyl)ethanone
0285,0732
+5C 3C
79
N-benzyl-1-phenylmethanamine
0285,0732
+5C 3C
79
0941
+5C 3C
79
Dipotassium clorazepate impurity B
0898,1466
+5C 3C
79
0234,1212,0
926
+5C 3C
79
100 mg
0850
+5C 3C
79
2.585 mg
0850
Yes
+5C 3C
79
10 mg
0234
Yes
-20C 5C
79
50 mg
1248
+5C 3C
79
20 mg
1460
+5C 3C
79
8 mg
+5C 3C
79
99.8% CHNO
1135
94.8 % CHON; (5-nitrofuran-2-yl)methylene diacetate
Yes
0058
1453
99.3% CHNOS
1453
7-chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
(corresponding also to pefloxacin impurity F)
1248
56
Yes
Yes
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0001301 Norfloxacin for peak identification
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
10 mg
1
Information
Monograph Leaflet
1248
Yes
Y0001609 Norflurane - reference spectrum
1 mg
Y0000724 Norgestimate
10 mg
1732
Y0000725 Norgestimate for system suitability
5 mg
1732
N1250000 Norgestrel
30 mg
0940
N1279000 Norpseudoephedrine hydrochloride - * psy
50 mg
0683
N1280000 Nortriptyline hydrochloride
10 mg
0941
Y0001296 Nortriptyline for system suitability
20 mg
100 mg
Batch 1 is valid until 31 May 2014
N1400000 Nystatin
100 mg
5880 IU per mg ; Batch 6 is valid until 31 August 2013
0517,1292,2
0702
O0100900 Octoxinol 10
300 mg
Y0000368 Octyl gallate
30 mg
O0101000 Octyldodecanol
400 mg
O0120000 Ofloxacin
50 mg
O0120010 Ofloxacin impurity A
20 mg
(RS)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido [1,2,3-de][1,4]
benzoxazine-6-carboxylic acid (FPA)
New O0120050 Ofloxacin impurity E
20 mg
Y0001370 Olanzapine
200 mg
Y0001392 Olanzapine impurity A
5 mg
Y0001380 Olanzapine for system suitability
10 mg
2258
Y0001204 Oleanolic acid
20 mg
90.9% CHO
2472
Y0001479 Oleic acid
2000 mg
98.3% CHO
Y0000805 Oleuropein
20 mg
82.2% CHO
Y0001405 Olmesartan medoxomil
100 mg
99.3 % CHNO
Y0001424 Olmesartan medoxomil for system suitability
10 mg
O0146000 Olsalazine sodium
70 mg
O0146010 Olsalazine sodium for performance test
60 mg
1457
Yes
O0150000 Omeprazole
50 mg
0942,1032,2
372, 2374
Y0001043 Omeprazole magnesium
10 mg
2374
Y0001042 Omeprazole for peak identification
10 mg
0942,1032,2
372, 2374
O0151000 Omeprazole impurity D
10 mg
New N1300000 Noscapine
Council of Europe, all rights reserved 2014
Storage
+5C 3C
Extra
Price
charges
79
a
l
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
0941
+5C 3C
79
0102,0515,0
516
+5C 3C
79
-20C 5C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
1455
+5C 3C
79
1455
+5C 3C
79
(RS)-9-fluoro-3-methyl-10-(piperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido
[1,2,3-de][1,4]benzoxazine-6-carboxylic acid ; Batch 3 is valid until 30 April
2014
1455
+5C 3C
79
99.8% CHNS
2258
+5C 3C
79
5-methyl-2-[(2-nitrophenyl)amino]thiophene-3-carbonitrile
2258
+5C 3C
79
Yes
+5C 3C
79
Yes
+5C 3C
79
2579
Yes
+5C 3C
79
1878
Yes
+5C 3C
79
2600
Yes
+5C 3C
79
2600
Yes
+5C 3C
79
+5C 3C
79
+5C 3C
79
Yes
-20C 5C
79
+5C 3C
79
Yes
-20C 5C
79
-20C 5C
79
Cathine hydrochloride
Yes
Yes
1553
2057
1136
94.8% CHO
Batch 1 is valid until 30 November 2013
Omeprazole sulphone
57
Yes
Yes
1457
0942,1032,2
372, 2374
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0000218 Ondansetron hydrochloride dihydrate
Effective from 2014/1/2
Batch n Quantity Sale
Information
per vial Unit
4
200 mg
1 89,9% CHClNO ; Batch 3 is valid until 1 June 2013
Monograph Leaflet
2016
Yes
Storage
+5C 3C
Extra
Price
charges
79
g
Y0000197 Ondansetron for LC system suitability
10 mg
2016
+5C 3C
79
Y0000196 Ondansetron for TLC system suitability
30 mg
2016
+5C 3C
79
Y0001345 Ondansetron impurity A
10 mg
(3RS)-3-[(dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4Hcarbazol-4-one
2016
+5C 3C
79
Y0000195 Ondansetron impurity D
10 mg
9-methyl-3-methylene-1,2,3,9-tetrahydro-4H-carbazol-4-one
2016
+5C 3C
79
Y0001326 Ondansetron impurity E
10 mg
Imidazole
2016
+5C 3C
79
Y0001320 Ondansetron impurity F
10 mg
2016
+5C 3C
79
Y0001346 Ondansetron impurity G
10 mg
2016
+5C 3C
79
Y0001125 Orbifloxacin
200 mg
2259
+5C 3C
79
Y0001147 Orbifloxacin impurity mixture
0.0008 mg
2259
+5C 3C
79
O0180000 Orciprenaline sulfate
100 mg
1033,1332
+5C 3C
79
Y0000895 Orciprenaline for system suitability
5 mg
1033
Yes
+5C 3C
79
Y0001501 Orientvine stem HRS
600 mg
2450
Yes
+5C 3C
79
Y0000100 Orphenadrine hydrochloride
100 mg
1760
+5C 3C
79
Y0000101 Orphenadrine citrate
100 mg
1759
+5C 3C
79
Y0001337 Oseltamivir phosphate (impurity B free)
300 mg
Y0001181 Orphenadrine for peak identification
0.42 mg
Y0001338 Oseltamivir impurity A
10 mg
(3R,4R,5S)-5-acetamido-4-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1carboxylic acid
Y0000102 Orphenadrine impurity E
60 mg
(RS)-N,N-dimethyl-2-[(3-methylphenyl)phenylmethoxy] ethanamine (metamethylbenzyl isomer) ; Batch 1 is valid until 1 May 2013
Y0001339 Oseltamivir impurity B
10 mg
Y0001340 Oseltamivir impurity C
10 mg
Y0001341 Oseltamivir impurity H
Y0001207 Osthole
O0200000 Ouabain
Y0000638 Oxacillin sodium monohydrate
Y0000560 Oxacillin for peak identification
Y0000271 Oxaliplatin
(3RS)-3-[(1H-imidazol-1-yl)methyl]-9-methyl-1,2,3,9-tetrahydro-4Hcarbazol-4-one (C-demethylondansetron)
Yes
2422
Yes
+5C 3C
79
1759,1760
Yes
+5C 3C
79
2422
+5C 3C
79
1759,1760
+5C 3C
79
ethyl (1R,2R,3S,4R,5S)-4-acetamido-5-amino-2-azido-3(1-ethylpropoxy)cyclohexanecarboxylate
2422
+5C 3C
79
(3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1carboxylic acid
2422
+5C 3C
79
30 mg
tributylphosphane oxide
2422
+5C 3C
79
20 mg
98.3 % CHO
2557
Yes
+5C 3C
79
150 mg
80.0% CHO
0048
Yes
+5C 3C
79
110 mg
93.8% CHNNaOS
2260
Yes
+5C 3C
79
10 mg
2260
Yes
+5C 3C
79
250 mg
99.9% CHNOPt ; Batch 3 is valid until 1 June 2013
2017
Yes
+5C 3C
79
Y0000272 Oxaliplatin impurity B
22 mg
94.4% CHNOPtS; ditosylato diaminocyclohexane platinum complex ;
Batch 7 is valid until 1 June 2013
Batch 8 is valid until 31 December 2013
2017
Yes
+5C 3C
79
Y0000273 Oxaliplatin impurity C
25 mg
(OC-6-33)-[(1R,2R)-cyclohexane-1,2-diamine-kN,kN'][ethane-dioato(2-)kO1,kO2]dihydroxyplatinum ; Batch 4 is valid until 1 April 2013
2017
+5C 3C
79
Council of Europe, all rights reserved 2014
99.7% CHNOP
58
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0000274 Oxaliplatin impurity D
Effective from 2014/1/2
Batch n Quantity Sale
Information
Monograph Leaflet
per vial Unit
4
10 mg
1 (SP-4-2)-[(1S,2S)-cyclohexane-1,2-diamine-kN,kN'][ethane2017
dioato(2-)-kO1,kO2]platinum (S,S-enantiomer of oxaliplatin) ; Batch 3 is valid
until 31 December 2013
+5C 3C
Extra
Price
charges
79
g
O0225000 Oxazepam - * psy
50 mg
+5C 3C
79
Y0000543 Oxazepam for peak identification
0.008 mg
Batch 1 is valid until 1 March 2013
0778
Yes
+5C 3C
79
Y0001576 Oxcarbazepine
120 mg
99.8 % CHNO
2577
Yes
+5C 3C
79
Y0001549 Oxcarbazepine impurity mixture
0.008 mg
2577
Yes
+5C 3C
79
Y0000350 Oxeladin hydrogen citrate
50 mg
1761
+5C 3C
79
Y0000404 Oxeladin impurity C
10 mg
2-(diethylamino)ethyl 2-ethyl-2-phenylbutanoate
1761
+5C 3C
79
Y0000390 Oxeladin impurity D
20 mg
2-(2-diethylaminoethoxy)ethyl 2-phenyl-butyrate dihydrogen citrate
1761
+5C 3C
79
O0225800 Oxfendazole for veterinary use
50 mg
1458
+5C 3C
79
10 mg
+5C 3C
79
New Y0000224 Oxfendazole impurity B
0778
Storage
See leaflet; methyl [5-(phenylsulphonyl)-1H-benzimidazole-2-yl]carbamate ;
Batch 1 is valid until 30 April 2014
1458
Yes
Y0000225 Oxfendazole with impurity D
10 mg
1458
+5C 3C
79
O0260000 Oxibendazole
100 mg
1386
+5C 3C
79
Y0000709 Oxitropium bromide
50 mg
2170
+5C 3C
79
Y0000715 Oxitropium bromide impurity B
15 mg
(1R,2R,4S,5S,7s)-7-[[(2S)-3-hydroxy-2-phenylpropanoyl]oxy]-9,9dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane (methylhyoscine)
2170
+5C 3C
79
Y0000713 Oxitropium bromide impurity D
10 mg
(1R,2R,4S,5S,7s,9r)-9-ethyl-9-methyl-7-[(2-phenylprop-2-enoyl)oxy]-3oxa-9-azoniatricyclo[3.3.1.02,4]nonane (apo-N-ethylhyoscine)
2170
+5C 3C
79
O0240000 Oxolinic acid
50 mg
1353
+5C 3C
79
O0240005 Oxolinic acid impurity A
20 mg
8-hydroxy-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid
1353
+5C 3C
79
O0240010 Oxolinic acid impurity B
20 mg
ethyl 5-ethyl-8-oxo-5,8-dihydro-1,3-dioxolo[4,5-g]quinoline-7- carboxylate
1353
+5C 3C
79
O0250000 Oxprenolol hydrochloride
50 mg
0628,0876,1
072
+5C 3C
79
O0270000 Oxybuprocane hydrochloride
150 mg
1251
+5C 3C
79
O0288000 Oxybutynin hydrochloride
150 mg
1354
+5C 3C
79
O0288005 Oxybutynin impurity A
20 mg
+5C 3C
79
Y0000492 Oxycodone hydrochloride - * narc
100 mg
Y0000453 Oxycodone impurity D
50 mg
O0290000 Oxymetazoline hydrochloride
80 mg
Y0001044 Oxymetazoline impurity A
15 mg
N-(2-aminoethyl)-2-[4-(1,1-dimethylethyl)-3-hydroxy-2,6-dimethylphenyl]
acetamide
O0400000 Oxytetracycline
100 mg
89.9% CHNO
O0500000 Oxytetracycline hydrochloride
20 mg
O0700000 Oxytocin
1 mg
Council of Europe, all rights reserved 2014
90.7% CHNO; 4-(diethylamino)but-2-ynyl()-2-(cyclohex-3-enyl)-2cyclohexyl-2-hydroxyacetate ; Batch 3 is valid until 31 December 2013
7,8-didehydro-4,5 alpha-epoxy-14-hydroxy-3-methoxy -17methylmorphinan-6-one (14-hydroxycodeinone) ; Batch 2 is valid until 31
March 2014
1354
Yes
1793
+5C 3C
79
1793
+5C 3C
79
0943
+5C 3C
79
0943
+5C 3C
79
Yes
+5C 3C
79
+5C 3C
79
Yes
-20C 5C
g(c)
90
0198,0199
0198,1030
0.96 mg per vial of CHNOS
59
0779,0780
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
O0770000 Oxytocin/Desmopressin validation mixture
Effective from 2014/1/2
Batch n Quantity Sale
Information
per vial Unit
4
20 mg
1 about 0.1 mg oxytocin + 0.1 mg desmopressin per vial ; Batch 3 is valid until
30 November 2013
Y0000698 Paclitaxel
Y0000699 Paclitaxel impurity C
Y0000700 Paclitaxel natural for peak identification
Y0000719 Paclitaxel semi-synthetic for peak identification
Y0000739 Paclitaxel semi-synthetic for system suitability
Monograph Leaflet
0712,0779,0
780
40 mg
99.4% CHNO
1794
5 mg
N-debenzoyl-N-hexanoylpaclitaxel
1794
10 mg
10 mg
1.013 mg
P0090000 Palmitic acid
100 mg
Y0000524 Pamidronate disodium pentahydrate
10 mg
P0100000 Pancreas powder (amylase and lipase) BRP
2000 mg
41.4 Ph. Eur. U. lipolytic activity per mg; 56.3 Ph. Eur. U. amylolytic activity
per mg
0350
Y0001632 Pancreas powder (amylase) BRP
2000 mg
See leaflet
Y0001631 Pancreas powder (lipase) BRP
2000 mg
See leaflet
New P0200000 Pancreas powder (protease) BRP
Batch 1 is valid until 1 April 2013
Storage
-20C 5C
Yes
Extra
Price
charges
79
c
+5C 3C
79
+5C 3C
79
1794
Yes
+5C 3C
79
1794
Yes
+5C 3C
79
1794
Yes
+5C 3C
79
0229,0882,1
474,
1663,2058,
+5C 3C
79
1779
+5C 3C
79
Yes
+5C 3C
79
0350
Yes
+5C 3C
79
0350
Yes
+5C 3C
79
0350
Yes
2000 mg
See leaflet ; Batch 3 is valid until 30 April 2014
P0250000 Pancuronium bromide
20 mg
Vecuronium impurity B
+5C 3C
79
0681,1769
+5C 3C
79
Y0000577 Pancuronium bromide for system suitability
20 mg
Y0000835 Pantoprazole sodium sesquihydrate
20 mg
0681
+5C 3C
79
2296
+5C 3C
79
Y0001001 Pantoprazole for system suitability
0.5055 mg
P0270000 Papaverine hydrochloride
25 mg
0102,0573
+5C 3C
79
+5C 3C
79
P0300000 Paracetamol
50 mg
Y0000780 Paraffin (hard)
10 mg
0049
+5C 3C
79
1034
+5C 3C
79
Y0000058 Paraffin (liquid) - reference spectrum
n/a
0239,0240
Y0000913 Paraffin (White soft)
10 mg
79
1799
+5C 3C
79
Y0000912 Paraffin (Yellow soft)
10 mg
P0305000 Parnaparin sodium
200 mg
Y0000578 Paroxetine hydrochloride (anhydrous)
100 mg
Y0000281 Paroxetine hydrochloride hemihydrate
200 mg
Y0000233 Paroxetine impurity A
Y0000579 Paroxetine hydrochloride (anhydrous) impurity C
2296
Batch 4 is valid until 31 December 2013
Yes
1554
+5C 3C
79
Batch 1 is valid until 31 March 2014
0828,1252
+5C 3C
79
+5C 3C
79
97.4% CHClFNO
2018,2283
+5C 3C
79
15 mg
(3S,4R)-3-[[1,3-benzodioxol-5-yloxy]methyl]-4-phenylpiperidine
(desfluoroparoxetine)
2018,2283
+5C 3C
79
10 mg
(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-1-benzyl-4-(4-fluo- rophenyl)
piperidine (N-benzylparoxetine)
2283
+5C 3C
79
Y0000256 Paroxetine impurity D
5 mg
(3R,4S)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine
((+)-trans-paroxetine)
2018,2283
+5C 3C
79
Y0000580 Paroxetine impurity E
5 mg
(3RS,4RS)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4fluorophe- nyl)piperidine
(cis-paroxetine)
2283
+5C 3C
79
Y0000581 Paroxetine hydrochloride (anhydrous) impurity H
10 mg
[(3S,4R)-1-benzyl-4-(4-fluorophenyl)piperidin-3-yl]methanol
2283
+5C 3C
79
Council of Europe, all rights reserved 2014
2283
60
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0000630 Paroxetine for system suitability
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
5 mg
1
Information
Monograph Leaflet
2018
Storage
+5C 3C
Extra
Price
charges
79
g
P0309000 Pefloxacin mesilate dihydrate
200 mg
1460
+5C 3C
79
P0309020 Pefloxacin impurity B
10 mg
1-ethyl-6-chloro-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydro- quinoline-3carboxylic acid (chlorinated homologue of pefloxacin)
1460
+5C 3C
79
P0309030 Pefloxacin impurity C
0.01 mg
1-ethyl-6-fluoro-5-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydro- quinoline-3carboxylic acid (isopefloxacin)
1460
+5C 3C
79
Y0001539 Pemetrexed disodium heptahydrate
200 mg
78.6 %
2637
+5C 3C
79
Y0001538 Pemetrexed for system suitability
20 mg
2637
+5C 3C
79
Y0001535 Pemetrexed impurity mixture
0.002 mg
2637
+5C 3C
79
P0307000 Penbutolol sulfate
100 mg
1461
+5C 3C
79
P0307005 Penbutolol impurity A
20 mg
1461
+5C 3C
79
P0310000 Penicillamine
100 mg
0566
+5C 3C
79
P0320000 Penicillamine disulfide
100 mg
93.0% CHNOS; 3,3-(disulphanediyl)bis[(2S)-2-amino-3methylbutanoic] acid
+5C 3C
79
P0400100 Pentaerythrityl tetranitrate diluted
600 mg
10.0% CHNO
1355
+5C 3C
79
30 mg
Batch 1 is valid until 31 May 2014
1137,1436
+5C 3C
79
P0405500 Pentazocine - reference spectrum
n/a
1462
79
P0405510 Pentazocine hydrochloride - reference spectrum
n/a
1463
79
Y0000417 Pentazocine lactate - reference spectrum
n/a
2000
Y0001051 Pentetate sodium calcium
100 mg
2353
+5C 3C
P0500000 Pentobarbital - * psy
500 mg
0200,0419
P0510000 Pentoxifylline
100 mg
0851
Y0000076 Pentoxyverine hydrogen citrate - reference spectrum
n/a
Y0000098 Pentoxyverine impurity A
10 mg
1-phenylcyclopentanecarboxylic acid
1621
Y0000099 Pentoxyverine impurity B
10 mg
2-(diethylamino)ethyl 1-phenylcyclopentanecarboxylate (caramiphen)
1621
P0525000 Pepsin powder
2000 mg
See leaflet
0682
Yes
Y0000010 Pergolide mesilate
150 mg
99.9% CHNOS
1555
Yes
Y0000237 Perindopril impurity A
10 mg
(2S,3aS,7aS)-octahydro-1Hindole-2-carboxylic acid ; Batch 1 is valid until 1
May 2013
2019
Y0000207 Perindopril for stereochemical purity
40 mg
Batch 1 is valid until 1 June 2013
2019
Y0000238 Perindopril tert-butylamine
40 mg
2019
Y0000771 Perindopril for peak identification
5 mg
2019
P0550000 Perphenazine
100 mg
0629,0904
Y0001045 Perphenazine for system suitability
5 mg
0629
New P0405000 Pentamidine diisetionate
Council of Europe, all rights reserved 2014
(2S)-1-[2-(cyclopent-1-enyl)phenoxy]-3-[(1,1-dimethylethyl) amino]
propan-2-ol ; Batch 1 is valid until 7 February 2013
0566
Yes
Yes
Yes
79
79
+5C 3C
79
+5C 3C
79
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
1621
61
Yes
Yes
Yes
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0000021 Pertussis toxin BRP
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
0.05 mg
2
Information
Monograph Leaflet
See leaflet,
1356, 1595,
1931, 1932,
1933, 1934,
2065, 2067,
2329
P0600000 Pethidine hydrochloride - reference spectrum
n/a
P0600002 Pethidine impurity A
20 mg
P0800000 Phenazone
20 mg
Y0001138 Phenazone impurity A
20 mg
P0850000 Pheniramine maleate
250 mg
Y0001428 Pheniramine impurity A
20 mg
P0900000 Phenobarbital - * psy
200 mg
Y0001350 Phenobarbital impurity A
15 mg
Y0001351 Phenobarbital impurity B
15 mg
P0950000 Phenoxyethanol
1 mL
P1000000 Phenoxymethylpenicillin
250 mg
P1100000 Phenoxymethylpenicillin potassium
250 mg
Y0001127 Phentolamine mesilate
10 mg
1138
Y0001251 Phentolamine mesilate for system suitability
10 mg
1138
P1109000 Phentolamine mesilate - reference spectrum
n/a
1138
P1150000 Phenylalanine
60 mg
0782,0796,1
161,2575
P1200000 Phenylbutazone
100 mg
Y0000147 Phenylbutazone impurity B
20 mg
P1240000 Phenylephrine
60 mg
P1250000 Phenylephrine hydrochloride
50 mg
Y0000683 Phenylephrine hydrochloride for peak identification
Y0000229 Phenylmercuric acetate - reference spectrum
P1255100 Phenylmercuric borate - reference spectrum
P1260000 Phenylpropanolamine hydrochloride - * Drug Precursor
Yes
Storage
-20C 5C
0420
1-methyl-4-phenylpiperidine (MPP)
5-methyl-2-phenyl-2,4-dihydro-3-pyrazol-3-one
2-benzylpyridine
79.1% CHNO
Extra
Price
charges
90
g(d)
79
0420
+5C 3C
79
0421
+5C 3C
79
0421
+5C 3C
79
1357
+5C 3C
79
1357
+5C 3C
79
0189,0201,0
630
+5C 3C
79
+5C 3C
79
0201
+5C 3C
79
0781
+5C 3C
79
0201
Yes
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
79
+5C 3C
79
0422,1574
+5C 3C
79
0422
+5C 3C
79
1035
+5C 3C
79
0632,1205
+5C 3C
79
2 mg
0632,1035
+5C 3C
79
n/a
2042
79
n/a
50 mg
P1290000 Phenytoin
100 mg
1253,1988
Y0001167 Phenytoin for system suitability
20 mg
0521,1253
P1300000 Phenytoin sodium
250 mg
Y0000493 Phloroglucinol (anhydrous)
210 mg
Y0000761 Pholcodine - * narc
10 mg
0522
Council of Europe, all rights reserved 2014
0148
99.2% CHKNOS
(4-butyl-4-hydroxy-1,2-diphenyl-3,5)-pyrazolidinedione
0113,0114,0
148, 0149
Yes
Yes
0103
Norephedrin hydrochloride
62
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
0521
+5C 3C
79
2301,2302
+5C 3C
79
+5C 3C
79
0683
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0000798 Pholcodine for peak identification - * narc
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
10 mg
1
Information
Monograph Leaflet
0522
Y0000766 Phthalic acid
20 mg
P1500000 Phthalylsulfathiazole
100 mg
P1600000 Physostigmine salicylate
100 mg
P1609000 Phytomenadione
150 mg
99.9 % phytomenadione C31H46O2 CHO; Vitamin K1 ; Batch 3 is valid
until 28 February 2014
1036
5 mg
Batch 2 is valid until 30 April 2014
P1645000 Picotamide monohydrate
125 mg
P1645005 Picotamide impurity A
25 mg
Y0001508 Picrotin
40 mg
2486
Y0001528 Picrotoxinin
40 mg
98.3 % CHO
2486
New Y0000124 Pidolate impurity B
110 mg
(2S)-2-[[[(2S)-5-oxopyrrolidin-2-yl]carbonyl]amino]pentane-dioic acid ;
Batch 2 is valid until 31 May 2014
Y0000123 Pidolic acid
125 mg
P1650000 Pilocarpine hydrochloride
50 mg
P1700000 Pilocarpine nitrate
50 mg
Y0000106 Pilocarpine nitrate for system suitability
20 mg
Y0000525 Pimobendan
Y0000401 Pimobendan for system suitability
P1750000 Pimozide
150 mg
P1800000 Pindolol
100 mg
Y0001520 Pioglitazone hydrochloride
120 mg
Y0001519 Pioglitazone for system suitability
15 mg
Y0001476 Pipemidic acid trihydrate
15 mg
Y0000061 Pipemidic acid trihydrate - reference spectrum
n/a
P1890000 Piperacillin
100 mg
P1900000 Piperazine adipate
250 mg
P2000000 Piperazine citrate
250 mg
P2100000 Piperazine hydrate
250 mg
Y0001217 Piperine
30 mg
99.0% CHNO
Y0000288 Piracetam
150 mg
99.9% CHNO ; Batch 2 is valid until 31 December 2013
Y0000038 Pirenzepine dihydrochloride monohydrate
250 mg
2001
P2120000 Piretanide
100 mg
1556
Y0001458 Piretanide for system suitability
10 mg
1556
P2130000 Piroxicam
50 mg
Batch 2 is valid until 31 January 2013
0944
Y0001475 Piroxicam for system suitability
15 mg
Y0001475 replaces P2130100
0944
New P1609010 trans-Epoxyphytomenadione
Council of Europe, all rights reserved 2014
benzene-1,2-dicarboxylic acid
Yes
Storage
+5C 3C
Extra
Price
charges
79
k
2348
+5C 3C
79
0352
+5C 3C
79
0286
+5C 3C
79
+5C 3C
79
1036
+5C 3C
79
1358
+5C 3C
79
1358
+5C 3C
79
Yes
+5C 3C
79
Yes
+5C 3C
79
1619
+5C 3C
79
1619
+5C 3C
79
0633
+5C 3C
79
0104
+5C 3C
79
0104,0633
+5C 3C
79
10 mg
2179
+5C 3C
79
0.1 mg
2179
+5C 3C
79
1254
+5C 3C
79
0634,0871,1
789
+5C 3C
79
4-methoxybenzene-1,3-dicarboxylic acid
Yes
2601
Yes
+5C 3C
79
2601
Yes
+5C 3C
79
1473
+5C 3C
79
79
+5C 3C
79
0423
+5C 3C
79
0424
+5C 3C
79
0425
+5C 3C
79
2453,2477
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
99.8% CHClNOS
1743
94.4% CHNOS ; Batch 3 is valid until 28 February 2014
63
1168,1169
1733
Yes
Yes
Yes
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Code
P2150000 Pivampicillin
Reference Standard
P2152000 Pivmecillinam hydrochloride
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
50 mg
2 99.2% CHNOS
2
100 mg
1 99.6% CHClNOS
Information
Monograph Leaflet
0808,0852
Yes
Storage
+5C 3C
Extra
Price
charges
79
a
1359
-20C 5C
79
1359
+5C 3C
79
(2RS)-2-ethylhexyl) benzene-1,2-dicarboxylate
90001,9000
2, 30114
+5C 3C
79
N,N'-ethylenedialcanamide
90001,30114
+5C 3C
79
500 mg
Epoxidised soya oil
90001,30114
+5C 3C
79
500 mg
Epoxidised linseed oil
90001,30114
+5C 3C
79
500 mg
ethylene bis[3,3-bis[3-(1,1-dimethylethyl)-4-hydroxyphenyl]butanoate]
+5C 3C
79
P2155009 Plastic additive 09
250 mg
pentaerythrityl tetrakis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate]
30103,3010
4,
30105,3010
30103,3010
+5C 3C
79
P2155010 Plastic additive 10
250 mg
4,4',4''-(2,4,6-trimethylbenzene-1,3,5-triyltrismethylene)trio[2,6-bis(1,1dimethylethyl)phenol]
+5C 3C
79
P2155011 Plastic additive 11
500 mg
Octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)-propionate
+5C 3C
79
P2155012 Plastic additive 12
250 mg
Tris (2,4-di-1,1-dimethylethylphenyl) phosphite R
+5C 3C
79
P2155013 Plastic additive 13
250 mg
1,3,5-tris(3,5-di-1,1-dimethylethyl-4-hydroxybenzyl)-1H,3H,5H-1,3,5triazine-2,4,6-trione
+5C 3C
79
P2155014 Plastic additive 14
250 mg
2,2'-Di(octadecycloxy)-5,5'-spirobi(1,3,2-dioxaphosphorinane) R
30103,3010
5, 30106
+5C 3C
79
P2155015 Plastic additive 15
500 mg
Dioctadecyl disulphide
+5C 3C
79
P2155016 Plastic additive 16
250 mg
Didodecyl 3,3'-thiodipropionate R
30103,3010
4,
30105,3010
30103,3010
+5C 3C
79
P2155017 Plastic additive 17
250 mg
Dioctadecyl 3,3'-thiodipropionate R
30103,3010
5, 30106
+5C 3C
79
P2155018 Plastic additive 18
100 mg
Batch 1 is valid until 22 July 2013
O0140000 Plastic additive 20
100 mg
Oleamide R
E1260000 Plastic additive 21
100 mg
Erucamide R
P2155022 Plastic additive 22
100 mg
Copolymer of dimethyl butanedioate and 1-(2-hydroxyethyl)-2,2,6,6tetramethylpiperidin-4-ol
Synonyms: copolymer of dimethyl succinate and (4-hydroxy-2,2,6,6tetramethylpiperidin-1-yl)ethanol
P2155023 Plastic additive 23
200 mg
di(isooctyl)2,2'-[(dioctylstannylene)bis(thio)]diacetate
containing about 27% of (tri(isooctyl)2,2',2''- [monooctyl- stannylidyne)tris
(thio)] triacetate.
P2152015 Pivmecillinam impurity C
10 mg
methylene 2,2-dimethylpropanoate (2RS,4S)-2-[[[(hexahydo- 1H-azepin-1-yl)
methylene]amino]methyl]-5,5-dimethylthiazolidin-4-carboxylate
P2155001 Plastic additive 01
2 ml
P2155003 Plastic additive 03
100 mg
E0800000 Plastic additive 04
P2155005 Plastic additive 05
P2155008 Plastic additive 08
Council of Europe, all rights reserved 2014
5,
30106,3010
30103,3010
5,
30106,3010
30103,3010
5,
30106,3010
30103,3010
5,
30106,3010
30103,3010
5, 30106
5, 30106
64
Yes
30103
+5C 3C
79
30103,3010
5,
30106,3010
30103,30107
+5C 3C
79
+5C 3C
79
30103
+5C 3C
79
30110,30111
+5C 3C
79
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
P2160000 Poliomyelitis vaccine (inactivated) BRP
Effective from 2014/1/2
Batch n Quantity Sale
Information
per vial Unit
2
0.5 ml
5 320-67-282 Ph. Eur. D-Antigen Units per ml for types 1-2-3, respectively
Monograph Leaflet
Storage
0214,2066,2
065,
2328,2061,2
067,
1934,2329,2
0720
Yes
Extra
Price
charges
90
-80C 10C
d
See leaflet,
0215
Yes
-20C 5C
90
P2161000 Poliomyelitis vaccine (oral) BRP
1 ml
P2163920 Poloxamer 124
30 mg
1464
+5C 3C
79
P2164009 Poloxamer 188
100 mg
1464
+5C 3C
79
P2164020 Poloxamer 237
100 mg
1464
+5C 3C
79
P2164021 Poloxamer 338
100 mg
1464
+5C 3C
79
P2164030 Poloxamer 407
100 mg
1464
+5C 3C
79
Y0001557 Poly (vinyl acetate)
100 mg
1962
+5C 3C
79
Y0000792 Poly(vinyl acetate) dispersion 30 per cent
1500 mg
2152
+5C 3C
79
P2600000 Poly(vinyl chloride)
100 mg
90001,9000
2, 30114
+5C 3C
79
P2170000 Polyacrylate - reference spectrum
n/a
0733
79
Y0001550 Poly(vinyl alcohol)
100 mg
1961
+5C 3C
79
P2400000 Polymyxin B sulfate
25.1 mg
65.1% polymyxin B1, 12.5% polymyxin, 3.3% polymyxin B3, 9.1% polymyxin
B1-I
0203
Yes
+5C 3C
79
Y0000355 Polymyxin B sulfate for microbiological assay
25 mg
205000 IU per vial
20702
Yes
-20C 5C
79
Y0000289 Polysorbate 20 - reference spectrum
n/a
0426
79
Y0000290 Polysorbate 40 - reference spectrum
n/a
1914
79
Y0000291 Polysorbate 60 - reference spectrum
n/a
0427
79
Y0000007 Polysorbate 80 - reference spectrum
n/a
0428
79
P2649610 Potassium clavulanate - reference spectrum
n/a
1140
79
Y0001168 Potassium clavulanate impurity G
5 mg
1653,1140
-20C 5C
g(c)
79
Y0000315 Potassium hydrogen aspartate hemihydrate
50 mg
2076
+5C 3C
79
P2650000 Potassium sorbate
100 mg
+5C 3C
79
Y0001275 Potassium sucrose octasulfate
100 mg
+5C 3C
79
P2660000 Povidone
50 mg
0685
+5C 3C
79
Y0000466 Povidone (iodinated)
10 mg
1142
+5C 3C
79
Y0001266 Pramipexole dihydrochloride monohydrate
5 mg
2416
+5C 3C
79
Y0001187 Pramipexole for system suitability
15 mg
2416
+5C 3C
79
Y0001267 Pramipexole impurity D
5 mg
+5C 3C
79
Y0000215 Pravastatin sodium - reference spectrum
n/a
79
Council of Europe, all rights reserved 2014
log CCID50/ml for types 1,2,3 and total virus content: 6.99, 6.06, 6.83 and
7.20, respectively
0618
1796
92.6% CHKOS
(6R)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine
2416
2059
65
Yes
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0000223 Pravastatin impurity A
Effective from 2014/1/2
Batch n Quantity Sale
Information
per vial Unit
5
0.1 mg
1 (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl-8[[(2S)-2-methylbutanoyl]oxy]-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]
heptanoic acid (6'-epipravastatin)
Monograph Leaflet
2059
Y0000204 Pravastatin 1,1,3,3-tetramethylbutylamine
30 mg
P2669000 Prazepam -* psy
50 mg
P2670000 Praziquantel
200 mg
Y0001533 Praziquantel for system suitability
10 mg
P2675000 Praziquantel impurity A
10 mg
P2680000 Prazosin hydrochloride
50 mg
P2698000 Prednicarbate
100 mg
Y0001443 Prednicarbate for system suitability
10 mg
Y0001630 Prednicarbate for system suitability A
10 mg
P2700000 Prednisolone
150 mg
Y0001359 Prednisolone for peak identification
10 mg
Y0001355 Prednisolone for system suitability
10 mg
P2800000 Prednisolone acetate
120 mg
Y0000582 Prednisolone acetate for peak identification
10 mg
0734
P2804000 Prednisolone hexanoate
10 mg
1212
New P2805000 Prednisolone pivalate
2059
76.4% CHO
-20C 5C
Yes
1466
99.8% CHNO
Extra
Price
charges
79
c
-20C 5C
79
+5C 3C
79
0855
Yes
+5C 3C
79
0855
Yes
+5C 3C
79
+5C 3C
79
0855
(11bRS)-2-benzoyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]
isoquinolin-4-one
Storage
0856
+5C 3C
79
1467
Yes
+5C 3C
79
1467
Yes
+5C 3C
79
1467
Yes
+5C 3C
79
0335,0353,0
354, 0735
Yes
+5C 3C
79
0353
Yes
+5C 3C
79
0353
Yes
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
99.1% CHO
99.2% CHO; Prednisolone CRS 6 is suitable for monographs
01/2011:0335, 01/2008:0353, 01/2008:0354 and 01/2008:0735 only.
Batch 3 is valid until 1 April 2013
0734,0736,0
933,
0975,1467,0
334
Yes
120 mg
0734,0736
+5C 3C
79
P2810000 Prednisolone sodium phosphate
100 mg
0549,0735,0
810
+5C 3C
79
P2900000 Prednisone
100 mg
0354
+5C 3C
79
P2920000 Pregnenolone isobutyrate
200 mg
0593,0993,2
397
-20C 5C
79
Y0000263 Prekallikrein activator in albumin BRP
1 mL
-20C 5C
90
P2939000 Prilocaine
150 mg
1362
+5C 3C
79
P2939060 Prilocaine hydrochloride
100 mg
1363
+5C 3C
79
Y0001408 Prilocaine impurity B
80 mg
2-methylbenzenamine hydrochloride
1362,1363
+5C 3C
79
P2939025 Prilocaine impurity E
25 mg
(RS)-N-(methylphenyl)-2-(propylamino)propanamide
1362,1363
+5C 3C
79
P2940000 Primaquine diphosphate
500 mg
Batch 2 is valid until 30 November 2013
0635
+5C 3C
79
P2950000 Primidone
150 mg
See leaflet CHNO
0584
Yes
+5C 3C
79
Y0000369 Primidone for peak identification
10 mg
0584
Yes
+5C 3C
79
P3000000 Probenecid
100 mg
0243
+5C 3C
79
Council of Europe, all rights reserved 2014
Batch 1 is valid until 30 April 2014
See leaflet,
20615
30 IU per vial
66
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
P3050000 Procainamide hydrochloride
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
100 mg
1
Information
Monograph Leaflet
0567
+5C 3C
250 mg
+5C 3C
79
P3100000 Procaine hydrochloride
100 mg
0050
+5C 3C
79
P3200000 Prochlorperazine maleate
100 mg
0244,20303
+5C 3C
79
P3300000 Progesterone
50 mg
0429
+5C 3C
79
Y0000148 Progesterone impurity C
10 mg
0429
+5C 3C
79
Y0000179 Proguanil hydrochloride - reference spectrum
n/a
79
Y0000181 Proguanil impurity C
10 mg
1,5-bis(4-chlorophenyl)biguanide
2002
+5C 3C
79
Y0000182 Proguanil impurity D
10 mg
1,5-bis(1-methylethyl)biguanide
2002
+5C 3C
79
P3350000 Proline
60 mg
Batch 2 is valid until 1 April 2013
0785,0910,0
911, 1049
+5C 3C
79
P3390000 Promazine hydrochloride
100 mg
0475,1365,2
0303
+5C 3C
79
P3400000 Promethazine hydrochloride
50 mg
+5C 3C
79
Y0000769 Promethazine impurity D
15 mg
(2RS)-N,N-dimethyl-1-(10H-phenothiazin-10-yl)propan-2-amine S-oxide ;
Batch 1 is valid until 28 February 2014
0524
Yes
+5C 3C
79
Y0000797 Promethazine for peak identification
5 mg
Batch 1 is valid until 31 March 2014
0524
Yes
+5C 3C
79
P3490000 Propacetamol hydrochloride - reference spectrum
n/a
1366
79
Y0000455 Propafenone hydrochloride
10 mg
2103
+5C 3C
79
Y0000456 Propafenone impurity B
10 mg
2103
+5C 3C
79
Y0000278 Propanol - reference spectrum
n/a
79
Y0000016 Propofol
370 mg
+5C 3C
79
Y0000017 Propofol for peak identification
0.1 ml
1558
+5C 3C
79
Y0000018 Propofol impurity J
20 mg
1558
+5C 3C
79
P3500000 Propranolol hydrochloride
30 mg
0568,0923
+5C 3C
79
P3600000 Propranolol hydrochloride for performance test
20 mg
0568
+5C 3C
79
Y0001547 Propylene glycol
150 mg
1403,1804,2
645
+5C 3C
79
Y0000318 Propylene glycol dilaurate
100 mg
2087
+5C 3C
79
Y0000319 Propylene glycol monolaurate
100 mg
1915
+5C 3C
79
P3640000 Propyl gallate
50 mg
P3650000 Propyl parahydroxybenzoate
150 mg
P3700000 Propylthiouracil
100 mg
P3750000 Propyphenazone
200 mg
P3760000 Protirelin
5.03 mg
5.03 mg per vial of pure protirelin peptide CHNO
P3760020 D-His-Protirelin
0.1 mg
approx. 0.1 mg per vial
39.7% CHNO (procaine); 96.3% CHNOS
(20R)-20-hydroxypregn-4-en-3-one
Yes
Extra
Price
charges
79
a
P3090000 Procaine benzylpenicillin
Council of Europe, all rights reserved 2014
0115
Storage
2002
0524
(2E)-1-[2-[(2RS)-2-hydroxy-3-(propylamino)propoxy]phenyl]-3phenylprop-2-en-1-one
2036
99.8% CHO ; Batch 4 is valid until 1 May 2013
2,6-bis (1-methylethyl)-1,4-benzoquinone
1558
Yes
Yes
1039
+5C 3C
79
+5C 3C
79
+5C 3C
79
0636
+5C 3C
79
1144
-20C 5C
79
1144
-20C 5C
79
0431,0852,1
263
99.9% CHO
0525
67
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Code
P3800000 Proxyphylline
Reference Standard
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
100 mg
1
P3850000 Pseudoephedrine hydrochloride - * Drug Precursor
50 mg
Y0000387 Pseudoisoeugenyl 2-methylbutyrate for peak
identification
100 mg
Y0001537 Purified quillaia saponins
30 mg
P3900000 Purpureaglycoside A
P4000000 Purpureaglycoside B
Information
Monograph Leaflet
0526
Storage
+5C 3C
0487,1367
Extra
Price
charges
79
a
+5C 3C
79
2108
Yes
+5C 3C
79
1843
Yes
-20C 5C
79
25 mg
0117
+5C 3C
79
25 mg
0117
+5C 3C
79
1680
+5C 3C
79
1680
+5C 3C
79
0859
+5C 3C
79
Star anise oil
Y0000402 Pyrantel embonate
10 mg
New Y0000403 Pyrantel impurity A
20 mg
P4050000 Pyrazinamide
30 mg
P4099900 Pyridostigmine bromide
30 mg
1255
+5C 3C
79
P4099910 Pyridostigmine impurity A
20 mg
pyridin-3-yl-dimethylcarbamate
1255
+5C 3C
79
Y0001486 Pyridostigmine impurity B
10 mg
3-hydroxy-1-methylpyridinium
1255
+5C 3C
79
P4100000 Pyridoxine hydrochloride
100 mg
0245
+5C 3C
79
Y0001226 Pyridoxine impurity A
5 mg
0245
+5C 3C
79
P4200000 Pyrimethamine
250 mg
0288
+5C 3C
79
Y0000659 Pyrrolidone
20 mg
+5C 3C
79
Y0001009 Quercetin dihydrate
25 mg
+5C 3C
79
New Y0001657 Quetiapine fumarate
50 mg
2541
+5C 3C
79
New Y0001419 Quetiapine for system suitability
2 mg
2541
Yes
+5C 3C
79
Y0001564 Quillaia saponin assay
30 mg
1843
Yes
+5C 3C
79
Y0001491 Quinapril hydrochloride
30 mg
1763
+5C 3C
79
Y0001502 Quinapril for peak identification
5.075 mg
1763
Yes
+5C 3C
79
Y0001503 Quinapril for system suitability
5.125 mg
1763
Yes
+5C 3C
79
Q0100000 Quinidine sulfate
300 mg
0017,0018,0
019
+5C 3C
79
Q0200000 Quinine sulfate
300 mg
0017,0018,0
019
+5C 3C
79
R0100000 Rabies vaccine (inactivated) for veterinary use BRP
86 mg
See leaflet
Y0000896 Racecadotril
110 mg
Y0000897 Racecadotril impurity A
1.1 mL
Y0000898 Racecadotril impurity G
10 mg
Y0000902 Racecadotril for peak identification
5 mg
Y0001134 Raloxifene hydrochloride
110 mg
Y0001135 Raloxifene hydrochloride for peak identification
10 mg
20 mg
R0145000 Ramipril
Council of Europe, all rights reserved 2014
1-methyl-2-[(Z)-2-(thiophen-2-yl)ethenyl]-1,4,5,6-tetrahydropyrimidine ;
Batch 1 is valid until 30 April 2014
6-methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol
2180
1827
90.5% CHO ; Batch 1 is valid until 31 August 2013
64.9 % CHNO; monoammonium glycyrrhizate
Yes
See leaflet,
0451
Yes
-20C 5C
90
99.9% CHNOS
2171
Yes
+5C 3C
79
92,8% CHCOSH; ethanethioic acid ; Batch 1 is valid until 1 July 2013
2171
Yes
+5C 3C
79
benzyl [[(2RS)-2-benzyl-3-sulfanylpropanoyl]amino]acetate
2171
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
2171
99.7% CHClNOS
2375
2375
68
Yes
Yes
79
1368
+5C 3C
a
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
R0145005 Ramipril impurity A
Effective from 2014/1/2
Batch n Quantity Sale
Information
per vial Unit
3
10 mg
1 (2S,3aS,6aS)-1-[(S)-2-[[(S)-1-(methoxycarbonyl)-3- phenylpropyl]amino]
propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (ramipril
methylester)
Monograph Leaflet
Storage
1368
+5C 3C
Extra
Price
charges
79
a
R0145010 Ramipril impurity B
10 mg
(2S,3aS,6aS)-1-[(S)-2-[[(S)-1-[(methylethoxy)carbonyl]-3- phenylpropyl]
amino]propanoyl]octahydrocyclopenta[b]pyrrole- 2-carboxylic acid (ramipril
isopropyl ester)
1368
+5C 3C
79
R0145015 Ramipril impurity C
10 mg
(2S,3aS,6aS)-1-[(S)-2-[[(S)-1-(ethoxycarbonyl)-3-cyclohexylpropyl]amino]
propanoyl]octahydrocyclopenta[b]pyrrole-2- carboxylic acid
(hexahydroramipril)
1368
+5C 3C
79
R0145020 Ramipril impurity D
10 mg
1368
+5C 3C
79
R0150000 Ranitidine hydrochloride
100 mg
ethyl (2S)-2-[(3S,5aS,8aS,9aS)-3-methyl-1,4-dioxodecahydro -1Hcyclopenta[e]pyrrolo[1,2a]pyrazin-2-yl]-4-phenylbutanoate (ramipril
diketopiperazine)
0.00025
mg
New Y0000416 Ranitidine impurity J
+5C 3C
79
0946
-20C 5C
79
10.25 micrograms of rBet v 1
1063
Yes
-20C 5C
90
0946
Yes
+5C 3C
79
1063
Yes
-20C 5C
90
+5C 3C
79
+5C 3C
79
+5C 3C
79
Y0001565 Recombinant Major Allergen rBet v 1
Y0000411 Ranitidine for system suitability
Y0001566 Recombinant Major Allergen rPhl p 5a
Y0000457 Repaglinide
20 mg
2135
Y0000458 Repaglinide for system suitability
6 mg
2135
Y0000459 Repaglinide impurity E
10 mg
2-ethoxy-4-[2-[[(1R)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]amino]-2oxoethyl]benzoic acid
R0200000 Reserpine
100 mg
99.8% CHNO
0528
Yes
+5C 3C
79
1.4 mL
Batch 4 is valid until 30 April 2014
20424
Yes
+5C 3C
79
Y0000767 Resorcinol
20 mg
benzene-1,3-diol
2348
+5C 3C
79
Y0001194 Resveratrol
20 mg
99.6% CHO
2433,2480
Yes
+5C 3C
79
R0300000 Retinol acetate
1000 mg
1 050 000 IU per g
0218,0219,0
220,
1192,1193
Yes
-20C 5C
79
R0290000 Retinol esters
100 mg
0217,0218,0
219, 0220
+5C 3C
79
R0500500 Reviparin sodium
250 mg
0828
+5C 3C
79
Y0000377 Ribavirin
150 mg
99.9% CHNO
+5C 3C
79
R0600000 Riboflavin
130 mg
Vitamin B2 ; Batch 3 is valid until 31 August 2013
+5C 3C
79
Y0000757 Riboflavin for peak identification
0.12 mg
0292
+5C 3C
79
R0630000 Riboflavin sodium phosphate
250 mg
0786
+5C 3C
79
Y0000662 Ribonucleic acid
100 mg
100.0 %
2090
+5C 3C
79
Y0000149 Rifabutin
150 mg
95.5% CHNO
1657
+5C 3C
79
Y0000184 Rifabutin impurity A
20 mg
1-(2-methylpropyl)piperidin-4-one
1657
+5C 3C
79
R0700000 Rifampicin
100 mg
0052
+5C 3C
79
100 mg
New R0250000 Residual solvents solution class 1
R0800000 Rifampicin quinone
Council of Europe, all rights reserved 2014
0.01025 mg 1
0946,1453
1,1'-N-[methylenebis(sulphanediylethylene)]bis(N'-methyl-2-nitroethene-1,1diamine) ; Batch 5 is valid until 30 April 2014
20 mg
0.00856 mg 1
8.56 micrograms of rPhl p 5a
69
Yes
2135
2109
Yes
0292,0786
Yes
Yes
79
0052
+5C 3C
a
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Code
R0900000 Rifamycin B
Reference Standard
New R0950000 Rifamycin S
R1000000 Rifamycin sodium
New Y0001074 Rifaximin
Effective from 2014/1/2
Batch n Quantity Sale
Information
per vial Unit
2
50 mg
1 Rifamycin impurity A
3
100 mg
1 Batch 2 is valid until 30 April 2014
Monograph Leaflet
0432
+5C 3C
0432
300 mg
856 IU per mg
See leaflet CHMgNOS*3HO ; Batch 1 is valid until 30 April 2014
Storage
Extra
Price
charges
79
a
+5C 3C
79
0432,20702
Yes
-20C 5C
79
160 mg
2362
Yes
+5C 3C
79
Y0001075 Rifaximin for system suitability
10 mg
2362
Yes
+5C 3C
79
Y0000250 Rilmenidine dihydrogenophosphate - reference spectrum
n/a
2020
79
Y0000187 Rilmenidine for system suitability
30 mg
2020
+5C 3C
79
Y0001541 Risedronate sodium 2.5-hydrate
15 mg
+5C 3C
79
Y0001558 Risedronate impurity A
15 mg
78.4 %
2572
+5C 3C
79
Y0001540 Risedronate impurity E
15 mg
2-(pyridin-3-yl)ethane-1,1-diyl]bis(phosphonic acid)
2572
+5C 3C
79
R1000600 Risperidone
50 mg
1559
+5C 3C
79
Y0000370 Risperidone for system suitability
20 mg
Y0001276 Risperidone impurity K
0.015 mg
3-[2-[4-(1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9tetrahydro-4Hpyrido[1,2-a]pyrimidin-4-one (desfluoro risperidone) ; Batch 1
is valid until 30 November 2013
1559
Y0000714 Ritonavir
80 mg
99.6% CHNOS
2136
Y0000706 Ritonavir for peak identification
10 mg
2136
Y0001516 Rivastigmine hydrogen tartrate
350 mg
Y0001485 Rivastigmine for system suitability
1.0114 mg
Y0001515 Rivastigmine impurity D
10 mg
3-[(1R)-1-(dimethylamino)ethyl]phenyl ethyl(methyl)carbamate ((R)enantiomer)
Y0001302 Rizatriptan benzoate
200 mg
99.8% CHNO
Y0001303 Rizatriptan for system suitability
15 mg
R1300000 RK 13 cells
1 ml
Y0001580 Rocuronium bromide
10 mg
1764
Y0000594 Rocuronium bromide - reference spectrum
n/a
1764
Y0000527 Rocuronium for peak identification
10 mg
1764
Y0000742 Ropivacaine hydrochloride monohydrate
10 mg
Y0000743 Ropivacaine impurity G
5 mg
(+)-(2R)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide ((R)ropivacaine)
Y0000786 Rosmarinic acid
50 mg
89.5% CHO ; Batch 1 is valid until 28 February 2013
R1500000 Roxithromycin
125 mg
96.7% CHNO
Y0000220 Roxithromycin for system suitability
5 mg
R2000000 Rubella vaccine (live) BRP
90 mg
3.6 log (ie 4000) infective viral units per vial
Y0000494 Ruscogenins
10 mg
38.2% ruscogenin
60.4% neoruscogenin
S0040000 Saccharin
30 mg
Council of Europe, all rights reserved 2014
2572
1559
99.9% CHNO
Yes
+5C 3C
79
+5C 3C
79
Yes
+5C 3C
79
Yes
+5C 3C
79
2629,2630
Yes
+5C 3C
79
2629,2630
Yes
+5C 3C
79
2629,2630
Yes
+5C 3C
79
2585
Yes
+5C 3C
79
2585
Yes
+5C 3C
79
Yes
Liquid nitrogen
100
-20C 5C
g(c)
79
79
-20C 5C
g(c)
79
2335
+5C 3C
79
2335
+5C 3C
79
cell lines (kidney, rabbit) titration of live measles, mumps and rubella vaccines 0162,1057
Yes
Yes
1447,2382,
2524
Yes
+5C 3C
79
1146
Yes
+5C 3C
79
+5C 3C
79
1057,0162
Yes
-80C 10C
90
1847
Yes
+5C 3C
79
+5C 3C
79
1146
0947
70
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
S0050000 Saccharin sodium
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
50 mg
1
Information
Monograph Leaflet
0787
+5C 3C
S0100000 Salbutamol
50 mg
Y0000030 Salbutamol impurity B
10 mg
(1RS)-2-[(1,1-dimethylethyl)amino]-1-(4-hydroxyphenyl)ethanol
; Batch 4 is valid until 30 September 2013
Y0000071 Salbutamol impurity D
10 mg
5-[(1RS)-2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-2hydroxybenzaldehyde ; Batch 4 is valid until 31 January 2013
0529,0687
Y0000031 Salbutamol impurity F
10 mg
93.4% CHNO x HSO; 1,1'-[oxybis[methylene(4-hydroxy-1,3phenylene)]]bis[2-[(1,1- dimethylethyl)amino]ethanol]
0529,0687
Y0000034 Salbutamol impurity G
5 mg
2-[benzyl(1,1-dimethylethyl)amino]-1-[4-hydroxy-3-(hydroxy- methyl)phenyl]
ethanone
Y0000032 Salbutamol impurity I
0.006 mg
Y0001186 Salbutamol impurity J
S0150000 Salbutamol sulfate
50 mg
Y0001288 Salbutamol sulfate for system suitability
10 mg
Y0000669 Salicin
50 mg
S0200000 Salicylic acid
100 mg
Y0000405 Salicylic acid impurity B
10 mg
4-hydroxyisophthalic acid ; Batch 1 is valid until 31 March 2014
0366
Y0000422 Salmeterol xinafoate
50 mg
99.6% CHNO
1765
Yes
Y0000423 Salmeterol xinafoate for system suitability
25 mg
1765
Y0001559 Salvianolic acid B
15 mg
92.2 % CHO
2663
Y0001052 Santonin
20 mg
99.8% CHO
Y0001625 Salmeterol xinafoate for peak identification
15 mg
Y0001049 Saquinavir mesilate
70 mg
Y0001056 Saquinavir for system suitability
0.3033 mg
Y0001483 Saw palmetto extract HRS
8000 mg
Y0000814 Selamectin
100 mg
Y0000815 Selamectin for system suitability
5 mg
2268
S0360000 Selegiline hydrochloride
50 mg
1260
S0360090 (RS)-Selegiline hydrochloride
25 mg
S0400000 Senna extract
50 mg
S0450000 Serine
50 mg
0788,1027
S0460000 Sertaconazole nitrate
125 mg
Y0000828 Sertraline hydrochloride
200 mg
99.9% CHClN
1705
Yes
Y0001285 Sertraline impurity E
15 mg
Mandelic acid CRS has been labelled as sertraline impurity E CRS in
anticipation of 01/2011:1705 corrected 7.1
1705
Y0000866 Sertraline for peak identification
5.4 mg
Batch 2 is valid until 30 September 2013
1705
Council of Europe, all rights reserved 2014
0.00045 mg 1
Storage
Extra
Price
charges
79
a
0529,1033
+5C 3C
79
0529
+5C 3C
79
Yes
+5C 3C
79
Yes
+5C 3C
79
0529
+5C 3C
79
(1RS)-2-[(1,1-dimethylethyl)amino]-1-[3-(hydroxymethyl)-4benzyloxyphenyl]ethanol
0529
+5C 3C
79
Batch 1 is valid until 31 August 2013
0687
+5C 3C
79
Batch 2 is valid until 30 November 2013
0687
99,6% CHO
+5C 3C
79
0687
Yes
+5C 3C
79
2312,1583
Yes
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
Yes
+5C 3C
79
Yes
+5C 3C
79
1391,1809
Yes
+5C 3C
79
1765
Yes
+5C 3C
79
+5C 3C
79
+5C 3C
79
0366,1185
2267
99.5% CHNOS
2267
Yes
1848
Yes
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
1260
+5C 3C
79
0206,0207,0
208, 1261
-20C 5C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
Yes
+5C 3C
79
Yes
+5C 3C
79
2268
97.6% CHNO
Yes
1148
71
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0000867 Sertraline for system suitability
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
2
6.18 mg
1
Y0000371 Sestamibi labelling kit
22 mg
Y0001046 Sevoflurane
1 ml
Y0001578 Sildenafil citrate
100 mg
Y0001579 Sildenafil impurity A
10 mg
S0500000 Silicone elastomer
2000 mg
New S0600000 Silicone oil
Information
Monograph Leaflet
1705
+5C 3C
Extra
Price
charges
79
g
1926
Yes
+5C 3C
79
2269
Yes
+5C 3C
g(b)
79
98.8 % CHNOS
2270
Yes
+5C 3C
79
5-[2-ethoxy-5[(4-methylpiperazin-1-yl)sulfonyl]phenyl]-1-methyl-3-(2methylpropyl)-6,7-dihydro-1H-pyrazol[4,3-d]pyrimidin-7-one
2270
+5C 3C
79
30109
+5C 3C
79
Batch 2 is valid until 31 March 2014
1 mL
Batch 1 is valid until 31 May 2014
S0650000 Simvastatin
100 mg
99.4% CHO
Y0001066 Simvastatin for peak identification
10 mg
Y0001208 Sinomenine
20 mg
81.8 % CHNO
S0660000 Sisomicin sulfate
60 mg
Y0000014 Sodium alendronate
150 mg
S0695000 Sodium amidotrizoate
125 mg
1150
Y0000300 Sodium aminosalicylate dihydrate - reference spectrum
n/a
1993
Y0000039 Sodium ascorbate
50 mg
1791
S0700000 Sodium calcium edetate
100 mg
0231
S0710000 Sodium cetostearyl sulfate
100 mg
S0750000 Sodium cromoglicate
10 mg
Y0001300 Sodium cromoglicate for system suitability
20 mg
S0760000 Sodium cyclamate
100 mg
S0765000 Diclofenac sodium
100 mg
Y0001410 Sodium fusidate
10 mg
S0781000 Sodium hyaluronate - reference spectrum
n/a
1472
S0780000 Sodium hyaluronate BRP
300 mg
Y0001468 Sodium iodohippurate
15 mg
Y0000620 Sodium laurilsulfate
40 mg
Y0000808 Sodium phenylbutyrate
5 mg
Y0000809 Sodium phenylbutyrate impurity C
10 mg
S0785000 Sodium picosulfate
100 mg
1031
Y0001104 Picosulfate for system suitability
0.5 mg
1031
Y0000210 Sodium polystyrene sulfonate - reference spectrum
n/a
Y0000268 Sodium propionate - reference spectrum
n/a
S0800000 Sodium salicylate
100 mg
0413
S0808000 Sodium stearyl fumarate
50 mg
1567
S0808060 Sodium stearyl maleate
10 mg
1567
Council of Europe, all rights reserved 2014
Storage
+5C 3C
79
1538,1563
Yes
-20C 5C
g(c)
79
1563
Yes
-20C 5C
g(c)
79
2450
Yes
+5C 3C
79
77.7% CHNOS
0331,1351
Yes
-20C 5C
79
83.3% CHNNaOP
1564
Yes
+5C 3C
79
+5C 3C
79
79
+5C 3C
79
+5C 3C
79
0847
+5C 3C
79
0562
+5C 3C
79
0562
+5C 3C
79
0774
+5C 3C
79
1002,1281
+5C 3C
79
0848
+5C 3C
79
79
0912
+5C 3C
79
2352
+5C 3C
79
0802
+5C 3C
79
2183
+5C 3C
79
2183
+5C 3C
79
+5C 3C
79
+5C 3C
79
1909
79
2041
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
Batch 3 is valid until 31 October 2013
4-cyclohexylbutanoic acid
72
30108
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
S0900000 Sodium taurocholate BRP
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
2
10000 mg 1
Information
Monograph Leaflet
0350
+5C 3C
S0930000 Sodium valproate
150 mg
S0945000 Somatostatin
2.32 mg
2.32mg somatostatin peptide per vial CHNOS
S0947000 Somatropin
55 mg
3.86 mg somatropin monomer per vial
See leaflet,
0950,
0951,0952
Y0000711 Somatropin/desamidosomatropin resolution mixture
33 mg
1.7 mg somatropin per vial
0950,0951,0
952
S0950000 Sorbic acid
10 mg
Y0000385 1,4-Sorbitan
50 mg
99,7% CHO ; Batch 1 is valid until 1 April 2013
S1000000 Sorbitol
1250 mg
98,7% CHO ; Batch 3 is valid until 31 December 2013
Y0000114 Sotalol hydrochloride
25 mg
Y0000115 Sotalol impurity B
20 mg
Y0001011 Spanish sage oil for peak identification
250 mg
Y0000597 Spectinomycin hydrochloride
100 mg
Y0000549 Spectinomycin for system suitability
20 mg
1152
Y0000655 Spectinomycin sulfate tetrahydrate
10 mg
1658
Y0001126 Spike lavender oil
400 l
2419
Yes
S1100000 Spiramycin
200 mg
4500 IU per mg
Spiramycin I: 87.3%, Spiramycin II: 0.2%, Spiramycin III: 4.4%
0179,0293,1
982,20702
Yes
Y0000381 Spirapril hydrochloride monohydrate
60 mg
95.9% CHClNOS
Y0000332 Spirapril for system suitability
15 mg
160 mg
See leaflet; Spironolactone CRS 2 is suitable for monograph 01/2008:0688
only. ; Batch 3 is valid until 30 April 2014
0688
Y0001295 Spironolactone for system suitability
2.057 mg
Batch 1 is valid until 28 February 2014
Y0000185 Squalane
250 l
99.7% CH
Y0001050 St. John's wort standardised dry extract
500 mg
0.050% of hypericin; St. John's wort standardised dry extract CRS has been
renamed as St. John's wort dry extract HRS in 01/2013:1874
Y0001091 Artichoke leaf dry extract HRS
60 mg
S1250000 Stanozolol
50 mg
S1250010 Stanozolol impurity A
10 mg
Y0001420 Stanozolol impurity B
10 mg
S1300000 Starch BRP
50000 mg
Y0000408 Stavudine
100 mg
New S1200000 Spironolactone
Council of Europe, all rights reserved 2014
Storage
Extra
Price
charges
79
a
0678
+5C 3C
79
0949
-20C 5C
90
Yes
-20C 5C
150
Yes
-20C 5C
150
+5C 3C
79
0592
2048
Yes
+5C 3C
79
0435,0436,0
437,
1235,1236,1
337,
1381,1531,2
048
Yes
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
-20C 5C
79
-20C 5C
79
-20C 5C
79
+5C 3C
79
-20C 5C
79
1766
+5C 3C
79
1766
+5C 3C
79
Yes
+5C 3C
79
0688
Yes
+5C 3C
79
1630
Yes
+5C 3C
79
1874
Yes
-20C 5C
79
2389
Yes
-20C 5C
79
1568
+5C 3C
79
1568
+5C 3C
79
1568
+5C 3C
79
0350
+5C 3C
79
2130
+5C 3C
79
2004
N-[4-[[(1-methylethyl)amino]acetyl]phenyl]methanesulphonamide
2004
1849
1152
81.3% CHClNO and CHClNO
(5,17)-17-hydroxy-17-methylandrostan-3-one
99.6% CHNO
73
Yes
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0000421 Stavudine for system suitability
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
10 mg
1
Information
Monograph Leaflet
2130
+5C 3C
S1340000 Stearic acid
100 mg
Plastic additive 19
S1350000 Stearyl alcohol
250 mg
99.5% CHO
Y0000868 Streptokinase for system suitability
30 l
S1400000 Streptomycin sulfate
100 mg
Y0001324 Sucralfate
10 mg
Y0001344 Sucralose
550 mg
100.0% CHClO
2368
Y0001342 Sucralose impurity B
0.5 mg
1,6-dichloro-1,6-dideoxy-?-D-fructofuranosyl 6-chloro-6-deoxy-?-Dglucopyranoside (1',6,6'-trichloro-1',6,6'-trideoxysucrose)
2368
S1600000 Sucrose
100 mg
0177,0178,0
187,
0188,0204,0
209,
1061,1570,2
318
+5C 3C
S1608100 Sufentanil - reference spectrum
n/a
1569
S1609000 Sufentanil citrate - reference spectrum
n/a
1269
Y0000529 Sulbactam sodium
10 mg
2209
Y0000528 Sulbactam
150 mg
2209
Yes
Y0000550 Sulbactam for peak identification
20 mg
2209
Yes
S1700000 Sulfacetamide sodium
50 mg
S1800000 Sulfadiazine
100 mg
Y0001480 Sulfadiazine for identification of impurity F
15 mg
Y0001469 Sulfadiazine impurity A
20 mg
S1900000 Sulfadimidine
100 mg
0295
Y0001495 Sulfadimidine for peak identification
50 mg
0295
S1950000 Sulfadoxine
50 mg
S1975000 Sulfafurazole
100 mg
S1975600 Sulfaguanidine
60 mg
S2000000 Sulfamerazine
100 mg
Council of Europe, all rights reserved 2014
0229,0882,1
474, 1663,
2058,
30105,
30106,3010
7,1663
0702,0753,0
Yes
Storage
+5C 3C
79
Yes
+5C 3C
79
0356
Yes
-20C 5C
79
0032,0033,0
053,
0485,20702
Yes
-20C 5C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
79
79
801,
0802,0847,0
969,
1123,1340,1
411
77 000 IU per vial
1796
99.7% CHNOS
pyrimidin-2-amine
Batch 1 is valid until 31 August 2013
74
Extra
Price
charges
79
a
Yes
79
79
-20C 5C
79
+5C 3C
79
0107,0295
+5C 3C
79
0294
+5C 3C
79
0294
+5C 3C
79
0294
+5C 3C
79
+5C 3C
79
+5C 3C
79
0740
+5C 3C
79
0741
+5C 3C
79
0295,1476
+5C 3C
79
0358,1571
+5C 3C
79
+5C 3C
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
S2050000 Sulfamethizole
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
100 mg
1
Information
Monograph Leaflet
Storage
0637
+5C 3C
Extra
Price
charges
79
a
S2100000 Sulfamethoxazole
50 mg
0108
+5C 3C
79
Y0000412 Sulfamethoxazole impurity A
5 mg
N-(4-(5-methyl)-isoxazol-3-ylsulphamoyl)phenylacetamide
0108
+5C 3C
79
Y0000413 Sulfamethoxazole impurity F
5 mg
4-amino-N-(3-methylisoxazol-5-yl)benznesulphonamide
0108
+5C 3C
79
S2150000 Sulfamethoxypyridazine
50 mg
0638
+5C 3C
79
New S2151000 Sulfanilamide
100 mg
1571
+5C 3C
79
S2159100 Sulfapyridine
20 mg
0863
+5C 3C
79
S2155000 Sulfasalazine
250 mg
98.1 % CHNOS ; Batch 3 is valid until 28 February 2013
S2155010 Sulfasalazine derivative for resolution
20 mg
2-hydroxy-5-[[4-[[(6-methylpyridin-2-yl)amino]-sulfonyl]phenyl]azo]benzoic
acid
S2158000 Sulfathiazole
100 mg
S2159000 Sulfinpyrazone
Y0001238 Sulfinpyrazone for system suitability
S2159010 Sulfinpyrazone impurity A
20 mg
1,2-diphenyl-4-[2-(phenylsulphonyl)ethyl]pyrazolidine-3,5-dione
S2159015 Sulfinpyrazone impurity B
20 mg
1,2-diphenyl-4-(2-phenylthioethyl)pyrazolidine-3,5-dione
S2180000 Sulindac
50 mg
Contains 0.3% m/m of E-isomer
S2190000 Sulpiride
100 mg
Batch 3 is valid until 31 January 2013
S2191000 Sulpiride impurity A
20 mg
[(2RS)-1-ethylpyrrolidin-2-yl]methanamine
S2192000 Sulpiride impurity B
20 mg
methyl 2-methoxy-5-sulphamoylbenzoate
Y0000530 Sultamicillin
10 mg
Y0000531 Sultamicillin tosilate
200 mg
Y0000532 Sultamicillin for peak identification
10 mg
Y0000022 Sumatriptan succinate
50 mg
Y0000026 Sumatriptan impurity mixture
3 mg
Y0000027 Sumatriptan for system suitability
2.02 mg
S2200000 Suxamethonium chloride
1000 mg
S2400000 Suxibuzone
50 mg
S2400004 Suxibuzone impurity B
10 mg
S2400006 Suxibuzone impurity C
10 mg
S5000001 Swine erysipelas bacteria, serotyp 1 (for vaccines - vet.
use) BRP
1 mg
6.5 x10 Cfu per vial
See leaflet,
0064
S5000002 Swine erysipelas bacteria, serotyp 2 (for vaccines - vet.
use) BRP
1 mg
2.6 x10 Cfu per vial
Y0001417 Tadalafil
200 mg
99.9% CHNO
T0010000 Talampicillin hydrochloride
50 mg
0808,0852
T0014000 Tamoxifen citrate
80 mg
1046
T0015000 Tamoxifen citrate for performance test
10 mg
1046
Council of Europe, all rights reserved 2014
Batch 1 is valid until 30 April 2014
0863,1457
+5C 3C
79
0863
+5C 3C
79
0742
+5C 3C
79
30 mg
0790
+5C 3C
79
0.5 mg
0790
+5C 3C
79
0790
+5C 3C
79
0790
+5C 3C
79
0864
+5C 3C
79
1045,1348
+5C 3C
79
1045,1490
+5C 3C
79
1045
+5C 3C
79
2211
+5C 3C
79
2211,2212
+5C 3C
79
92.5% CHNOS
Yes
Yes
2211
Yes
+5C 3C
79
1573
Yes
-20C 5C
79
1573
Yes
-20C 5C
79
1573
Yes
-20C 5C
79
0248
+5C 3C
79
1574
+5C 3C
79
(4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methyl ethyl butanedioate
1574
+5C 3C
79
4-butyl-4-(hydroxymethyl)-1,2-diphenyl-1,2-dihydro-4H-pyrazole-3,5-dione
1574
+5C 3C
79
Yes
+5C 3C
e(b)
90
See leaflet,
0064
Yes
+5C 3C
e(b)
90
2606
Yes
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
98.8% CHNOS
Batch 4 is valid until 31 August 2013
75
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0000650 Tamsulosin hydrochloride
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
10 mg
1
Information
Monograph Leaflet
2131
Storage
+5C 3C
Y0000653 Tamsulosin racemate
15 mg
Batch 1 is valid until 28 February 2014
2131
Y0001560 Tanshinone IIa
15 mg
98.4 % CHO
2663
Y0000651 Tamsulosin impurity D
10 mg
2-methoxy-5-[(2R)-2-[[2-(2-methoxyphenoxy)ethyl]amino]propyl]
benzenesulfonamide ; Batch 1 is valid until 1 June 2013
Y0000652 Tamsulosin impurity H
10 mg
Y0001102 Teicoplanin
52 mg
Y0001047 Teicoplanin for identification
40 mg
Y0000648 Telmisartan
30 mg
Y0000649 Telmisartan for peak identification
10 mg
Batch 1 is valid until 31 January 2013
2154
Yes
Y0001003 Telmisartan for system suitability
0.26 mg
Batch 2 is valid until 1 April 2013
2154
Yes
T0040000 Temazepam - * psy
50 mg
Y0000344 Temazepam impurity C
5 mg
Y0000345 Temazepam impurity D
5 mg
Y0000346 Temazepam impurity F
Y0000347 Temazepam impurity G
Extra
Price
charges
79
a
+5C 3C
79
+5C 3C
79
2131
+5C 3C
79
(2R)-N-[2-(2-ethoxyphenoxy)ethyl]-1-(4-methoxyphenyl)propan-2-amine ;
Batch 1 is valid until 1 June 2013
2131
+5C 3C
79
51550 IU per ampoule
2358
Yes
-20C 5C
79
2358
Yes
-20C 5C
79
+5C 3C
79
+5C 3C
79
Yes
2154
+5C 3C
79
0954
+5C 3C
79
(3RS)-7-chloro-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4benzodiazepin-3-yl acetate
0954
+5C 3C
79
(3RS)-7-chloro-3-methoxy-1-methyl-5-phenyl-1,3-dihydro-2H-1,4benzodiazepin-2-one
0954
+5C 3C
79
5 mg
(5RS)-7-chloro-1-methyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3dione
0954
+5C 3C
79
5 mg
(5RS)-7-chloro-1,4-dimethyl-5-phenyl-4,5-dihydro-1H-1,4benzodiazepine-2,3-dione
0954
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
T0040800 Tenoxicam
100 mg
1156
Y0001114 Tenoxicam impurity mixture
0.0042 mg
1156
Y0000621 Terazosin hydrochloride dihydrate
40 mg
2021
Y0000666 Terazosin for system suitability
0.5 mg
2021
Y0000622 Terazosin impurity A
10 mg
2-chloro-6,7-dimethoxyquinazolin-4-amine
2021
+5C 3C
79
Y0000665 Terazosin impurity E
10 mg
2,2'-(piperazine-1,4-diyl)bis(6,7-dimethoxyquinazolin-4-amine)
2021
+5C 3C
79
Y0000623 Terazosin impurity L
10 mg
1-(furan-2-ylcarbonyl)piperazine
2021
+5C 3C
79
Y0000624 Terazosin impurity N
10 mg
93.1% CHNO; 1-[[(2RS)-tetrahydrofuran-2-yl]carbonyl]piperazine
2021
+5C 3C
79
Y0000535 Terbinafine hydrochloride
10 mg
1734
+5C 3C
79
Y0001143 Terbinafine for system suitability
10 mg
1734
+5C 3C
79
New T0050000 Terbutaline sulfate
Yes
Yes
Yes
Yes
100 mg
Batch 1 is valid until 30 April 2014
0690
+5C 3C
79
T0050015 Terbutaline impurity C
15 mg
1-(3,5-dihydroxyphenyl)-2-[(1,1-dimethylethyl)amino]-ethanone
0690
+5C 3C
79
T0060000 Terconazole
250 mg
1270
+5C 3C
79
T0071000 Terfenadine
100 mg
0955
+5C 3C
79
T0080000 Terfenadine impurity A
20 mg
1-[4-(1,1-dimethylethyl)phenyl]-4-[4-(hydroxydiphenylmethyl) piperidin-1-yl]
butan-1-one
0955
+5C 3C
79
T0100000 Testosterone
30 mg
Batch 2 is valid until 31 August 2013
1373
+5C 3C
79
Council of Europe, all rights reserved 2014
76
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
T0210000 Testosterone caproate
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
50 mg
1
Information
Monograph Leaflet
1048
T0240000 Testosterone decanoate
50 mg
Y0000696 Testosterone decanoate for system suitability
0.4 mg
1736
+5C 3C
1048, 1736
99.8% CHO
Storage
Yes
Extra
Price
charges
79
g
-20C 5C
g(c)
79
-20C 5C
g(c)
79
T0250000 Testosterone enantate
100 mg
1048
-20C 5C
g(c)
79
Y0001317 Testosterone enantate for system suitability
2 mg
1048
Yes
-20C 5C
g(c)
79
Y0001312 Testosterone enantate for peak identification
10 mg
1048
Yes
Y0001313 Testosterone enantate impurity H
10 mg
Y0000342 Testosterone for impurity D identification
20 mg
Y0000343 Testosterone for system suitability
20 mg
-20C 5C
g(c)
79
1048
-20C 5C
g(c)
79
1373
+5C 3C
79
1373
+5C 3C
79
delta-5-testosterone-3,17-dienantate
T0260000 Testosterone isocaproate
50 mg
Y0000716 Testosterone isocaproate for system suitability
5 mg
1048,1737
T0300000 Testosterone propionate
60 mg
Y0001409 Testosterone propionate for system suitability
5 mg
T0400000 Tetanus vaccine (adsorbed)
30 mg
490 IU per ampoule for challenge assays in guinea-pigs
260 IU per ampoule for challenge assays in mice
Y0001087 Tetra-O-acetyl-mannose triflate
60 mg
100.0% CHFOS
99.9% CHO
99.8% CHO; Testosterone propionate CRS 1 is suitable for 01/2008:1048
only
+5C 3C
79
1737
Yes
+5C 3C
79
0297
Yes
+5C 3C
79
0297
Yes
+5C 3C
79
See leaflet,
20708
Yes
-20C 5C
90
2294
Yes
-20C 5C
79
T0500000 Tetracaine hydrochloride
100 mg
0057
+5C 3C
79
Y0001002 Tetracaine for system suitability
2 mg
0057
Yes
+5C 3C
79
T0550000 Tetracosactide
0.366 mg
366 g per vial of CHNOS
0644
Yes
-20C 5C
79
T0600000 Tetracycline hydrochloride
100 mg
97.1% CHClNO ; Batch 2 is valid until 31 December 2013
0173,0198,0
199,
0210,0211,1
654
Yes
+5C 3C
79
Y0001165 Tetrandrine
20 mg
99.7% CHNO
+5C 3C
79
Y0000015 Tetrazepam - reference spectrum
n/a
79
Y0000008 Tetrazepam impurity C
20 mg
+5C 3C
79
Y0000460 Tetryzoline hydrochloride
10 mg
+5C 3C
79
Y0000723 Thebaine - * narc
15 mg
+5C 3C
79
T0700000 Theobromine
100 mg
0298
+5C 3C
79
T0800000 Theophylline
100 mg
0300,0301
+5C 3C
79
Y0000294 Theophylline - reference spectrum
n/a
0299,0302
79
Y0000336 Thiamazole
125 mg
0884,1706
+5C 3C
79
Y0000372 Thiamazole impurity A
15 mg
2,2-dimethoxy-N-methylethanamine
1706
Y0000373 Thiamazole impurity C
20 mg
1-methyl-2-(methylsulphanyl)-1H-imidazole ; Batch 1 is valid until 31 August
2013
1706
Y0000467 Thiamine hydrochloride
10 mg
Council of Europe, all rights reserved 2014
2478
1738
7-chloro-5-cyclohexyl-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one
1738
2101
1839,1841
99.5% CHNO
0303
77
Yes
Yes
+5C 3C
79
+5C 3C
79
+5C 3C
79
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0000059 Thiamine impurity E
Effective from 2014/1/2
Batch n Quantity Sale
Information
per vial Unit
2
10 mg
1 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4methylthiazol-2(3H)-thione
Y0000060 Thiamine nitrate
n/a
Monograph Leaflet
Storage
Extra
Price
charges
79
a
0303,0531
+5C 3C
0531
+5C 3C
79
+5C 3C
79
+5C 3C
79
T1100000 Thiamphenicol
125 mg
Y0000546 Thioctic acid
110 mg
0109
Y0000592 Thioctic acid for system suitability
10 mg
1648
+5C 3C
79
Y0000545 Thioctic acid containing impurity B
30 mg
1648
+5C 3C
79
Y0000109 Thiomersal
30 mg
1625
+5C 3C
79
T1200000 Thiopental
500 mg
0212
+5C 3C
79
Y0001478 Thiopental for system suitability
10 mg
0212
+5C 3C
79
Y0000704 Thioridazine
10 mg
2005
+5C 3C
79
+5C 3C
79
+5C 3C
79
1648
99.8% CHOS
Yes
Yes
T1300000 Thioridazine hydrochloride
100 mg
0586
Y0000541 Thioridazine for system suitability
0.21 mg
0586, 2005
T1305100 Thioxanthene
20 mg
1347
+5C 3C
79
T1305000 Thioxanthone
10 mg
1347
+5C 3C
79
T1340000 Threonine
50 mg
0785,1049
+5C 3C
79
T1350000 Thymol
50 mg
0791
+5C 3C
79
Yes
T1410000 Tiabendazole
50 mg
Y0000414 Tiamulin for peak identification
10 mg
Batch 1 is valid until 30 November 2013
0866
Y0000333 Tiamulin hydrogen fumarate
500 mg
98.6% CHNOS
Y0000379 Tiamulin - reference spectrum
n/a
1660
Y0000151 Tianeptine sodium - reference spectrum
n/a
2022
Y0000152 Tianeptine for system suitability
30 mg
2022
+5C 3C
Y0000153 Tianeptine impurity A
20 mg
2022
+5C 3C
79
T1405000 Tiapride hydrochloride
60 mg
1575
+5C 3C
79
T1405050 Tiapride N-oxide
20 mg
1575
+5C 3C
79
T1410900 Tiaprofenic acid
50 mg
1157
+5C 3C
79
1157
+5C 3C
79
79
ethyl 7-bromoheptanoate
+5C 3C
79
1659
Yes
+5C 3C
79
1659,1660
Yes
+5C 3C
79
79
79
79
T1410910 Tiaprofenic acid impurity C
20 mg
Y0000748 Tibolone - reference spectrum
n/a
Y0000668 Tibolone for system suitability
10 mg
1739
Yes
+5C 3C
79
Y0000465 Ticarcillin monosodium
250 mg
93.2% CHNNaOS
Correction factor 1.054
0956
Yes
+5C 3C
79
T1420010 Ticarcillin impurity A
50 mg
89.8% CHNOS; (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[[(thiophen-3-yl)
acetyl]-amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(decarboxyticarcillin)
0956
+5C 3C
79
T1423000 Ticlopidine hydrochloride
50 mg
1050
+5C 3C
79
T1423025 Ticlopidine impurity F
10 mg
1050
+5C 3C
79
Council of Europe, all rights reserved 2014
(2RS)-2-(5-benzoylthiophen-3-yl)propanoic acid
1739
6-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine
78
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Effective from 2014/1/2
Order
Reference Standard
Batch n Quantity Sale
Code
per vial Unit
Y0000325 Tilidine hydrochloride hemihydrate - reference spectrum
1
n/a
1
Information
Monograph Leaflet
1767
T1450000 Timolol maleate
100 mg
Y0000644 (R)-timolol
20 mg
Y0001270 Timolol for system suitability
5.045 mg
0572
T1470000 Tinidazole
100 mg
1051
Y0000899 Tinidazole impurity A
15 mg
2-methyl-5-nitro-1H-imidazole
T1471000 Tinidazole impurity B
20 mg
1-[2-(ethylsulphonyl)ethyl]-2-methyl-4-nitro-1H-imidazole
Batch 1 is valid until 30 November 2013
Extra
Price
charges
79
l
0572
+5C 3C
79
0572
+5C 3C
79
+5C 3C
79
+5C 3C
79
1051
+5C 3C
79
1051
+5C 3C
79
+5C 3C
79
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
T1490000 Tinzaparin sodium
250 mg
0828
Y0000292 Tioconazole - reference spectrum
n/a
2074
Y0000282 Tioconazole for system suitability
50 mg
2074
Y0001188 Tiotropium bromide monohydrate
10 mg
2420
Y0001189 Tiotropium for system suitability
10 mg
2420
Y0001179 Tiotropium impurity mixture
0.08 mg
2420
New Y0001216 Tiotropium impurity F
Storage
Yes
Yes
Yes
15 mg
dithiophen-2-ylmethanone ; Batch 1 is valid until 31 May 2014
2420
+5C 3C
79
T1500000 Tobramycin
49 mg
49 mg per vial of CHNO; Suitable for LC assay only
0645
Yes
+5C 3C
79
Y0000383 All-rac-alpha-tocopherol for peak identification
50 mg
Batch 1 is valid until 31 August 2013
0692
Yes
+5C 3C
79
Y0000384 All-rac-alpha-tocopheryl acetate for peak identification
30 mg
0439
Yes
+5C 3C
79
T1550000 alpha-Tocopherol
500 mg
97,7% CHO ; Vitamin E ; Batch 6 is valid until 31 December 2013
0692,1256,2
0432
Yes
+5C 3C
79
T1600000 alpha-Tocopheryl acetate
500 mg
98.8% CHO ; Batch 8 is valid until 28 February 2014
0439,0691,1
257
Yes
+5C 3C
79
Y0001210 Tobramycin for identification
250 mg
Suitable for identification tests only
+5C 3C
79
T1610000 RRR-alpha-Tocopheryl hydrogen succinate
150 mg
98.6% CHO
+5C 3C
79
0645
1258,1259
Yes
T1700000 Tolbutamide
100 mg
0304
+5C 3C
79
Y0000154 Tolfenamic acid
100 mg
2039
+5C 3C
79
T1707000 Tolnaftate
60 mg
1158
+5C 3C
79
Y0001123 Tolnaftate for system suitability
10 mg
1158
+5C 3C
79
Y0000461 Torasemide anhydrous
10 mg
2132
+5C 3C
79
Y0001366 Torasemide impurity E
0.0006 mg
2132
+5C 3C
79
Y0000462 Torasemide for system suitability
5 mg
2132
+5C 3C
79
Y0000155 Tramadol hydrochloride
75 mg
1681
+5C 3C
79
Y0000156 Tramadol impurity A
25 mg
(1RS,2SR)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)-cyclohexanol ;
Batch 3 is valid until 31 January 2013
1681
+5C 3C
79
Y0000157 Tramadol impurity E
15 mg
(2RS)-2-[(dimethylamino)methyl]cyclohexanone
1681
+5C 3C
79
Y0000072 Tramazoline hydrochloride monohydrate
20 mg
1597
+5C 3C
79
Y0000065 Tramazoline impurity A
15 mg
+5C 3C
79
Council of Europe, all rights reserved 2014
ethyl [[4-[(3-methylphenyl)amino]pyridin-3-yl]sulfonyl]carbamate
N-(naphthalen-1-yl)-4,5-dihydro-1H-imidazol-2-amine ; Batch 1 is valid until
31 August 2013
79
1597
Yes
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0000066 Tramazoline impurity B
Effective from 2014/1/2
Batch n Quantity Sale
Information
per vial Unit
1
10 mg
1 75% CHNO; Mixture of 1-acetyl-N-(5,6,7,8-tetrahydronaphthalen-1yl)-4,5-dihydro-1H-imidazol-2-amine and 1-[(EZ)-1-[(5,6,7,8tetrahydronaphthalen-1-yl)imino]ethyl]imidazolidin-2-one
Monograph Leaflet
1597
Storage
+5C 3C
Extra
Price
charges
79
g
Y0000501 Trandolapril
10 mg
2245
+5C 3C
79
Y0000495 Trandolapril impurity C
10 mg
(2S,3aR,7aS)-1-[(2S)-2-[[(1S)-3-cyclohexyl-1-(ethoxycarbonyl)propyl]amino]
propanoyl]octahydro-1H-indole-2-carboxylic acid (hexahydrotrandolapril)
2245
+5C 3C
79
Y0000496 Trandolapril impurity D
10 mg
ethyl (2S)-2-[(3S,5aS,9aR,10aS)-3-methyl-1,4-dioxodecahydro
pyrazino[1,2-a]indol-2(1H)-yl]-4-phenylbutanoate (trandolapril
diketopiperazine)
2245
+5C 3C
79
T1810000 Tranexamic acid
50 mg
0875
+5C 3C
79
T1820000 Trapidil
50 mg
1576
+5C 3C
79
T1820002 Trapidil impurity A
20 mg
5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-ol
1576
+5C 3C
79
T1820004 Trapidil impurity B
20 mg
1,2,4-triazol-3-amine
1576
+5C 3C
79
Y0001172 Trehalose dihydrate
250 mg
89.8% CHO,2HO
+5C 3C
79
T1850000 Tretinoin
50 mg
0693,1019,1
385
+5C 3C
g(b)
79
T1899000 3,4,6-Tri-O-acetyl-D-glucal - reference spectrum
n/a
1325
79
G0400010 Triacetin - reference spectrum
n/a
1106
T1899990 Triamcinolone
150 mg
1376
T1900000 Triamcinolone acetonide
150 mg
Y0001459 Triamcinolone acetonide for system suitability
10 mg
T1950000 Triamcinolone hexacetonide
100 mg
Y0000050 Triamcinolone impurity C
10 mg
Y0000837 Triamterene
10 mg
Y0000870 Triamterene impurity B
0.5 mg
Y0000279 Tri-n-butyl phosphate
300 l
Y0001113 Triolein
30 mg
T1975000 Triazolam - * psy
10 mg
Y0000165 Tribenoside
150 mg
98.3% CHO ; Batch 1 is valid until 31 August 2013
1740
Yes
Y0000166 Tribenoside impurity A
70 mg
90.3% CHO; 3,5,6-tri-O-benzyl-1,2-O-(1-methylethylidene)-alpha-Dglucofuranose ; Batch 3 is valid until 1 May 2013
1740
Yes
Y0001628 Tribenoside impurity D
35 mg
Benzyl ether
1740
Y0001055 Tributyl acetylcitrate
1 mL
1770
Y0000799 Tributyl acetylcitrate for peak identification
25 mg
1770
T1977990 Tricaprin
150 mg
T1977995 Tricaproin
40 mg
T1978000 Tricaprylin
225 mg
Council of Europe, all rights reserved 2014
2297
Yes
Yes
79
+5C 3C
79
0533,0867,1
075
Yes
+5C 3C
79
0533
Yes
+5C 3C
79
0533,0867
+5C 3C
79
1376
+5C 3C
79
0058
+5C 3C
79
+5C 3C
79
+5C 3C
79
-20C 5C
79
+5C 3C
79
+5C 3C
79
-20C 5C
g(c)
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
1410
-20C 5C
79
1410
-20C 5C
79
1410
-20C 5C
79
98.6% CHFO
9-fluoro-11,16alpha,17,21-tetrahydroxypregn-4-ene-3,20-dione
0058
2,7-diamino-6-phenylpteridin-4-ol
Yes
1682
2454
98.7 % CHO
Yes
1065
80
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0000111 Trichloroacetic acid - reference spectrum
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
n/a
1
Information
Monograph Leaflet
1967
T1985000 Trichlorotrifluoroethane
2.5 ml
0393
T1986000 Triethyl citrate - reference spectrum
n/a
1479
T2000000 Trifluoperazine hydrochloride
100 mg
0059,20303
T2005000 Triflusal
50 mg
1377
T2005010 Triflusal impurity B
25 mg
Y0000720 Triglycerol diisostearate
200 mg
Y0000108 Trihexyphenidyl hydrochloride
100 mg
Y0000068 Trihexyphenidyl impurity A
20 mg
Storage
2-hydroxy-4-(trifluoromethyl)benzoic acid
1-phenyl-3-(piperidin-1-yl)propan-1-one
Yes
+5C 3C
Extra
Price
charges
79
l
g
79
79
+5C 3C
79
+5C 3C
79
1377
+5C 3C
79
2032
+5C 3C
79
1626
+5C 3C
79
1626
+5C 3C
79
T2009000 Trilaurin
1250 mg
1410
-20C 5C
79
Y0001319 Trimebutine maleate
10 mg
2182
+5C 3C
79
Y0001260 Trimebutine for system suitability
1.017 mg
2181,2182
+5C 3C
79
Y0000092 Trimetazidine dihydrochloride - reference spectrum
n/a
1741
79
New Y0000093 Trimetazidine for system suitability
Yes
50 mg
Batch 2 is valid until 31 May 2014
1741
+5C 3C
79
T2100000 Trimethadione
250 mg
100% CHNO
0440
+5C 3C
79
Y0001497 3-Trimethylsilyl-1-propanesulfonic acid sodium salt
120 mg
91.8 % CHOSSi,Na
T2200000 Trimethoprim
50 mg
Y0000684 Trimethoprim for system suitability
T2200010 Trimethoprim impurity B
15 mg
T2450000 Trimethyltetradecylammonium bromide
200 mg
T2500000 Trimipramine maleate
100 mg
Y0000759 Trimipramine for peak identification
T2500100 Trimyristin
T2501200 Tristearin
T2545000 Trolamine
+5C 3C
79
0060
+5C 3C
79
Batch 2 is valid until 31 January 2013
0060
+5C 3C
79
(2,4-diaminopyrimidin-5-yl)(3,4,5-trimethoxyphenyl)methanone
0060
+5C 3C
79
0378
+5C 3C
79
0534
+5C 3C
79
0.51 mg
0534
+5C 3C
79
500 mg
1410
-20C 5C
79
100 mg
1410
-20C 5C
79
2250 mg
Batch 2 is valid until 31 August 2013
1577
+5C 3C
79
Y0001184 Trolamine impurity A
250 mg
Ethanolamine
1577
+5C 3C
79
Y0001183 Trolamine impurity B
1 ml
Diethanolamine
1577
+5C 3C
79
T2550000 Trometamol
100 mg
T2580000 Tropicamide
50 mg
Batch 1 is valid until 28 February 2014
Y0001247 Tropicamide impurity C
10 mg
Y0001248 Tropicamide impurity D
10 mg
Y0001316 Tropicamide for peak identification
10 mg
Y0000616 Tropisetron hydrochloride
40 mg
Y0000618 Tropisetron impurity B
10 mg
T2580300 Tropine
50 mg
Y0000429 Trospium chloride
10 mg
Council of Europe, all rights reserved 2014
0.00075 mg 1
2645, 2165
Yes
Yes
1053
+5C 3C
79
1159,1197
+5C 3C
79
(2RS)-3-hydroxy-2-phenylpropanoic acid (tropic acid)
1159
+5C 3C
79
Phenylacetic acid
1159
+5C 3C
79
1159
+5C 3C
79
2102
+5C 3C
79
2102
+5C 3C
79
1308
+5C 3C
79
1798
+5C 3C
79
1H-indole-3-carboxylic acid
81
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0000432 Trospium impurity A
Y0000431 Trospium impurity B
Effective from 2014/1/2
Batch n Quantity Sale
Information
per vial Unit
1
20 mg
1 hydroxydiphenylacetic acid (benzilic acid)
2
20 mg
1 (1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl hydroxydiphenylacetate
Y0000430 Trospium impurity C
Y0000497 Troxerutin
T2600000 Trypsin BRP
Monograph Leaflet
+5C 3C
1798
+5C 3C
79
1798
+5C 3C
79
30 mg
100 mg
T2610000 Tryptophan
100 mg
T2880000 Tylosin
150 mg
T2880100 Tylosin D
5 mg
1273,1274,1
661
Y0000498 Tylosin phosphate for peak identification
10 mg
1273,1274,1
661
T2880200 Tylosin tartrate - reference spectrum
n/a
T2900000 Tyrosine
50 mg
2133
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
1578
+5C 3C
79
1578
+5C 3C
79
0476,0579,0
580, 0694
0.707 microkatal per mg
Yes
1272
1273,1274,1
661, 20702
1025 IU per mg ; Batch 1 is valid until 31 August 2013
Yes
Yes
1274
0782,0895,1
161,
1272,1384
Batch 1 is valid until 30 November 2013
Extra
Price
charges
79
a
1798
5 mg
(1R,3r,5S)-3-hydroxyspiro[8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium]
Storage
T3000000 Tyrothricin
20 mg
U0020000 Ubidecarenone
50 mg
U0020001 Ubidecarenone for system suitability
1 mg
U0020008 Ubidecarenone impurity D
5 mg
U0100000 Uracil arabinoside
60 mg
0760
+5C 3C
79
U0600000 Urea
100 mg
0743
+5C 3C
79
U0800000 Ursodeoxycholic acid
100 mg
+5C 3C
79
Y0001163 Ursodeoxycholic acid for system suitability
1.26 mg
Batch 1 is valid until 1 May 2013
1275
Yes
+5C 3C
79
Y0000834 Valaciclovir hydrochloride (anhydrous)
100 mg
96.5% CHNOCl
1768
Yes
+5C 3C
79
Y0001523 Ursolic acid
25 mg
94.0 % CHO
2439
Yes
+5C 3C
79
Y0001225 Valaciclovir for system suitability
10 mg
1768
Yes
+5C 3C
79
Y0001096 Valaciclovir impurity D
10 mg
2-[(2-amino-6-oxo-1,6dihydro-9H-purin-9-yl)methoxy]ethyl N-ethyl-L-valinate
1768
+5C 3C
79
Y0001097 Valaciclovir impurity E
10 mg
2-[(2-amino-6-oxo-1,6dihydro-9H-purin-9-yl)methoxy]ethyl N-[(benzyloxy)
carbonyl]-L-valinate
1768
+5C 3C
79
Y0001098 Valaciclovir impurity F para-toluenesulfonate
12 mg
2-hydroxyethyl L-valinate
1768
+5C 3C
79
Y0001099 Valaciclovir impurity G
10 mg
N,N-dimethylpyridin-4-amine
1768
+5C 3C
79
New Y0001662 Valaciclovir impurity P
5 mg
1768
+5C 3C
79
New Y0001655 Valaciclovir impurity S
15 mg
2751
+5C 3C
79
400 mg
Y0000583 Valerian standardised dry extract
Council of Europe, all rights reserved 2014
0907,1662
Yes
1578
Batch 1 is valid until 1 June 2013
5,6-dimethoxy-3-methyl-2-[(all-E)-3,7,11,15,19,23,27,31,35nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaenyl]benzene-1,4dione
1189,1275
0.43 % of CHO
82
79
0453,1898,1 Yes
-20C 5C
c
899,2400,25
26
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Code
V0030000 Valine
Reference Standard
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
50 mg
1
Y0000584 Valnemulin hydrochloride
Y0000533 Valnemulin hydrogen tartrate
Y0000585 Valnemulin for peak identification
Information
Monograph Leaflet
+5C 3C
2137
+5C 3C
79
+5C 3C
79
+5C 3C
79
2137
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
120 mg
10.25 mg
Y0000586 Valnemulin impurity E
10 mg
V0033000 Valproic acid
100 mg
1378
Y0001422 Valproic acid for system suitability
10 mg
0678,1378
Y0001132 Valsartan
10 mg
2423
Y0001131 Valsartan for peak identification
10 mg
Y0001145 Valsartan for system suitability
0.202 mg
Batch 1 is valid until 31 August 2013
V0045000 Vancomycin hydrochloride
100 mg
102000 IU per vial
V0050000 Vanillin
100 mg
0747
Y0001198 Varicella vaccine ( live)
420 mg
0648
Y0000561 Vecuronium bromide
10 mg
1769
Y0000625 Vecuronium for peak identification
10 mg
1769
Y0001093 Vedaprofen
5 mg
2248
Y0001118 Vedaprofen impurity mixture
0.006 mg
2248
Y0000587 Venlafaxine hydrochloride
50 mg
2119
Y0000588 Venlafaxine for system suitability
1.002 mg
V0100000 Verapamil hydrochloride
100 mg
V0100018 Verapamil impurity I
5 mg
(2RS)-2-(3,4-dimethoxyphenyl)-2-[2-[[2-(3,4-dimethoxy-phenyl)ethyl]
(methyl)amino]ethyl]-3-methylbutanenitrile hydrochloride
V0100026 Verapamil impurity M
10 mg
5,5'-[[2-(3,4-dimethoxyphenyl)ethyl]imino]bis[2-(3,4-dimethoxyphenyl)-2-(1methylethyl)pentanenitrile]
Y0000661 Verbenalin
11 mg
0.97 mg per vial of CHO
V0180000 VERO cells
1 ml
Cell lines (kidney, african green monkey, Cercopithecus aethiops) titration of
live measles, mumps and rubella vaccines
Y0001400 Vigabatrin
10 mg
Y0001401 Vigabatrin impurity A
25 mg
94.7% CHNO; (5RS)-5-ethenylpyrrolidin-2-one
2305
Y0001402 Vigabatrin impurity B
20 mg
(2E)-2-(2-aminoethyl)but-2-enoic acid
2305
Y0001404 Vigabatrin impurity D
50 mg
4-aminobutanoic acid
Y0001403 Vigabatrin impurity E
10 mg
2-[(2RS)-2-aminobut-3-enyl]propanedioic acid
V0300000 Vinblastine sulfate
5.01 mg
5.01 mg per vial of CHNOS
V0305000 Vinblastine sulfate - reference spectrum
n/a
V0400000 Vincristine sulfate
4.96 mg
Council of Europe, all rights reserved 2014
2137
2137
(3aS,4R,5S,6S,8R,9R,9aR,10R)-6-ethenyl-5-hydroxy-4,6,9,10-tetramethyl-1oxodecahydro-3a,9-propano-3aH-cyclopenta[8]annulen-8-yl 2-hydroxyacetate
(pleuromulin)
Yes
Yes
2423
Yes
+5C 3C
79
2423
Yes
+5C 3C
79
1058,20702
Yes
-20C 5C
79
+5C 3C
79
-80C 10C
90
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
2119
+5C 3C
79
0573
+5C 3C
79
0573
+5C 3C
79
0573
+5C 3C
79
Yes
Yes
Yes
1854
Yes
+5C 3C
79
0213,0538,1
057
Yes
Liquid nitrogen
100
+5C 3C
79
-20C 5C
79
+5C 3C
79
2305
+5C 3C
79
2305
+5C 3C
79
-80C 10C
g(d)
79
79
79
2305
0748,0749
Yes
Yes
0748
4.98 mg per vial of CHNOS
83
Extra
Price
charges
79
a
0770,0771,0
796
10 mg
98.7% CHNOS
Storage
0748,0749
Yes
-80C 10C
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
V0405000 Vincristine sulfate - reference spectrum
Effective from 2014/1/2
Batch n Quantity Sale
per vial Unit
1
n/a
1
Information
Monograph Leaflet
Storage
0749
V0500000 Vindesine sulfate
5 mg
V0500010 Vindesine sulfate - reference spectrum
n/a
Y0000463 Vinorelbine tartrate
50 mg
Y0000464 Vinorelbine impurity B
7 mg
Y0000589 Vinpocetine
10 mg
Y0000590 Vinpocetine impurity A
10 mg
(12RS,13aSR,13bSR)-13a-ethyl-12-hydroxy-2,3,5,6, 12,13,13a,13boctahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12carboxylate (ethyl vincaminate)
Y0000591 Vinpocetine impurity B
10 mg
Y0000790 Vinpocetine impurity C
10 mg
Y0000760 Vinpocetine impurity D
Y0000793 Vinyl acetate
Y0001395 Voriconazole
5.19 mg per vial of CHNOS ; Batch 2 is valid until 24 April 2013
1276
Yes
-80C 10C
1276
Extra
Price
charges
79
l
g(d)
79
79
2107
-80C 10C
g(d)
79
2107
-80C 10C
g(d)
79
2139
+5C 3C
79
2139
+5C 3C
79
(13aS,13bS)-13a-ethyl-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1-de]pyrido
[3,2,1-ij][1,5]naphthyridine-12-carboxylate (apovincamine)
2139
+5C 3C
79
ethyl (13aS,13bS)-13a-ethyl-9-methoxy-2,3,5,6,13a,13b-hexahydro-1Hindolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
(methoxyvinpocetine)
2139
+5C 3C
79
10 mg
(12RS,13aRS,13bRS)-13a-ethyl-2,3,5,6,12,13,13a,13b-octahydro-1H-indolo
[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
(dihydrovinpocetine)
2139
+5C 3C
79
200 mg
+5C 3C
79
120 mg
100% CHFNO
2576
+5C 3C
79
Y0001396 Voriconazole impurity B
10 mg
(2RS,3SR)-2-(2,4-difluorophenyl)-3-pyrimidin-4-yl-1-(1H-1,2,4-triazol-1-yl)
butan-2-ol
2576
+5C 3C
79
Y0001398 Voriconazole impurity D
10 mg
(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4triazol-1-yl)butan-2-ol (epi-voriconazole)
2576
+5C 3C
79
Y0001397 Voriconazole impurity E
50 mg
[(1R,4S)-7,7-dimethyl-2-oxobicyclo[2.2.1]hept-1-yl]methanesulfonic acid
((+-)-camphorsulfonic acid)
2576
+5C 3C
79
4-O-deacetylvinorelbine
Yes
2152,2523
Yes
W0100000 Warfarin sodium
10 mg
0698,0699
+5C 3C
79
Y0000778 Warfarin sodium clathrate
10 mg
0699
+5C 3C
79
Y0001599 Wedelolactone
15 mg
2564
-20C 5C
79
X0075000 Xylazine hydrochloride
125 mg
1481
+5C 3C
79
Y0000158 Xylazine impurity C
50 mg
2,6-dimethylphenyl isothiocyanate
1481
+5C 3C
79
Y0000159 Xylazine impurity E
15 mg
87.5% CHNS ; methyl (2,6-dimethylphenyl)carbamodithioate
1481
Yes
+5C 3C
79
Y0001224 Xylazine impurity mixture
0.02 mg
1481
Yes
+5C 3C
79
500 mg
1381
Yes
+5C 3C
79
X0100000 Xylometazoline hydrochloride
100 mg
0972,1162
+5C 3C
79
X0101000 Xylometazoline impurity A
10 mg
1162
+5C 3C
79
X0200000 Xylose
100 mg
+5C 3C
79
Y0000656 Yohimbine hydrochloride
20 mg
99.1% CHClNO
2172
+5C 3C
79
Z1900000 Zidovudine
60 mg
99.5% CHNO
1059
+5C 3C
79
10 mg
+5C 3C
79
New X0080000 Xylitol
New Y0001641 Zidovudine for system suitability
Council of Europe, all rights reserved 2014
See leaflet ; Batch 1 is valid until 30 April 2014
N-(2-aminoethyl)-2-(4-1,1-dimethylethyl-2,6-dimethylphenyl) acetamide
Yes
1278
1059
84
Yes
Yes
For extra charges, please see supply terms and conditions.
List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Z1902000 Zidovudine impurity A
Effective from 2014/1/2
Batch n Quantity Sale
Information
per vial Unit
2
10 mg
1 1-[(2,5)-5-hydroxymethyl-2,5-dihydro-2-furyl]-5-methyl pyrimidine-2,4
(1,3)-dione
Monograph Leaflet
Storage
1059
+5C 3C
Extra
Price
charges
79
a
Z1904000 Zidovudine impurity B
15 mg
1-(3-chloro-2,3-dideoxy--D-ribofuranosyl)-5-methylpyrimidine-2,4(1,3)dione
1059
+5C 3C
79
New Y0001654 Zidovudine impurity D
15 mg
Triphenylmethanol / Trityl alcohol / Triphenylcarbinol
1059
+5C 3C
79
Z2000000 Zinc acexamate
50 mg
1279
+5C 3C
79
Z2000010 Zinc acexamate impurity A
50 mg
6-[[6-(acetylamino)hexanoyl]amino]hexanoic acid
1279
+5C 3C
79
Y0001286 Ziprasidone hydrochloride monohydrate
100 mg
95.6% CHClNOS
+5C 3C
79
30 mg
2648
+5C 3C
79
New Y0001626 Ziprasidone mesylate trihydrate
2421,2649
Yes
Y0001272 Ziprasidone for system suitability 1
10 mg
2421
Yes
+5C 3C
79
Y0001241 Ziprasidone for system suitability 2
0.465 mg
2421
Yes
+5C 3C
79
Z2500000 Zolpidem tartrate - * psy
200 mg
1280
+5C 3C
79
Z2500010 Zolpidem impurity A
10 mg
N,N'-dimethyl-2-[7-methyl-2-(4-methylphenyl)imidazol[1,2-a] pyridin-3-yl]
acetamide
1280
+5C 3C
79
Z3000000 Zopiclone -* psy
40 mg
Batch 1 is valid until 31 January 2013
1060
+5C 3C
79
Z3001000 Zopiclone oxide
20 mg
Batch 2 is valid until 1 April 2013
1060
+5C 3C
79
Y0000062 Zuclopenthixol decanoate - reference spectrum
n/a
79
Y0000534 Zuclopenthixol for system suitability
0.26 mg
+5C 3C
79
Y0000083 Zuclopenthixol impurity B
10 mg
+5C 3C
79
Council of Europe, all rights reserved 2014
1707
1707
2-chloro-9H-thioxanthen-9-one
85
1707
Yes
For extra charges, please see supply terms and conditions.
You might also like
- List of European Pharmacopeia StandardsNo ratings yetList of European Pharmacopeia Standards88 pages
- USP Daily Reference Standards Catalog: Catalog # Product Description Current Lot Unit Price Previous LotNo ratings yetUSP Daily Reference Standards Catalog: Catalog # Product Description Current Lot Unit Price Previous Lot87 pages
- European Pharmacopoeia 6 0 Vol 1 Evropeyskaya Farmakopeya 6 PDFNo ratings yetEuropean Pharmacopoeia 6 0 Vol 1 Evropeyskaya Farmakopeya 6 PDF1,129 pages
- USP Reference Standards Catalog: Last Updated On: August 21, 2019No ratings yetUSP Reference Standards Catalog: Last Updated On: August 21, 2019426 pages
- USP-Ref-Substances & Authentic SubstancesNo ratings yetUSP-Ref-Substances & Authentic Substances113 pages
- The Technical Basis LLC: Tom FitzsimmonsNo ratings yetThe Technical Basis LLC: Tom Fitzsimmons4 pages
- 101 Useful Websites for Tech EnthusiastsNo ratings yet101 Useful Websites for Tech Enthusiasts3 pages
